Structural and functional studies into branchpoint sequence recognition and the U4/U6 di-Snrnp in cyanidioschyzon merolae by Black, Corbin (author) et al.
 
STRUCTURAL AND FUNCTIONAL STUDIES INTO BRANCHPOINT 
SEQUENCE RECOGNITION AND THE U4/U6 DI-SNRNP IN 
CYANIDIOSCHYZON MEROLAE 
 
 
by 
 
 
Corbin Black 
 
B.Sc., University of Northern British Columbia, 2014 
 
 
 
 
 
 
 
 
 
 
 
THESIS SUBMITTED IN PARTIAL FULFILLMENT OF 
THE REQUIREMENTS FOR THE DEGREE OF 
MASTER OF SCIENCE 
IN 
BIOCHEMISTRY 
 
 
 
 
 
 
 
 
 
 
 
UNIVERSITY OF NORTHERN BRITISH COLUMBIA 
 
July 2018 
 
 
© Corbin S. Black, 2018 
 
!! II 
Abstract 
Pre-mRNA splicing ensures mRNA transcripts contain contiguous coding 
sequences prior to protein synthesis. 5’ splice site recognition of pre-mRNA is unknown 
in Cyanidioschyzon merolae, because it lacks the U1 snRNP. Conservation among the 
core splicing proteins is low, and there is potential for novel adaptations. Similar to yeast, 
branchpoint sequence recognition appears driven by Msl5 and stabilized by Mud2. 
Electrophoretic mobility assays showed Msl5, with its canonical KH-QUA2 domain, 
specifically binds to the conserved branchpoint sequence. Mud2 is a novel 
ScMud2/U2AF65 homolog. Conversely, U4/U6 di-snRNP assembly appears conserved. 
Fluorescence polarization assays with the U4 5’ stem loop and the crystal structure of 
Snu13 revealed a conserved interaction. Snu13 and the Sm heptamer were able to bind 
base-paired U4/U6. Finally, circular dichroism spectroscopy and in silico mapping of 
intrinsic disorder found several proteins were partially unstructured; this would allow a 
minimal spliceosome to functionally fulfill the roles of otherwise necessary proteins. 
 
 
 
 
 
 
 
 
 
!! III 
Table of Contents 
Abstract                                                          II 
Table of Contents                                              III 
List of Tables                                                              VI 
List of Figures                                                                                              IX 
List of Equations                                              XIII 
Acknowledgements                                                                      XIV 
Table of Abbreviations                                                                                                     XV 
References                                                           i 
Chapter 1: Introduction                         
1.1  Pre-mRNA Splicing and the Spliceosome.                                             1 
1.2  Cyanidioschyzon merolae as a Model Organism.                                            3 
1.3  Initiation of Pre-mRNA Splicing.                                              5 
1.4  Bridging the Branchpoint Sequence to the 5’ Splice Site.                                           7 
1.5  The Branchpoint Bridging Protein Msl5 and U2 Auxiliary                                                 8 
 Factor Mud2.             
1.6  U4/U6 Di-snRNP in Pre-mRNA Splicing.                                           11 
1.7  Snu13 In di-snRNP Assembly.                                             15 
1.8  Research Goals.                                               16 
Chapter 2: Recognition of the pre-mRNA branch site by Msl5     
2.1  Methods – Expression and Purification of C. merolae Msl5                                               18 
            and Mud2 Proteins.   
2.2  Methods – Flouorescence Polarization of Msl5 Against                                         26 
       Branchpoint RNA.         
2.3  Methods – In vitro Transcription of Truncated Cm 072C RNA.                                                    29 
!! IV 
2.4 Methods – EMSAs of Msl5 with Various RNA.                                           33 
2.5 Methods - Circular Dichroism Spectroscopy of Msl5 with Cm                                         34 
      BPS RNA.     
2.6  Results and Discussion.                                              36 
Chapter 3: Functional and Structural Characterization of Snu13   
3.1  Methods - Expression and Purification of C. merolae                               74 
       Snu13 Protein.            
3.2  Methods - Fluorescence Polarization of Purified Snu13.                                                77 
3.3  Methods - Bioinformatics and Structural Modeling.                                                   78 
3.4  Methods - X-ray Crystallography of Snu13.                                                78 
3.5  Results and Discussion.                                                                            79 
Chapter 4: Assembly of the Cm U4/U6 di-snRNP 
4.1  Methods – Preparation of Proteins Used in U4/U6                                                           97 
       di-snRNP Assembly.  
4.2  Methods – In vitro Transcription of Cm U4 and U6 snRNA.                                                       98 
4.3  Methods – Assembly of the U4/U6 di-snRNP.                                                         100 
4.4  Methods – Recombinant Expression of Cm Proteins Prp3,                                                102 
       Prp4, and Prp31. 
4.5  Methods – Protein Disorder Predictions.                                                          110 
4.6  Results and Discussion.                                                      110 
Chapter 5: General Discussion and Conclusion                                        
5.1  Improving the yield of the Msl5/Mud2 dimer.                                        126 
5.2  Role of the branchpoint bridging protein Msl5.                                                    126 
5.3  Bridge between Msl5 and the 5’ splice site.                                                   127 
5.4  Role of the U2 Auxiliary Factor Mud2 in C. merolae.                                       128 
!! V 
5.5    Displacement of Msl5/Mud2 from the pre-mRNA.                                                  129 
5.6    Prp4 connects Snu13 and the 5’ Stem Loop with Stem II.                                      129 
5.7    Assembly of the U4/U6 di-snRNP.                                                               130 
5.8    Chaperones and solubility factors of thermophilic organisms.                                      130 
5.9    Intrinsically disordered regions and splicing proteins.                                                  131 
5.10  Conclusion.                                                                             132 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
!! VI 
List of Tables 
Table 1.1    Common names for the branchpoint bridging protein and                                 9 
       U2 auxiliary factors in various model organisms.        
 
Table 2.1    DNA primers used in the subcloning of Msl5 and Mud2                               19 
       genes into pQLinkH plasmid vector. 
Table 2.2    Composition of buffers used in the Ni-NTA purification                                      22  
       of recombinant Msl5 and co-expressed Mud2/Msl5 from  
       Rosetta pLysS (DE3) cells.  
 
Table 2.3    Composition of buffers used in the cation exchange                                       24    
                   chromatography purification of recombinant Msl5. 
Table 2.4    Composition of the buffer used in the size exclusion                                     24   
                   chromatography purification of recombinant  
                   Msl5 and co-expressed Mud2 and Msl5. 
Table 2.5    Reagents used in the detection of Msl5 in purified                                                25 
                   Mud2/Msl5 dimer. 
Table 2.6    Fluorescein-labeled RNA oligo probes used in FP                                                 27  
                   Binding Assays. 
Table 2.7    FP reagents used for the binding experiments of Msl5                                         28 
       with BP RNA Probe. 
Table 2.8    Sequences of the Cm 072C transcripts used in binding                                            29 
       experiments with Msl5. 
Table 2.9    Reactions and thermocycler conditions used to                                                      30 
                   generate the DNA template for Cm 072C pre-mRNA  
                   and mRNA. 
 
Table 2.10  PCR primers used to generate Cm 072C DNA templates for                                  30 
                   in vitro transcription and their respective annealing temperatures. 
Table 2.11  Composition of the IVT reactions that generated Cm 072C RNA                       31 
       transcripts. 
Table 2.12  Composition of the 5’ end-labeling reaction with [!-32P]-labeled                            32  
                   ATP.  
Table 2.13  EMSA reagents used for the binding experiments of Msl5                            33 
       with 072C RNA. 
!! VII 
Table 2.14  Parameters used for far UV wavelength scans of Msl5.                                 34 
Table 2.15  Parameters used for thermal denaturation of Msl5.                                         35 
Table 2.16  Ratios for wavelengths 260:280 (nm) of protein and RNA.                           38 
Table 2.17  Binding affinities of Msl5 homologs for the branchpoint                                    49 
       sequence of pre-mRNA. 
Table 2.18. Binding affinities of Msl5 for RNA oligonucleotides                                        52 
                   measured by FP. 
 
Table 2.19  Binding affinities of Msl5 for RNA oligonucleotides                                        54 
       measured by EMSA. 
Table 2.20  Binding affinities of Msl5 for various Cm 072C Nascent                                           62 
                   transcripts.   
Table 2.21  Secondary structure of Msl5 by Circular Dichroism and                                    65 
       predictive software. 
Table 2.22 Dissociation constants and Hill Coefficients for FP binding                                    71 
       assays of the Msl5/Mud2 dimer against the Cm BPS. 
Table 3.1   Primers used to clone Snu13 from the Cm genome into                                         74 
                  pMCSG7.  
Table 3.2   Complete list of the buffers used in the purification of Snu13.                       75 
Table 3.3   Fluorescein-labeled RNA oligonucleotide probes used in FP                          77 
      Binding Assays. 
Table 3.4. FP reagents used for the binding experiments of Msl5 with 6                               77 
     BP RNA probe. 
Table 3.5  UniProt and RCSB Accession numbers for Snu13 homologs.                         78 
Table 3.6. Data collection, phasing, and refinement statistics.                                         85 
Table 3.7  Comparison of Protein-RNA Affinities.                                           94 
Table 4.1  PCR primers used to generate Cm U4 and U6 DNA templates                                98 
      for in vitro transcription and their respective annealing temperatures. 
Table 4.2  Composition of the IVT reactions that generated Cm U4 and U6                 99 
     RNA transcripts. 
!! VIII 
Table 4.3  Sequences of the full-length U4 and U6 snRNA generated from                                      100 
                    IVT. 
Table 4.4  Buffer components used in U4 and U6 snRNA annealing                                          100 
                     reactions. 
Table 4.5  Primers used to modify pQLinkN into pQLinkC, as well as to                               104  
         subclone Cm Prp4 and Prp31 into pQLinkH and C plasmid vectors. 
Table 4.6  Components of the MDG and ZYM-5052 media used in Auto-                                 109 
         Induction. 
Table 4.7  NCBI and UniProt accession numbers of U4/U6 di-snRNP                                110 
                     proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
!! IX 
List of Figures 
Figure 1.1  Pre-mRNA splicing, including the two transesterification                                                  3 
       reactions and snRNP conformational changes. 
Figure 1.2  Pre-mRNA recognition and the Commitment Complex (Complex E).                             6 
Figure 1.3  Model for bridging the branchpoint sequence and 5’ splice site                                7 
                   via U1 and the Msl5 and Mud2 splicing factors. 
 
Figure 1.4  Model for displacement of the Msl5 and Mud2 splicing factors,                                       8 
                           representing the transition to Pre-Spliceosome (Complex A). 
 
Figure 1.5  The U4/U6 di-snRNP.                                                                   13 
Figure 2.1  Expression and affinity purification of Msl5.                                                         37 
Figure 2.2  Cation exchange purification of Msl5.                                                               39 
Figure 2.3  Size exclusion purification of Msl5.                      41 
Figure 2.4  Alignment and predicted domain structures of the Msl5                                      43 
                   against human (SF1) and yeast (BBP) homologs. 
Figure 2.5  The crystal structure of the SF1-U2AF65 complex highlights the                         45 
                   interaction between the ULM and UHM. 
 
Figure 2.6  Predicted structure and domains of Msl5.                                                          47 
Figure 2.7  Simulated RNA folding of the U4 5’ Stem Loop                                            50 
                            (nucleotides 22-50), corresponding to ro52 used in various  
                             binding experiments. 
 
Figure 2.8  Saturation curve from fluorescence polarization measurements                     51 
       of Msl5 titrated against three RNA targets (15 nM). 
Figure 2.9   EMSA measurements of Msl5 binding Cm BPS.                                               53 
Figure 2.10 Saturation curve from EMSA binding assay of Msl5 titrated                           54 
        against two RNA targets (25 nM). 
Figure 2.11 Simulated RNA folding and predicted secondary                                            56 
                    structure of WT pre-mRNA. 
 
Figure 2.12 Simulated RNA folding and predicted secondary structure                             57 
                    of mutant pre-mRNA. 
!! X 
Figure 2.13 Simulated RNA folding and predicted secondary structure                             58 
                           of WT mRNA. 
 
Figure 2.14 EMSA measurement of Msl5 binding the WT 072C pre-                                       59 
                    mRNA transcript. 
 
Figure 2.15 EMSA measurements of Msl5 binding the mutant 072C                                        60 
                    pre-mRNA transcript. 
 
Figure 2.16 EMSA measurements of Msl5 binding the 072C mRNA                                   60 
                    transcript. 
 
Figure 2.17       Saturation curves of CmMsl5 against various 072C RNA                                          61 
        transcripts: WT pre-mRNA (black); mutant pre-mRNA (grey);  
         mRNA (dotted grey).   
Figure 2.18 CD spectra of Msl5 and the Cm consensus BPS.                                           63 
 
Figure 2.19 Thermal stability analysis of Msl5.                                                                    64 
 
Figure 2.20 Co-expression and Ni-NTA batch purification of                                            65 
        His-Mud2 and Msl5analyzed on a 12% SDS-PAGE. 
Figure 2.21 Size exclusion chromatography purification of the                                        67 
                         Mud2/Msl5 heterodimer. 
 
Figure 2.22 Western Blot of His-CmMsl5 and His-CmMud2                                                        68 
                    affinity pull-downs.   
Figure 2.23 The standardization of CmMud2/Msl5 by comparison                                    69 
        against known amounts of CmMsl5. 
Figure 2.24 Fluorescence polarization of the CmMud2/Msl5                                              70 
        heterodimer titrated against the Cm BPS RNA. 
Figure 2.25 Alignment and predicted secondary structure of the U2                                  73 
            Homology Motif (UHM) of Mud2 against human (SF1))  
             and yeast (BBP homologs. 
Figure 3.1  The expression and affinity purification of Snu13.                                         80 
Figure 3.2  Purification and Crystallography of Snu13.                                          81 
Figure 3.3  X-ray diffraction of Snu13 crystals at the Stanford                    82 
           Synchrotron Light Source. 
!! XI 
Figure 3.4  Sequence alignment with sequences from G. sulphuraria                              84 
       (Snu13g), Homo sapiens (15.5K), and S. cerevisiae (Snu13p). 
Figure 3.5  Structural comparison of C. merolae Snu13 with orthologs.                             87 
Figure 3.6  Close-up of the RNA binding domain of human 15.5K                                           89 
                  (light blue) associated with the kink-turn of human U4 snRNA  
                  (pink) and Prp31 (human 61K, green). 
Figure 3.7  Hydrophobic pocket of Snu13 is clearly seen from the                   90 
       molecular surface, while the rest of the protein is shown  
       in ribbon. 
 
Figure 3.8  Saturation curve of Snu13 against the U4 5’ SL.                                                     92 
Figure 3.9  Functionally active fraction of Snu13 determined by                                                                96 
                       RNA titration. 
Figure 4.1  Overview of ligase-independent cloning to produce a                                               103 
       single plasmid with two genes. 
Figure 4.2  Overview of the reactions and incubations used in LIC to                                  106 
       build the various Cm Prp3/4- and Prp31-containing constructs. 
Figure 4.3  The Cyanidioschyzon merolae U4/U6 di-snRNP, based                                        111 
       on human and yeast modeling. 
Figure 4.4  SDS-PAGE analysis of purified Cm Snu13, LSm, and                                                     112 
       Sm proteins for use in the assembly assays. 
Figure 4.5  U4 and U6 RNA annealing assay.                                                                   113 
Figure 4.6  U4 and U6 Cm di-snRNP assembly assays done by                                                     115 
       electromagnetic mobility shift with 9% polyacrylamide gels. 
 Figure 4.7  U4 and U6 di-snRNP assembly assay with Snu13,                                       116 
                   LSm, and Sm proteins. 
 
Figure 4.8  Cloning of Prp4 and Prp3 into pQLinkH.                                                            118 
           Amplification of Prp4gene by PCR. 
Figure 4.9  SDS-PAGE analysis of Cm Prp3 and Prp4 co-                                                119 
        expression through IPTG induction at 37°C. 
 
!! XII 
Figure 4.10 SDS-PAGE analysis of Cm Prp3 and Prp4 co-                                                            120 
                expression through IPTG and auto-induction at  
                 various temperatures. 
Figure 4.11 SDS-PAGE analysis of Cm Prp31 expression through IPTG                                   120 
        induction at 37°C. 
Figure 4.12 SDS-PAGE analysis of Cm Prp31 expression through IPTG                                    121 
        induction at various temperatures. 
Figure 4.13 Output for Predicted Intrinsic Disorder of the DisEMBL                                         122 
                    Intrinsic Protein Disorder Prediction 1.5 server. 
 
Figure 4.14 Map of predicted intrinsically disordered regions within the                                124 
        U4/U6 di-snRNP proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
!! XIII 
List of Equations 
Equation 1                                                28 
Equation 2                                                28 
Equation 3                                                28 
Equation 4                                                35 
Equation 5                                                95 
Equation 6                                                95 
Equation 7                                                95 
Equation 8                                                95 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
!! XIV 
Acknowledgements 
To my supervisor Dr. Stephen Rader, and my “hidden” supervisor Dr. Martha 
Stark, I give my utmost respect and gratitude. Together, Stephen and Martha provided 
world-class training both at the bench and in critical thinking. I pursued interesting 
research goals and gained independence as a junior scientist. Stephen was extremely 
generous with providing opportunities to attend workshops and conferences, from which 
I gained communication and networking skills. I am also deeply grateful to the brilliant 
Dr. Liz Dunn for wonderful conversations and support. I thank past and present members 
of the Rader Lab (Kirsten Reimer, Fatimat Shidi, Viktor Slat, Mona Aminorroayaee, and 
the undergraduate students) for a highly enjoyable workplace. For insightful 
conversations and practical training, I thank Dr. Andrea Gorrell, Dr. Maggie Lee, and Dr. 
Chow Lee. To Dr. Daniel Erasmus, Dr. Jane Young, and committee member Dr. Keith 
Egger, I thank you for your recommendation and participation, for which I was able to 
become a graduate student. For their indispensible assistance during our collaboration, I 
thank Dr. Erin Garside and Dr. Andrew MacMillan. Finally, my family and friends – 
Shane, Colleen, Joel, Bode, Lorelie, Kurumi, Sebastian, and Victor – were more  
supportive and loving than they could ever know. 
 
 
 
 
 
 
!! XV 
Table of Abbreviations 
 
Abbreviation Definition 
15.5K H. sapiens RNA kink-turn binding protein 
3’ SS 3’ Splice Site 
5’ SS 5’ Splice Site 
6-FAM 6-Carboxyfluorescein (a fluorescent molecule) 
BBP S. cerevisiae branchpoint bridging protein 
bp base pair 
BPS branchpoint sequence 
CD spec Circular Dichroism Spectroscopy 
Cm Cyanidioschyzon merolae 
di-snRNP di-small nuclear ribonucleoprotein particle 
dsRNA/dsDNA double-stranded RNA/DNA 
E. coli Escherichia coli (Gram-negative bacteria) 
EMSA Electrophoretic Mobility Shift Assay 
FA/FP Fluorescence Anisotropy/Polarization 
Gs Galdieria sulphuraria 
Hs Homo sapiens 
IVT In vitro transcription 
KD binding affinity/specificity (usually in nM) 
L.B. Luria Broth 
LIC ligase-independent cloning 
ME mean elipticity 
Msl5 C. merolae branchpoint bridging protein 
Mud2 U2 Auxiliary Factor 
PCR Polymerase chain reaction 
pre-mRNA precursor messenger ribonucleic acid 
RE restriction enzyme 
Sc Saccharomyces cerevisiae 
ScMud2 S. cerevisiae U2 Auxiliary Factor 
SF1 H. sapiens branchpoint bridging protein 
SL Stem Loop/Kink-Turn motif (RNA fold) 
snRNA small nuclear ribonucleic acid 
snRNP small nuclear ribonucleoprotein particle 
Snu13 C. merolae RNA kink-turn binding protein 
Snu13p S. cerevisiae RNA kink-turn binding protein 
ssRNA/ssDNA single stranded RNA/DNA 
TM melting temperature/unfolding 
tri-snRNP tri-small nuclear ribonucleoprotein particle 
U2AF65 H. sapiens U2 Auxiliary Factor (large subunit) 
!! 1 
Chapter 1 
Introduction 
Life can be viewed as an information transmission process. Information is contained 
within DNA (deoxyribonucleic acid), transcribed to RNA (ribonucleic acid), and 
translated to proteins within a cell. After a precursor messenger RNA (pre-mRNA) 
molecule is created, processing of that pre-mRNA occurs prior to protein synthesis. 
These modifications include the addition of a methylated guanosine triphosphate to the 
end of the RNA in a 5’ to 5’ phosphodiester linkage to prevent degradation, poly-
adenylation to produce a 3’ poly A-tail and to promote translation, and pre-mRNA 
splicing. Similar to protein synthesis with regards to the ribosome, pre-mRNA splicing 
requires an intricate protein-RNA complex to facilitate the necessary chemical reactions. 
1.1 Pre-mRNA Splicing and the Spliceosome 
Pre-mRNA splicing is critical to the survival of the Eukaryotic cell; previous research 
has shown that if it was affected by even a single mutation, the cell could exhibit 
temperature sensitivity or even lethality. Following transcription, pre-mRNA contains 
both non-protein coding (intronic) sequences and protein coding (exonic) sequences. 
Introns are non-coding pre-mRNA sequences that must be removed in order to have an 
uninterrupted series of coding sequence. Once the intronic sequences are removed and 
the exonic sequences are joined (or spliced) together, the pre-mRNA is now a mature 
mRNA biomolecule. This mature RNA (mRNA), containing nucleotides only from the 
start codon to the stop codon, is then transported into the cytosol for protein synthesis. 
The machinery carrying out the process of pre-mRNA splicing, the spliceosome, is a 
multi-mega-Dalton ribonucleoprotein complex with over 200 distinct protein and RNA 
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components. The size and complexity of the spliceosome is likely attributed to a series of 
evolutionary adaptations that have allowed the spliceosome to differentiate between 
splice sites that change with certain genes through cellular differentiation (Graveley, 
2001). The five snRNAs (U1, U2, U4, U5, and U6) each interact with certain 
spliceosome-associated proteins to form individual small nuclear ribonucleoproteins, or 
snRNPs. 
Pre-mRNA splicing has been extensively researched, and the current model for yeast 
and humans follows a similar path (Fig. 1.1). The U1 snRNP first binds to the 5’ splice 
site of an intron located on a pre-mRNA (Green, 1991). The U2 snRNA, facilitated by 
associated proteins, then base-pairs with the branchpoint sequence (BPS) and 3’ splice 
site (Query et al., 1996). At this point, the U4/U6.U5 tri-snRNP [notation used to indicate 
the U4/U6 di-snRNP in complex with U5 snRNP] enters and binds to the mRNA intron 
(Stark and Lürhmann, 2006). The U1 snRNP, followed by the U4 snRNP each dissociate. 
The U2, U6, and U5 snRNP cluster completes two transesterification reactions and 
subsequently detach from the spliced mature mRNA (Green, 1991). In the first reaction, 
the 2’ OH group of the conserved branchpoint sequence adenosine is a nucleophile for 
the attack on the conserved guanine of the 5’ splice site. The second transesterification 
happens when the 3’ OH of the released exon attacks the phosphodiester bond of the 
conserved guanine of the 3’ splice site, thereby releasing the lariat intron. The snRNPs 
are then regenerated for future splicing reactions (Staley and Guthrie, 1998). 
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Figure 1.1. Pre-mRNA splicing, including the two transesterification reactions and 
snRNP conformational changes. This model for animals and budding yeast was 
adapted from Will and Lührmann, 2011. 
 
1.2 Cyanidioschyzon merolae as a Model Organism 
Given that the human spliceosome boasts 200+ proteins, 5 distinct snRNAs, and 
multiple conformations, it’s not surprising that attention has been paid to other organisms 
that offer simplicity with regards to spliceosomes – namely yeast. Saccharomyces 
cerevisiae is a budding yeast species with 5 snRNAs and approximately half as many 
splicing factors. Identities of the individual S. cerevisiae splice factors have been 
determined, and a number of snRNA and proteins have been characterized (Stevens et 
al., 2002; Fabrizio et al., 2009). Similar to the human spliceosome, detailed structural 
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and mechanistic information is missing for the majority of the yeast spliceosome. In light 
of the tremendous amount of work necessary to understand the mechanism and structure 
of the spliceosome throughout the cycle, a novel organism has been selected to study pre-
mRNA splicing: Cyanidioschyzon merolae. The human genome has over 18,000 introns. 
When the complete C. merolae genome was published, it was discovered that it had only 
27 introns; the yeast genome, of similar size, has more than 250 (Spingola et al., 1999). 
The reduced number of introns hinted at a more reduced splicing system, with possibly 
even fewer splicing factors than are expressed in S. cerevisiae (Stark et al., 2015). 
Using bioinformatics to look into the C. merolae genome, specifically at those genes 
pertaining to pre-mRNA splicing, has revealed only 4 snRNAs (U2, U4, U5, and U6) and 
68 splicing factors. Of the 68 splicing factors, 49 core proteins have been identified as 
being directly associated with snRNP and spliceosomal assembly (Stark et al., 2015). 
Based on current information from co-immunoprecipitation assays and extensive 
bioinformatics searches, there is no evidence to suggest the presence of either the U1 
snRNA and its associated proteins, or the minor spliceosome (Stark et al., 2015).   
Tangential to the advantages of studying a reduced splicing system are the advantages 
gained by the inherent properties inherent to C. merolae. C. merolae is a unicellular red 
alga both thermophilic and acidophilic in nature, living at 45°C and at a pH of 1.5 
(Matsuzaki et al., 2004). Proteins of thermophilic organisms, i.e. C. merolae, would 
likely have more charged and/or polar residues to form additional ionic interactions and 
exhibit thermo-stability (Dalhus et al., 2002). This is a desirable property when 
considering crystallization conditions, and another advantage over the human and yeast 
variants. 
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1.3 Initiation of Pre-mRNA Splicing 
The first step of splicing is the identification of an intron-containing pre-mRNA 
transcript. Recognition occurs at both the 5’ and 3’ ends of the intron: specifically the 5’ 
splice site (5’ SS) and the branchpoint sequence (BPS) near the 3’ SS. In humans and 
fission yeast (Schizosaccharomyces pombe), the 5’ splice site of the pre-mRNA is base-
paired with U1 snRNA (Fig. 1.2). At the 3’ end, the BPS and downstream 
polypyrimidine tract are respectively recognized by the branchpoint bridging protein and 
the U2 auxiliary factor. Humans and fission yeast have two auxiliary factors 
U2AF65/U2AF35, while budding yeast (S. cerevisiae) has ScMud2. Shown below are the 
branchpoint bridging protein SF1/BBP/Msl5 and the large U2AF Mud2 (Fig. 1.2). It is 
likely that the auxiliary factors serve to guide the branchpoint binding protein because the 
BPS is degenerate in higher eukaryotes (Keller and Noon, 1984). While 5’ and 3’ splice 
site recognition are independent of each other, stability of the snRNA-5’ SS complex is 
improved with the presence of the branchpoint bridging protein already bound to the BPS 
(Larson and Hoskins, 2017). Once the 5’ and 3’ splice sites are appropriately occupied, 
the pre-mRNA splicing reaction is at the Commitment Complex (CC) stage and will 
proceed to the pre-spliceosome (Rosbash and Sepharin, 1991; Colot et al., 1996). The 
commitment complex and pre-spliceosome are equivalent to Complex E and Complex A, 
respectively (Fig. 1.1).  
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Figure 1.2. Pre-mRNA recognition and the Commitment Complex (Complex E). 
Cyanidioschyzon merolae contains Msl5 and Mud2 but lacks the U1 snRNA present 
in all other eukaryotes. This C. merolae Model was created using Paint. 
 
Cyanidioschyzon merolae differs from previously studied models in both 5’ and 3’ 
splice site recognition due to the absence of several genes. The U1 snRNA and associated 
proteins are missing in C. merolae, a component otherwise believed to be necessary for 
5’ splice site (5’ SS) recognition. Without the U1 snRNP, 5’ SS recognition is unknown 
in C. merolae. This is the first organism ever studied that lacks U1, and there are 
currently several hypotheses for 5’ SS definition that include 2 possible snRNA 
candidates (U5 or U6) or proteins bypassing the function of U1 (Stark et al., 2015). 
Similar to budding yeast (S. cerevisiae), the polypyrimidine tract and one of the U2 
auxiliary factors is also missing in C. merolae (Romfo and Wise, 1997; Stark et al., 
2015). This leaves only the branchpoint bridging protein (Msl5) and the larger U2 
auxiliary factor (Mud2) responsible for initially recognizing the BPS/3’ SS.  
Without a polypyrimidine tract, it is unclear how Mud2 functions in recognizing the 
BPS. It is possible that Msl5 and Mud2 bind to the branchpoint region in a stepwise 
manner, with one protein guiding or stabilizing the other. It may also be that Msl5 and 
Mud2 form a heterodimer prior to binding the BPS. Msl5 and Mud2 have been 
previously shown to interact without RNA, but that was in fission yeast and the resulting 
complex was a heterotrimer due to the presence of the smaller U2 auxiliary factor (Huang 
et al., 2002). 
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1.4 Bridging the Branchpoint Sequence to the 5’ Splice Site 
The current budding yeast model for the Commitment Complex (or Complex E in 
animals) involves both binding and base-pairing interactions between proteins and RNA 
(Fig. 1.2; Abovich et al., 1994; Becerra et al., 2015). Through these interactions, the BPS 
is connected to the 5’ SS through a “bridge” of protein and RNA (Fig. 1.3). Integral to 
the CC is the branchpoint bridging protein Msl5 that directly interacts with Mud2, the 
BPS, and the U1 splicing protein Prp40 (Kao and Siliciano, 1996; Abovich and Rosbash, 
1997). Prp40 serves as the final link to the bridge as it is bound to U1 snRNA which is 
base-paired to the 5’ SS (Abovich and Rosbash, 1997; Rutz and Sepharin, 1999). Of 
course, Prp40 along with every other U1 related gene has not been found in 
Cyanidioschyzon merolae and no obvious candidate exists (Stark et al., 2015).  
 
                                       
 
Figure 1.3. Model for bridging the branchpoint sequence and 5’ splice site via U1  
and the Msl5 and Mud2 splicing factors. This budding yeast model was adapted  
from Abovich and Rosbash (1997). 
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In order for U2 snRNA to base-pair with the BPS and 3’ SS and form the “Pre-
Spliceosome” (or Complex A in animals), Msl5 and Mud2 are replaced by U2 snRNP 
associated proteins (Fig. 1.4). While the detailed mechanism of displacement remains 
unknown, genetic and biochemical work revealed two DExD/H box proteins Sub2 and 
Prp5 are involved (Perriman and Ares, 2000; Kistler and Guthrie, 2001; Liang and Chen, 
2015). Following incorporation of the U2 snRNP, the U4/U6.U5 tri-snRNP is added and 
the rest of the splicing cycle continues as outlined above.  
 
        
 
Figure 1.4. Model for displacement of the Msl5 and Mud2 splicing factors, representing 
the transition to Pre-Spliceosome (Complex A). This C. merolae model was created using 
Paint. 
 
1.5 The Branchpoint Bridging Protein Msl5 and U2 Auxiliary Factor Mud2 
The majority of splicing research has been done on human and yeast (both budding 
and fission). Not surprisingly, orthologous gene products have amassed multiple names. 
The branchpoint binding protein and U2 auxiliary factors are SF1 and U2AF65/35 
(respectively) in humans and fission yeast. In budding yeast, these proteins are BBP and 
ScMud2, while in C. merolae they are Msl5 and Mud2 (Table 1.1). With a degenerate 
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BPS and conserved polypyrimidine tract (Py-tract), human U2AF65 drives branchpoint 
sequence (BPS) selection through interactions with both SF1 and the polypyrimidine 
tract (Ruskin and Green, 1985; Zamore et al., 1992). Indeed, the binding affinity of 
human U2AF65 for the Py-tract is 50-300 X greater than SF1 for the BPS; similarly, 
there is a 20x increase in binding affinity for the BPS when SF1 is in complex with 
U2AF65 (Berglund et al., 1998a; Guth and Valcárcel, 2000). Cross-linking assays have 
revealed that there is only 1 free nucleotide between the BPS and Py-tract when SF1 and 
U2AF65 are bound to human pre-mRNA (Berglund et al., 1998b). Footprinting assays 
have found that SF1/BBP will protect the 7 nucleotide BPS UACUAAC plus two 
nucleotides on either side, and U2AF65 will only protect the Py-tract (Berglund et al., 
1997).  
Table 1.1. Common names for the branchpoint bridging protein and  
U2 auxiliary factors in various model organisms. 
Protein Species Specific Name Size (kDa) UniProt ID 
Branchpoint Bridging 
Protein 
H. sapiens SF1 68.3 ZNF162 
Branchpoint Bridging 
Protein 
S. cerevisiae BBP 53.0 YLR116W 
Branchpoint Bridging 
Protein 
C. merolae Msl5 36.2 CMI292C 
U2 Auxiliary Factor 
(large) 
H. sapiens U2AF65 53.5 U2AF65 
U2 Auxiliary Factor S. cerevisiae ScMud2 60.5 YKL074C 
U2 Auxiliary Factor C. merolae Mud2 142.5 CMS438C 
 
In budding yeast, there is no polypyrimidine tract but there is enrichment in uridine 
content between the BPS and 3’ splice site, named the poly-U region (Patterson and 
Guthrie, 1991; Stark et al., 2015). Introns are more efficiently spliced when transcripts 
contain a poly-U region, which is thought to cause more contacts and stronger binding 
with the spliceosome (Ma and Xia, 2011). Through binding experiments with several 
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modified "-tropomyosin pre-mRNA transcripts, it was discovered that 11 continuous 
uridines placed anywhere between the BPS and 3’ SS were optimal for 3’ SS selection 
(Ma and Xia, 2011). Any reduction of the poly-U region reduced splicing efficiency, and 
required that the reduced poly-U be immediately adjacent to the 3’ SS (Ma and Xia, 
2011). While the poly-U region varies wildly across the S. cerevisiae intronome, there is 
generally uridine enrichment 5-18 nucleotides upstream of the 3’ SS (Patterson and 
Guthrie, 1991). Furthermore, uridine enrichment 9 nucleotides upstream of the 3’ SS in 
budding yeast functions in the second transesterification reaction of splicing (Patterson 
and Guthrie, 1991). 
Just as the Py-tract has been lost in S. cerevisiae, so too is ScMud2 divergent from 
U2AF65 of human and fission yeast S. pombe (Abovich et al., 1994). Since ScMud2 is so 
different from its human/yeast homologs and is not required for survival, there may have 
been a weaker selection constraint on the evolution of the Py-tract in S. cerevisiae (Ma 
and Xia, 2011). Indeed, the S. cerevisiae genome is AT rich, and it stands to reason that 
cytosines may have been continually replaced by thymines, which would ultimately 
enrich uridine content (Ma and Xia, 2011). Since the poly-U region does enhance 3’ SS 
selection and splicing efficiency, perhaps the evolution of the poly-U region owes itself 
to both random mutation and selection (Ma and Xia, 2011). In C. merolae, there is no Py-
tract or poly-U region. While Mud2 presumably recognizes a sequence downstream of 
the BPS that is not enriched with uridine or cytosine, no other information is yet known 
which brings to mind several interesting questions. Whether Mud2 and Msl5 recognize 
the BPS as a dimer, or whether one of the proteins bind RNA first is unknown. The 
sequence or binding determinant region recognized by Mud2 remains unidentified. It 
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would be interesting to investigate whether or not there is still a preference for uridine 
despite the lack of a Py-tract or poly-U region? The 145 kDa Mud2 is also unique in size, 
as it is much larger than the 54 kDa human or 60 kDa yeast homologs (NCBI; Stark et 
al., 2015). Various structures of yeast and human Msl5 and Mud2 homologs have been 
determined through X-ray Crystallography, Small Angle X-ray Scattering (SAXS), and 
Nuclear Magnetic Resonance (NMR) (Liu et al., 2001; Selenko et al., 2003; Zhang et al., 
2012; Wang et al., 2013; Jacewicz et al., 2015). 
1.6 U4/U6 Di-snRNP in Pre-mRNA Splicing 
One of the essential components of the spliceosome, the U4 snRNA, acts as a 
chaperone and regulator of the U6 snRNA. And while U1, U2, U5, and U6 are all found 
to exist as individual ribonucleoprotein particles, almost all U4 is found conjugated with 
U6 (Bringmann et al., 1984; Hashimoto and Steitz, 1984; Jandrositz and Guthrie, 1995). 
At any given time, there would be a very small portion of the U4 snRNP existing as an 
individual entity after it is dislodged from the active spliceosome and before it is reunited 
with the U6 snRNP. The catalytic activity of the spliceosome could be seen as the result 
of a series of conformational changes associated with the U6 snRNP. Thus U4 likely also 
has an inhibitory role on splicing, preventing the event by base pairing to U6. Prior to its 
engagement with the intron, the U6 snRNP exists in di-snRNP form with U4 through 
base pairing (Nottrott et al., 2002). The di-snRNP then assembles into a tri-snRNP with 
U5 (the U4/U6.U5 tri-snRNP). After the tri-snRNP binds the 5’ intronic sequence and 
forms a complex with the U1 and U2 snRNPs, U1 dissociates from the 5’ splice site. The 
U4/U6 di-snRNP then undergoes a conformational shift so as to disrupt the base pairs 
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causing U4 to dissociate and a new series of interactions between U6, U2, and the pre-
mRNA nucleotides on the 5’ end to occur (Fig. 1.1; Nottrott et al., 2002) 
Structurally, U4 snRNA is dynamic in that it can be found in three different states: 
the U4 snRNP, the U4/U6 di-snRNP, and the U4/U6.U5 tri-snRNP. It contains several 
conserved stem loops and features a kink-turn motif common to protein-RNA 
interactions. Both the 5’ stem loop and the core domain have been solved for human U4 
snRNA (Vidovic et al., 2000; Leung et al., 2011). The core domain is a single-stranded 
uridine-rich RNA sequence that is targeted by the Sm core proteins prior to re-entry into 
the nucleus (Fischer et al., 1993). The C. merolae U4 snRNA secondary structure 
appears to be well conserved when compared with the human homolog. In Stem Loop III 
of the base-paired U4/U6 particle, however, there is an additional 18 nucleotides (Fig. 1.5 
A; Stark et al., 2015).  
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Figure 1.5. The U4/U6 di-snRNP. (A) Predicted secondary structure of the U4/U6-
disnRNA in C. merolae. Adapted from Stark et al. (2015). (B) Predicted secondary 
structure of the human U4/U6 di-snRNP with all associated proteins.  
Adapted from Hardin et al. (2015). 
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Assembly of the U4/U6 di-snRNP has been studied in humans and yeast (Nottrott et 
al., 2002; Hardin et al., 2015). The di-snRNP consists of U4 and U6 snRNAs, along with 
associated proteins Sms, LSms, Snu13, Prp3, Prp4, and Prp31 (Horowitz et al., 1997; 
Nottrott et al., 1999; Sander et al., 2006). U4 and U6 snRNAs are transcribed in the 
nucleus, followed by nuclear-localized LSm proteins binding the 3’ uridine-rich region of 
U6 snRNA (Mayes et al., 1999; Achsel et al., 1999). U4 is exported to the cytoplasm 
where the Sm proteins similarly assemble onto the 3’ uridine-rich tail; U4-Sm is then 
imported into the nucleus (Karaduman et al., 2006). With U4-Sm and U6-LSms together 
in the nucleus, di-snRNP assembly continues with Watson Crick base-pairing between 
the two snRNAs (Fig. 1.5 A; Bringmann et al., 1984; Hashimoto and Steitz, 1984). The 
small, globular Snu13 then binds the U4 5’ stem loop and acts as an anchor for the 
subsequent assembly of Prp3, Prp4, and Prp31 (Nottrott et al., 2002). Prp3 and Prp4 exist 
as a heterodimer prior to di-snRNP assembly and require Snu13 already present on the 
U4 5’ stem loop, as does Prp31 (Nottrott et al., 2002). Functional studies with human and 
yeast models suggest that the Prp3/4 dimer and Prp31 bind independently of each other 
(Hardin et al., 2015). Recent cryogenic electron microscopy (cryo-EM) structures of 
human and yeast spliceosomes have revealed several details pertaining to the architecture 
of the di-snRNP (Fig. 1.5 B; Nguyen et al., 2015; Agafonov et al., 2016). Both the 
Prp3/4 dimer and Prp31 contact Snu13, the U4 5’ stem loop, and Stem II of the di-snRNP 
(Nguyen et al., 2015). A high-resolution structure under 2 Angstroms for U4 snRNA has 
yet to be solved. C. merolae U4 snRNA is a good candidate for crystallization due to the 
thermo-stability and reduction of splicing factors. Fewer components would also behoove 
functional studies to study the interaction between complete U4 and U6 snRNPs. The 
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simplicity of the C. merolae splicing system is reflected in the U4 snRNP: no homolog 
has been found for the human CypH U4/U6 associated splicing factor (Stark et al., 2015). 
1.7 Snu13 In di-snRNP Assembly 
One of the proteins associated with the U4 snRNA is Snu13, a globular protein with 
an "-#-" fold reminiscent of the L30 ribosomal protein (Vidovic et al., 2000). While the 
size similarity between human (15.5 kDa) and algal (15.8 kDa) homologs may suggest 
similarity in structure, no experimental data is available for validation. The classic RNA 
motif to which Snu13 binds is the helix-bulge-helix, or kink-turn motif (Marmier-
Gourrier et al., 2003). In general, the kink-turn motif is characterized as having an 
asymmetrical internal loop that causes the flanking stems to fold towards each other, 
creating a “kink” (Klein et al., 2001). The U4 5’ stem loop is highly conserved across all 
organisms, with the internal loop consisting of 5 nucleotides on one side of the flanking 
stems, and 2 on the other (Nottrott et al., 1999). Interestingly, the Archaeal homolog is 
unique in that it does not discriminate between the kink-turn and similar motifs (Oruganti 
et al., 2005). Although the fidelity of C. merolae Snu13 is as of yet uncharacterized, 
specificity and structure is expected to be comparable to previously studied Eukaryotic 
homologs and not the Archaeal variant (Oruganti et al., 2005). The structure of the 
human and yeast variants have been solved by X-ray crystallography. There has not been 
functional or structural characterization on any component of the C. merolae 
spliceosome. Structures for Snu13 homologs both free and bound to U4 snRNA have 
been previously characterized, making the algal variant an attractive starting point for 
structural and functional characterization of U4 snRNP splicing factors (Vidovic et al., 
2000; Oruganti et al., 2005). 
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1.8 Research Goals 
The first research objective was to study recognition of an intron-containing pre-
mRNA transcript in Cyanidioschyzon merolae using fluorescence anisotropy and 
electrophoretic mobility shift assays. Recombinant Msl5 and Mud2 proteins were to be 
titrated against labeled synthetic pre-mRNA to measure binding. These experiments were 
meant to determine whether branchpoint sequence recognition was a stepwise process 
(cooperative) or if Msl5 and Mud2 were a heterodimer prior to binding. If time permitted, 
recombinant Prp5 and Sub2 would be titrated against the Msl5-Mud2-RNA complex to 
determine which DExD/H box protein was necessary for Msl5 and Mud2 displacement.  
The second research goal was to study structural properties of Msl5 both free and 
bound to RNA. Circular dichroism spectroscopy would measure conformational changes 
in Msl5 structure upon binding the branchpoint sequence of pre-mRNA. X-ray 
crystallography was to be used to elucidate high-resolution structures of the protein both 
free and bound to RNA, which would have revealed details of branchpoint sequence 
recognition. 
The third objective was to study the interaction between Snu13 and the 5’ stem loop 
of U4 snRNA. The binding affinity of Snu13 for U4 was to be measured by fluorescence 
polarization. This objective would be reached by measuring the anisotropy of a 
fluorescently labeled U4 snRNA 5’ stem loop oligonucleotide titrated with recombinant 
Snu13. The data would then be analyzed to determine affinity and cooperativity. 
The fourth research objective was to characterize the order of assembly of the Cm 
U4/U6 di-snRNP. Using gel shift assays, in vitro transcribed U4 and U6 snRNAs would 
be mixed with recombinant di-snRNP associated proteins (Snu13, LSms, Sms, Prp3, 
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Prp4, Prp31). EMSAs allow for a visual representation of step-wise assembly because 
bands would appear sequentially higher as more components interact with each other. 
The fifth research objective was to crystallize Snu13 both bound and free of U4 
snRNA. C. merolae offers the very small, globular, thermo-stable protein Snu13. Upon 
successfully acquiring crystals, X-ray crystallography would be done to obtain diffraction 
patterns and elucidate a structure for each crystal. Structure determination of C. merolae 
Snu13 would then complete the proof of principle for X-ray crystallography of the algal 
spliceosome. Upon achieving the primary objectives, we will have a better understanding 
of the structure and assembly of the U4 snRNP. 
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Chapter 2 
Recognition of the pre-mRNA branch site by Msl5 
This chapter contains the experiments performed in order to investigate the 
interaction of the Msl5 and Mud2 proteins with the branchpoint sequence inherent to C. 
merolae introns. To that end, several techniques were employed including fluorescent 
polarization, radioactive electrophoretic mobility shift assay, and circular dichroism 
spectroscopy. 
2.1 Methods – Expression and Purification of C. merolae Msl5 and Mud2 Proteins 
2.1.1. Transformation of Rosetta pLysS (DE3) cells with pQLinkH-Msl5 
Full length Msl5 was amplified from the Cyanidioschyon merolae genome by 
PCR and subcloned into the pQLinkH plasmid vector (Addgene plasmid 13667) using 
primers found in Table 2.1. Rader lab member Fatimat Shidi made modifications to 
pQLinkH prior to its use by inserting SwaI and PacI restriction enzyme cut sites to make 
the plasmid appropriate for ligase independent cloning (LIC). LIC is illustrated in section 
4.4.1. The gene is flanked by an N-terminus 6x His-tag followed by TEV protease 
cleavage site ENLYFQS, whereby cleavage occurs between the Q and S. pQLinkH also 
contains an ampicillin resistance gene for selection and a T7 promoter for expression. 
Once Msl5 was subcloned into pQLinkH, pQLinkH-Msl5 was then transformed into 
DH5" cells for preparation of a glycerol stock. The plasmid was later isolated and made 
available to use for expression purposes.  
pQLinkH-Msl5 was used to transform Rosetta (DE3) pLysS competent E. coli 
cells (Novagen) which contain a plasmid that features genes for rare codon tRNA 
(optimized to humans) and chloramphenicol antibiotic resistance expressed through a T7 
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promoter. 50 uL of Rosetta pLysS (DE3) cells were thawed on ice in a 1.5 mL Eppendorf 
tube (Fisher Scientific) for 15 minutes before adding 150 ng of pQLinkH-Msl5. The tube 
sat on ice for 30 minutes followed by 45 seconds at 42°C. 250 uL of Luria Broth (L.B., 
Fischer Scientific) was added then the cell suspension was incubated at 37°C for 30 
minutes. L.B. consists of tryptone (10 g/L), yeast extract (5 g/L), and sodium chloride (10 
g/L) dissolved in 1 L of distilled water, which was autoclaved prior to use. 
 Cells were spun down (Eppendorf, model Centrifuge 5417 C) for 10 seconds 
then resuspended in 100 uL fresh L.B. broth and plated on L.B. agar supplemented with 
20 ug/mL ampicillin (IBI Scientific) and chloramphenicol (Sigma-Aldrich) antibiotics. 
The plate was incubated at 37°C for 18 hours and subsequently resulted in (~50) colonies 
containing the pQLinkH-Msl5 plasmid. 
Table 2.1. DNA primers used in the subcloning of Msl5 and Mud2 genes  
into pQLinkH plasmid vector. 
Gene Sequence 
Msl5 (fwd) TAC TTC CAA TCC CAC GCA CCG CGG AAC AGT GAG 
Msl5 (rev) TTA TCC ACT TCC CAC G TTA AGA ATC GCC CTG GAC C 
Mud2 (fwd) TAC TTC CAA TCC CAC GCA CCG AGA ACA GGC TCG G 
Mud2 (rev) TTA TCC ACT TCC CAC G TTA CCG CAG GTA GGG C 
 
2.1.2. Transformation of Rosetta pLysS (DE3) cells with pQLinkH-  
          Mud2/Msl5 
 
A modified pQLinkH plasmid vector (Addgene) was previously assembled with 
full length tagged Mud2 (N-terminus 6x His-tag and TEV protease site), as well as full 
length untagged Msl5. Primers used to subclone the genes are detailed in Table 2.1. The 
transformation was performed as previously described using 200 ng of plasmid DNA. 
The plasmid pQLinkH-Mud2/Msl5 was used to transform 50 uL Rosetta pLysS cells. 
After 19 hours of incubation, the ampicillin- and chloramphenicol-supplemented L.B. 
agar plate yielded about 20 colonies. 
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2.1.3. Induction of pQLinkH-Msl5 transformed Rosetta pLysS (DE3) cells 
One transformant colony containing the pQLinkH-Msl5 plasmid was used to 
inoculate 50 mL L.B. broth supplemented with 20 ug/mL each of ampicillin and 
chorlamphenicol in a 250 mL Erlenmeyer flask. The culture was incubated in a shaker set 
at 300 RPM (New Brunswick Scientific, model Innova 40) at 37°C for 18 hours. 10 mL 
of the overnight broth was added to 4X 3L Fernbach flasks each containing 1L L.B. broth 
(20 ug/mL ampicillin and chloramphenicol) for large-scale expression. The 1 L cultures 
were put in the same shaker for 3.5 hours at 300 RPM and 37°C until they reached an 
OD600 of 0.55 (Beckman Coulter, model DU 800). The cells were induced with 1 mM 
isopropyl-#-D-1-thiogalactopyranoside (IPTG, VWR). Induction was carried out for 4 
hours under the same conditions before each litre was centrifuged for 15 min at 3200 
RPM and 4°C (Beckman Coulter, model Avanti HP-20 XPI) and resuspended in 10 mL 
Msl5 Ni Wash buffer (Table 2.2). The 4 cell suspensions were combined and split 
between two 50 mL conical tubes (VWR) then centrifuged for 15 min at 3200 RPM and 
4°C (Beckman Coulter, model Allegra X-12R). The supernatants were discarded and the 
two pellets were flash-frozen in liquid nitrogen before storage in -80°C.  
Both before and after induction, 1 mL of each culture and resuspended in SDS 
loading buffer to a final concentration of 1 OD unit per 100 uL (A600) before being 
stored at -20°C. The samples were later run on a 12% polyacrylamide (37.5:1 
acrylamide/Bis, Bio-Rad) gel via sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE). For the rest of this section, unless otherwise stated, all 
SDS-PAGE was performed under the following conditions: samples boiled at 95°C for 5 
minutes then centrifuged at 20000 Xg for 3 minutes. 10 uL of each sample was loaded 
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into a lane of the gel and ran at 22 mA for 50 minutes. For all standard SDS-PAGE, the 
Broad Range Molecular Weight Marker (Bio-Rad) was used. 
2.1.4 Induction of pQLinkH-Mud2/Msl5 transformed Rosetta pLysS cells 
 Mud2 and Msl5 were co-expressed using 2 L of L.B. media inoculated with 
pQLinkH-Mud2/Msl5-containing cells. 1 mM IPTG (VWR) was used for induction when 
an OD600 of 0.67 was reached. Induction was carried out for 16 hours at 22°C before the 
cells were harvested at an OD600 of 3.54. Both the L.B. media and the Wash Buffer were 
supplemented with 200 uM of L-arginine and L-aspartate (Sigma-Aldrich) at a pH of 7.5. 
The Wash Buffer was also supplemented with 0.5 M urea (Fisher Scientific). 
2.1.5 Multi-step Chromatography of Recombinant Msl5 and Mud2/Msl5 
Recombinant Cm Msl5 was purified using 3 chromatographic techniques that 
included affinity, cation exchange, and size exclusion chromatography. Co-expressed 
recombinant Cm Mud2 and Msl5 were purified using affinity and size exclusion 
chromatography.  
2.1.5.1. Step 1: Ni-NTA Purification 
Recombinant Msl5 and the Mud2/Msl5 dimer were each isolated from Rosetta 
pLysS (DE3) cells using the following buffer and purification scheme covered by Table 
2.2 and below. The only difference in the treatment of Mud2/Msl5 was the inclusion of 
amino acids (L-Arg and L-Asp) and urea in the wash and elution buffers. 
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Table 2.2. Composition of buffers used in the Ni-NTA purification of recombinant 
Msl5 and co-expressed Mud2/Msl5 from Rosetta pLysS (DE3) cells. 
Components Msl5 Ni 
Wash 
Buffers 
Mud2Msl5 
Ni Wash 
Buffer 
Msl5 Ni 
Elution 
Buffer 
Mud2Msl5 Ni 
Elution Buffer 
Msl5 
Dialysis 
Buffer 
HEPES-NaOH 
pH 7.5 
30 mM 30 mM 30 mM 30 mM 20 mM 
NaCl 300 mM 300 mM 300 mM 300 mM 90 mM 
Imidazole 30 mM 30 mM 500 mM 500 mM 15 mM 
#-
mercaptoethanol 
5 mM 5 mM 5 mM 5 mM 5 mM 
L-Arginine - 200 uM - 200 uM - 
L-Arspartate - 200 uM - 200 uM - 
Urea - 0.5 M - 0.5 M - 
 
Two frozen Rosetta pLysS cell pellets were each treated with half of a tablet of 
protease inhibitor (Sigma-Aldrich) then resuspended in 20 mL Msl5 Ni Wash Buffer. 
After re-suspension, the samples were sonicated (Fisher Scientific, model 100) in 15 
second bursts with 1 minute rests. Max power was used and 12 bursts were executed. 
Streptomycin sulfate (Amresco) was added to the cells at 0.1 g/mL and the conical tubes 
were swapped for centrifuge tubes. The lysate was cleared by centrifugation (Beckman 
Coulter, model Avanti HP-20 XPI) at 25000 Xg for 30 minutes at 4°C. The supernatant 
was mixed with 1 mL of Msl5 Ni Wash buffer-equilibrated nickel nitriloacetic acid (Ni 
NTA) agarose beads (Thermo Fisher) in a 50 mL conical (VWR) and incubated at 4°C 
fastened to a tube rotator (Mandel Scientific) for 2 hours. The pellet was collected via 
centrifugation at 800 X g and the lysate was removed by aspiration. The resin was 
washed 6 times with 7 mL Msl5 Ni Wash Buffer. Msl5 was eluted in 20 X 1 mL 
fractions using Msl5 Ni Elution Buffer. Based on A280 values from a spectrophotometer 
(Nanodrop Spectrophotometer, model ND-1000), only the first 15 elution samples were 
kept and combined. The Ni-NTA-purified protein was mixed with 1 mg of recombinant 
TEV protease and put in 10 cm of dialysis tubing (Spectrum Lab, 6-8000 MWCO). TEV 
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protease is a cysteine protease from the Tobacco Etch Virus, which was recombinantly 
expressed and purified from pRK793-transformed Rosetta pLysS E. coli and according to 
the recommended conditions (Addgene). The sample was dialyzed in Msl5 Dialysis 
Buffer for 8 hours at 4°C. The buffer was exchanged three times over 24 hours. The 
TEV-protease/Ni-NTA elution mixture was then incubated with 1 mL equilibrated 
(dialysis buffer) Ni NTA in a 15 mL conical (VWR) for 2 hours with rotation at 4°C. The 
sample was spun and the supernatant (containing cleaved Msl5) was collected and 
quantified on a 12% polyacrylamide gel.  
The cell pellet (from 2L) with expressed Mud2/Msl5 was treated similarly to 
above but was not dialyzed nor treated with TEV protease. Ni-NTA wash and elution 
buffers were supplemented with L-Arg, L-Asp, and urea for improved solubility. The 
protein-bound resin was washed 6 times with 8 mL Mud2Msl5 Ni Wash Buffer and 
eluted in 1 mL fractions (Table 2.2). The Nanodrop spectrophotometer was used to 
analyze the fractions, of which 12 were pooled and saved for further purification by size 
exclusion chromatography. The sample was concentrated from 12 mL to 3 mL using a 15 
mL 10 k spin concentrator (Millipore) and centrifuging at 3200 RPM and 4°C (Beckman 
Coulter, model Allegra X-12R). 
2.1.5.2. Step 2: Cation Exchange Column Chromatography Purification 
 
The second purification step for Msl5 was performed with an 8 mL strong cation 
exchange column (MonoS 10/100 GL) attached to a fast protein liquid chromatography 
system (ÄKTA Purifier 10, GE Healthcare Life Sciences). The purified Msl5 (no His-tag 
present) was concentrated from 15 mL to 1.2 mL using the 15 mL 10 k spin concentrator 
at 3200 RPM and 4°C. Concentrated Msl5 was then quickly mixed with 3.9 mL of a “pH 
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emersion buffer” (pHE Buffer) and syringed into the FPLC sample injection loop before 
a MonoS purification program was ran. The program ran from 0 to 100% in terms of 
Buffer A to Buffer B (Table 2.3). 
Table 2.3. Composition of buffers used in the cation exchange chromatography 
purification of recombinant Msl5. All buffers were filter sterilized and de-gassed. 
Components pHE Buffer Buffer A Buffer B 
2-(N-morpholino)ethanesulfonic acid (MES) 100 mM 30 mM 30 mM 
NaCl 90 mM 90 mM 1 M 
#-mercaptoethanol 5 mM 5 mM 5 mM 
 
From the chromatogram and 12% polyacrylamide electrophoresis of the MonoS 
elution fractions, only fractions B7-B4 were kept (8 mL). The 8 mL was concentrated to 
4 mL using a 15 mL 10 k spin concentrator as previously described. 
2.1.5.3. Step 3: Size Exclusion Column Chromatography Purification 
 
The final purification step of both recombinant Msl5 and the Mud2/Msl5 dimer 
was done using a 24 mL size exclusion column (Superdex200 10/300 GL, GE Healthcare 
Life Sciences) attached to the ÄKTA Purifier 10. In 0.5 mL portions, protein was 
syringed into the sample injection loop and loaded onto the size exclusion column (SEC). 
In total, 8 runs were made for Msl5 and 6 were made for the Mud2/Msl5 dimer. The 
method involved either Msl5 or Mud2Msl5 SEC Buffer with a constant flow of 0.25 
mL/min and collection of 0.5 mL fraction sizes (Table 2.4). 
Table 2.4. Composition of the buffer used in the size exclusion chromatography 
purification of recombinant Msl5 and co-expressed Mud2 and Msl5.  
The buffers were filter sterilized and de-gassed. 
 
Components Msl5 SEC Buffer Mud2Msl5 SEC Buffers 
HEPES-NaOH pH 7.5 25 mM 25 mM 
NaCl 100 mM 100 mM 
#-mercaptoethanol 5 mM 5 mM 
L-Arginine - 200 uM 
L-Aspartate - 200 uM 
Urea - 0.5 M 
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From the chromatogram and 12% polyacrylamide electrophoresis of the SEC 
elution fractions, fractions that looked the cleanest by SDS-PAGE were kept and pooled 
together. Recombinant Msl5 was over 95% pure as determined by band intensity 
quantification. Msl5 was ready for experimentation. 
2.1.6. Western blot of the Msl5/Mud2 Heterodimer 
 
In order to verify the presence of Msl5 in the presumed Mud2/Msl5 dimer after 
Ni-NTA and SEC purification, a Western blot was performed using the reagents listed in 
Table 2.5. 
Table 2.5. Reagents used in the detection of Msl5 in purified Mud2/Msl5 dimer. 
Reagent Components 
10 x Towbin buffer 25 mM Tris pH 8.3, 192 mM glycine, 20% 
methanol (v/v) 
10 x Phosphate Buffered Saline (PBS) 137 mM NaCl, 2.7 mM KCl, 4.3 mM 
Na2HPO4x7H20, 1.4 mM KH2PO4 
PBS – Tween 20 (PBS-T) solution 0.1% Tween 20 in 1 x PBS solution (v/v) 
5% Blocking solution 5% w/v skim milk powder in PBS-T 
Wash solution 1% w/v skim milk powder in PBS-T 
1° antibody solution (polyclonal rat " 
Msl5, Dr. John Burke Lab UVIC) 
1:1500 in 1% milk/PBS-T (w/v) 
2° antibody solution (monoclonal goat " 
rat, Santa Cruz Biotechnology sc-2065) 
1:1800 in 1% milk/PBS-T (w/v) 
 
A 10% polyacrylamide (37.5:1 acrylamide/Bis) gel was loaded with ~14 ug 
purified Msl5, Dual Color™ pre-stained protein marker (Bio-Rad), and 2 uL purified 
Mud2/Msl5. Electrophoresis was done for 45 min at 22 mA before the gel was taken off 
and trimmed for transfer. Nitrocellulose and Whatman filter papers were cut to gel size 
(8.2 Cm X 5.6 Cm) and 3 pieces of Whatman were stacked in the Owl™ semidry 
electroblotting system (Thermo Fisher). 1X Towbin buffer was poured onto each layer as 
the sandwich was stacked, and pooled buffer was spotted before the transfer began. The 
transfer was ran at 70 mA for 1 hour, after which the nitrocellulose membrane was placed 
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in on a rocker at 4°C with 5% Blocking solution for 16 hours. The membrane was treated 
with 1° antibody solution (rat " Msl5, gift of Dr. Burke, UVIC) on a rocker at room 
temperature for 4 hours then washed 3X with Wash solution for 10 minutes each. 1° 
antibody was generated from rat by Dr. Robert Burke’s Laboratory at the University of 
Victoria. The 2° antibody solution (goat " rat, sc-2065, Santa Cruz Biotechnology) was 
applied for 12 hours on a shaker at 4°C. The membrane was then washed 3X with Wash 
solution before treatment with Luminol Reagent (Santa Cruz Biotechnology) and 
exposed using the Fluor Chem Q imager (Protein Simple). 
After the presence of Msl5 was confirmed by Western, the Mud2/Msl5 dimer 
needed to be quantified. This was not easily quantified by common methods (i.e. 
spectrophotometry or BCA assay) because of the presence of two proteins of unknown 
stoichiometry. A concentration gradient of previously purified Msl5 (16667 nm to 1.7 
nM) was run next to 2 uL of concentrated Mud2/Msl5 dimer on a 10% polyacrylamide 
(37.5:1 acrylamide/Bis) gel. All bands were quantified using a program built-in the Flour 
Chem software. The band intensities of Msl5 in the dimer were compared with the band 
intensities of previously purified Msl5 to determine the concentration of dimer, which 
was assumed to have a stoichiometry of 1:1. 
2.2 Methods - Fluorescence Polarization of Msl5 Against Branchpoint RNA 
 
 2.2.1. Generation of RNA probes for the Cm BPS and Controls 
 
The interaction between Msl5 and the conserved Cm branchpoint sequence was 
measured using fluorescence polarization (FP). Fluorescein-labeled RNA probes for the 
branchpoint sequence and two negative controls were designed and later synthesized by 
Integrated DNA Technologies (Table 2.6). Two negative controls were used for FP in 
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order to see if Msl5 would discriminate against single or double-stranded RNA. An 
additional unlabeled probe (ro62) was also designed and ordered to act as a negative 
control in a subsequent EMSA experiment. 
Table 2.6. RNA oligo probes used in FP Binding Assays. 
Identity Sequence Fluorescein 
ro52: U4 5’ stem 5'-UUGCCCAGAUGAGG 
UUCUCCGAUGGGUAA-3’ 
5’-(6-FAM) 
ro62: U6 3’ end 5’-AGGUAUACCUUUUU-3’ none 
ro64: Conserved 
Branchpoint Sequence 
5’-AAACUAACCAU-3' 
 
3’-(6-FAM) 
ro66: U4 3’ end AAAUUUUUGGAAAGUAUUU-3’ 5’-(6-FAM) 
 
2.2.2. Set-up of the Fluorescence Polarization Binding Assay 
 
Msl5 or Mud2/Msl5 dimer was mixed with RNA probe in 90 uL reactions using 
1.5 mL Eppendorf tubes according to Table 2.7 and pipetted them into 384-well black 
microplates (VWR). The FP Reaction Buffer was 25 mM HEPES-NaOH pH 7.5, 100 
mM NaCl, and 5 mM #-mercaptoethanol. Plates were incubated at 42°C then on ice for 
10 minutes each before FP was measured with the Synergy 2 Multi-Mode Microplate 
Reader (Biotek Instruments). Excitation and emission of the fluorescein-labeled samples 
was done with 485 nm and 528 nm, respectively, which was well within the peak ranges 
for these parameters (Sjöback et al., 1995). The Msl5 FP assay was ran in triplicate 8X 
and the dimer in triplicate once. A negative control was always included corresponding to 
either a U6 snRNA single stranded or U4 5’ stem loop double stranded probe.  
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Table 2.7. FP reagents used for the binding experiments of Msl5 with BP RNA probe. 
Reactions were each set-up in 1.5 mL microtubes with total volumes of 90 uL. 
FP Reaction Reagents Volume Final Concentration 
Msl5 40 uL 0 to 10000 nM 
Mud2/Msl5 40 uL 0 to 222 nM 
FP Reaction Buffer 45 uL 1 X 
Fluorescein-labelled probe 
(ro64, ro66, ro52) 
5 uL 15 nM 
 
 
2.2.3. Analysis of FP data 
 
Fluorescence polarization measurements (parallel and perpendicular) were 
converted into anisotropy values with Gen5 Data Analysis Software (Biotek Instruments) 
and subsequently into percent of RNA probe bound by protein. RNA % bound values 
were plotted with their respective protein concentration using Kaleidagraph Software 
against a Hill Equation (see below) to determine binding affinity (kD). Equation 1 
converted anisotropy to percent of RNA probe bound, while Equations 2 and 3 fit 
percentages of bound fractions to floating/variable and fixed Hill Equations, respectively:  
FractionBOUND of n = (Anisotropyn - AnisotropyFREE) /                                             Equation 1 
(AnisotropyBOUND - AnisotropyFREE) 
 
Hill equations used to determine binding affinity: 
 
Floating (non-constrained): 
m1+((m2-m1)/(1+((m3/m0)^ m4)));m1=0.001;m2=100;m3=200;m4=#                 Equation 2 
 
Fixed (constrained, forced Hill Coefficient): 
m1+((m2-m1)/(1+((m3/m0)^ #))); m1=0.001; m2=1; m3=100                                  Equation 3 
 
Where m1 = offset, m2 = max bound (%), m3 = KD, m4 = Hill Coefficient. 
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2.3 Methods – In vitro Transcription of Truncated Cm 072C RNA 
 
2.3.1. Preparation of DNA Templates For In vitro Transcription 
 
Three versions of Cm 072C pre-mRNA DNA templates were used for in vitro 
transcription (IVT): wild-type (WT) pre-mRNA, mutant pre-mRNA, and mRNA. All 
transcripts retain full intron length but specific truncations were made to the 5’ and 3’ 
ends of the flanking exons. Both pre-mRNA transcripts kept the full 85 nucleotide-long 
intron but only 40 nucleotides of the 5’ exon and 50 of the 3’ exon. WT and mutant pre-
mRNA transcripts were 175 nucleotides, while mRNA was 90 (Table 2.8). 
 
Table 2.8. Sequences of the Cm 072C transcripts used in binding experiments with Msl5. 
Transcript Sequence (BPS underlined, 5’ and 3’ intron boundaries bold) 
WT 072C pre-
mRNA 
5’-UUGCGGCAUUCUAGGUACCACCUACACCGGACAAUUUG 
AAGCAAGUUGACGAAACUUCUGGGGCUUUUCCUCAGAAA
UAACCGAACAUGAAACUAACCAUUGCGAAACAAUCGAUUC
GAGUCUAGGACAUUGCCACUUUGGACGCUCUCGUGACGCA
GAUGAACGAGCAGAAGGG-3’ 
Mutant 072C 
pre-mRNA 
5’-UUGCGGCAUUCUAGGUACCACCUACACCGGACAAUUUG 
AAGGCCGUUGACGAAACUUCUGGGGCUUUUCCUCAGAAA
UAACCGAACAUGAAACGGGCCAUUGCGAAACAAUCGAUUC
GAGUCUAGGACAUUGCCACUUUGGACGCUCUCGUGACGCA
GAUGAACGAGCAGAAGGG-3’ 
072C mRNA 5’-UUGCGGCAUUCUAGGUACCACCUACACCGGACAAUUUG 
AAGACAUUGCCACUUUGGACGCUCUCGUGACGCAGAUGAA
CGAGCAGAAGGG-3’ 
 
WT pre-mRNA cDNA template was previously generated and subcloned into a 
plasmid by Dr. Martha Stark. Using the WT cDNA template, mutations were made to the 
5’ splice site and the branchpoint sequence to create the mutant pre-mRNA cDNA 
template. Primers were then designed to make an exon-truncated cDNA template of WT 
mRNA from previously extracted Cm total RNA. The T7 promoter sequence was 
incorporated upstream of the 5’ end of the forward primer. The reactions and 
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thermocycler conditions that generated the mRNA cDNA template is outlined below 
(Tables 2.9 and 2.10). 
Table 2.9. Reactions and thermocycler conditions used to  
generate the DNA template for Cm 072C pre-mRNA and mRNA. 
 
Components of Reaction                                                     Thermocycler Program 
 
Cm total RNA (250 ng/uL)                 2 uL                            65°C    5 minutes 
Reverse primer (20 uM)                      1.5 uL                         22°C    10 minutes         1 cycle 
Water                                                   up to 12.5 uL 
 
To the previous reaction was added: 
Superscript III RT (200 units/uL)                   0.7 uL                              
1st Strand Buffer (5x)                                                                          5 uL                              
DTT (100 mM)                                       2.5 uL                           
SUPERaseIn (20 units/uL)                  1 uL                            42°C    60 minutes 
dNTPs (10 mM)                                     2.5 uL                         70°C    15 minutes         1 cycle 
Total volume                                               24.2 uL 
 
Previous Reaction (24.2 uL)                  7 uL 
Taq Polymerase (5000 units/mL)        0.4 uL                          95°C    2 minutes 
Taq Reaction Buffer (10x)                   5 uL                             95°C    20 seconds 
Forward primer (10 uM)                       2.5 uL                         56°C    20 seconds     35 cycles 
Reverse primer (10 uM)                      2.5 uL                         68°C    45 seconds 
dNTPs (10 mM)                                     1 uL                               68°C    5 minutes 
Water                                                    up to 50 uL 
 
 
Table 2.10. PCR primers used to generate Cm 072C DNA templates for in vitro 
transcription and their respective annealing temperatures. 
Identity Sequence 
072C fwd GCAGATGAATTCTTGCGGCATTCTAGGTACCACC 
072C rev GCAGATGGATCCCCCTTCTGCTCGTTCATCTGC 
072C mutate 5’ SS CTG AGG AAA AGC CCC AGA AGT TTC GTC AAC GGC 
CTT CAA ATT GTC C 
072C mutate BPS CT GGG GCT TTT CCT CAG AAA TAA CCG AAC ATG AAA 
CGG GCC ATT GCG AAA C 
072C mRNA fwd GCATGAATTC TAATACGACTCACTATAGGG AGC 
TTGCGGCATTCTAGGTACCACC 
072C mRNA rev GCAGATGGATCCCCCTTCTGCTCGTTCATCTGC 
 
 
!! 31 
Cm 072C mRNA cDNA template was isolated by electrophoresis with a 1.2% 
agarose gel ran at 120 V for 80 minutes. The mRNA-sized gel band was excised and 
purified it as per the gel extraction protocol of the Nucleospin Gel and PCR cleanup kit 
(Macherey-Nagel). 
2.3.2. In vitro Transcription of Cm 072C pre-mRNA and mRNA 
 
In vitro transcription (IVT) of truncated Cm 072C WT and mutant pre-mRNA, as 
well as mRNA was done cold as per the HiScribe T7 High Yield RNA Synthesis kit 
(New England Biolabs). Reactions were carried-out in 0.2mL clear PCR tubes (Corning). 
and 5’ end labeled using [!-32P]-labeled ATP. IVT reactions and the subsequent end 
labeling are outlined below (Table 2.11). 
Table 2.11. Composition of the IVT reactions that generated Cm 072C RNA transcripts. 
The reactions were carried out in 20 uL for 12 hours at 37°C. 
IVT Reaction 
Reagents 
WT pre-mRNA 
Reaction 
Mutant pre-mRNA 
Reaction 
mRNA Reaction 
Template DNA 4 uL linear plasmid 
(1 ug) 
10 uL PCR product 
(500 ng) 
5 uL PCR product 
(500 ng) 
T7 RNA 
Polymerase Mix 
1.5 uL 1.5 uL 1.5 uL 
T7 Reaction Buffer 
(10x) 
1.5 uL 1.5 uL 1.5 uL 
ATP (100 mM) 1.5 uL 1.5 uL 1.5 uL 
UTP (100 mM) 1.5 uL 1.5 uL 1.5 uL 
GTP (100 mM) 1.5 uL 1.5 uL 1.5 uL 
CTP (100 mM) 1.5 uL 1.5 uL 1.5 uL 
Water 7 uL 1 uL 6 uL 
 
Each IVT product was mixed with equal volume formamide, heated at 65°C for 3 
minutes then purified on a 6% polyacrylamide (19:1) 7M urea gel which ran in 1 x TBE 
at 400 V for 60 minutes. RNA gel bands were visualized by UV shadowing, excised into 
a 1.5 mL Eppendorf tube and crushed with a micro pestle (DWK Life Sciences). The 
crushed gel was mixed with 400 uL water and heated for 10 minutes at 70°C. The gel 
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slurry was subsequently loaded onto a Performa Spin Column (Edge Bio) and spun for 3 
minutes at 850 xg. RNA precipitation was done by adding 1.5 uL glycogen (20 mg/mL), 
1/10 volume 3M sodium acetate, and 1 mL cold ethanol (100%) and subsequently being 
stored for 18 hours at -20°C. The precipitated RNA was pelleted by centrifugation at 
17000 xg for 30 minutes at 4°C. Each RNA pellet was washed twice with 70% cold 
ethanol before being resuspended in 50 uL water and stored at -20°C before being end-
labeled. 
2.3.3. 5’ End Labeling of RNA Probes And Cm 072C RNA Transcripts 
 
Five RNA sequences were end-labeled: 3 072C RNA IVT transcripts and 2 
probes ro64 and ro62 (Table 2.6). All were prepared to 10 uM and reactions were set up 
according to Table 2.12 and subsequently incubated at 37°C for 10 minutes. 
Table 2.12. Composition of the 5’ end-labeling reaction with [!-32P]-labeled ATP. 
Reagents for 5’ end-labeling Volumes added (total 25 uL) 
RNA (10 uM) 2.5 uL 
T4 Polynucleotide Kinase (PNK, 10000 units/mL, NEB) 1 uL 
PNK Buffer (10 x) 2.5 uL 
[!-32P]-labeled ATP 3 uL 
Water 16 uL 
 
When the reactions were completed, they were briefly centrifuged then diluted to 
50 uL with water. Each diluted sample was centrifuged through a Micro G-25 Spin 
Column (Santa Cruz Biotechnology) and quantified (1 uL into 1 mL scintillation fluid) 
before and after the column using a Hidex scintillation counter. Each labeled RNA was 
stored at -20°C. 
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2.4. Methods - EMSAs of Msl5 With Various RNA 
 
2.4.1. Set-up of the Msl5 binding reactions using EMSA 
 
Electrophoretic mobility shift assays (EMSAs) were set up for Msl5 with each of 
the 3 072C RNA transcripts (WT pre-mRNA, mutant pre-mRNA, WT mRNA) according 
to Table 2.13. Within each reaction was a final concentration of Msl5 that ranged from 0 
to 10000 nM, and 1 uL of RNA had between 24000 to 28000 cpm depending on the 
RNA. Each reaction was 20 uL. The FP Reaction Buffer (1 X) was 25 mM HEPES-
NaOH pH 7.5, 100 mM NaCl, and 5 mM #-mercaptoethanol. 
Table 2.13. EMSA reagents used for the binding experiments of Msl5 with 072C RNA. 
EMSA Reaction Components Volume Final Concentration 
FP Reaction Buffer 10 uL 1 X 
E. coli tRNA (Sigma-Aldrich) 0.5 uL 5 ug/mL 
BSA (Sigma-Aldrich) 0.1 uL 2.5 ug/mL 
Superasin (Thermo Fisher) 0.25 uL 0.2 units/uL 
Water 4 uL - 
Msl5 protein 4 uL 0 to 10000 nM 
[!-32P]-labeled RNA 1 uL 25 nM (24000-28000 cpm) 
 
Each EMSA reaction was incubated at 42°C for 30 minutes prior to running on a 
6% polyacrylamide (acrylamide/Bis, Bio-Rad 29:1) native gel in 1 x TBE for 72 minutes 
at 200 V. The gels were then exposed for 16 hours at -80°C. 
2.4.2. Analysis of EMSAs 
 
After sufficient exposure at -80°C, gels were visualized with a phosphor imager 
(Packard Instrument Company). Bands were quantified with Optiquant Software. Band 
intensities were converted to percentages of free and bound RNA. Those percentages 
were then fit to the Hill Equation (Equations 2 and 3, section 2.2.3) against their 
respective protein concentration. Kaleidagraph (Synergy Software) was used to 
determine binding affinity (kD) and cooperativity. 
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2.5. Methods - Circular Dichroism Spectroscopy of Msl5 with Cm BPS RNA 
 
2.5.1. Wavescan of Msl5 free and bound to ro64  
 
Circular dichroism spectroscopy (CD) was used to study the structure and thermal 
stability of both free and RNA-bound Msl5 protein with the Jasco J-815 CD 
Spectropolarimeter. Msl5 was diluted to 2.75 uM in CD Buffer (15 mM NaH2PO4 pH 
7.5, 40 mM NaF) and either scanned alone or with 10 uM RNA corresponding to the BPS 
(ro64, Table 2.6). Each sample was incubated at 42°C then put on ice for 15 minutes 
before injection into a quartz cuvette (1 mm path length). For an assessment of total "-
helical and #-strand content of Msl5, wavelength scans were performed in the far UV 
range (260 nm to 185 nm) at 25°C (Peltier temperature controller). Blank measurements 
were taken for buffer subtraction using the identical make-up excluding presence of 
protein (when RNA was mixed with protein, it was also present in the blank sample). 
Program parameters for wavelength scans are included below in Table 2.14. 
Table 2.14. Parameters used for far UV wavelength scans of Msl5. 
Parameter Value Parameter Value 
Accumulations 6 x Photometric modes CD and HT 
Bandwidth 1.00 nm Scanning mode Continuous 
Baseline correction CD Buffer (baseline) Scanning speed 10 nm/minute 
D.I.T. 2 seconds Sensitivity Standard (100 mdeg) 
Data pitch 0.5 nm Wavelength range 260 to 185 nm 
 
2.5.2. Secondary Structure Estimations of Free And RNA-Bound Msl5 
 
CD Spectra data points were data-dumped and converted from CD units (mdeg) 
into mean elipticity (ME; degXCm2dmol-1) using SpectraManager software (Jasco). 
Importantly, the data-dump was also done with CD spectra points from the buffer and 
RNA together, and was subtracted from the protein + RNA data, so that the effect of 
RNA was removed from the analysis of protein conformation. CD spectra graphs were 
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also generated from SpectraManager. The data points were then transferred to Microsoft 
Excel and converted into mean residue molar ellipticity via the Equation 4 below. 
ME(deg X Cm2dmol-1) = [Ellipticity(mdeg) X 106] /                                    Equation 4 
[Pathlength(mm)X Protein(uM) X #peptides] 
 
Mean residue molar ellipticity values for Msl5 and BP RNA-bound Msl5 were 
each uploaded to the K2D3 server for estimations of total "-helical and #-strand content. 
From this analysis, anything not attributed to either structural motif is assumed to be an 
intrinsically disordered region (i.e. flexible linker or random coil). Due to limited (45) 
input values allowed by the K2D3 server, data points collected from 190 to 245 nm at 1 
nm intervals were submitted for analysis. Upon submission, K2D3 utilized a database of 
theoretical CD spectra provided by DichroCalc to estimate secondary structure (Louis-
Jeune et al., 2011). 
2.5.3. Thermal Stability Of Free Msl5 
 
The Jasco J-815 spectropolarimeter and Peltier temperature controller were used 
for a thermal denaturation experiment to measure the melting temperature (or stability) of 
Msl5 by observing the CD signal at a wavelength of 222 nm over the temperature range 
25°C to 90°C. Msl5 was diluted to 18 uM in CD Buffer (15 mM NaH2PO4 pH 7.5, 40 
mM NaF) and immediately transferred to the 1 mm quartz cuvette. Program parameters 
are as previously described except where outlined in Table 2.15. 
Table 2.15. Parameters used for thermal denaturation of Msl5. 
Parameter Value 
D.I.T. 4 seconds 
Data pitch 0.5°C 
Ramp rate 2°C/minute 
Wavelength 222 nm 
Temperature Range (°C) 30°C - 80°C 
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The melting temperature (TM) is the temperature at which the sample has lost 
50% ellipticity, or the protein is 50% unfolded (Consalvi et al., 2000). Once a thermal 
spectrum was acquired, TM of Msl5 was calculated from a built-in TM algorithm in the 
SpectraManager software suite (Jasco). 
2.6 Results and Discussion 
2.6.1. Recombinant Expression and Purification of Msl5 
His-CmMsl5 was affinity purified by incubation with Ni-NTA resin, washed, and 
then eluted by centrifugation. The expression and elution fractions were subsequently 
analyzed on a 12% polyacrylamide SDS-PAGE (25 mA, 50 min) (Fig 2.1 A). The His-
Msl5 construct is 38.64 kDa; on 10-12% polyacrylamide SDS-PAGE, it migrated very 
near the 45 kDa band of the Broad Range Molecular Weight Marker. 
After batch purification, His-Msl5 was mixed with His-TEV protease (28.62 kDa) 
and dialyzed. Cleaved Msl5 was isolated from non-cleaved Msl5, cleaved His-tag, and 
TEV protease (which contains a His-tag), by mixing with the Ni-NTA resin followed by 
centrifugation. The flow-through should contain cleaved Msl5, while everything with a 
His-tag should remain bound to the Ni-NTA resin. Cleaved Msl5 is 36.39 kDa in size and 
ran slightly below the non-cleaved product that is 38.64 kDa (lanes 2-3, Fig. 2.1 B). Also 
visible is a band near 31 kDa marker that corresponds to the TEV protease (lane 3, Fig. 
2.1 B). The flow-through looked to contain cleaved Msl5 and some contaminants, but not 
non-cleaved product or TEV protease (lanes 4-5, Fig. 2.1 B). 
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A 
                     
B 
                                    
Figure 2.1. Expression and affinity purification of Msl5. (A) The expression and Ni-NTA 
batch purification of His-CmMsl5 analyzed on a 12% SDS-PAGE. Pre- and post-induced 
lysates (lanes 1-2) revealed the expressed protein was near the 45 kDa marker. The load, 
insoluble, flow-through, and wash are not readable (lanes 4-7). Both elution lanes show 
high amounts of His-Msl5. (B) SDS-PAGE analysis of Msl5 after cleavage by TEV-
protease and subsequent purification through Ni-NTA resin. The cleaved protein (lanes 
3-4) migrates slightly faster than His-Msl5 (lanes 2 and 4). E* contains uncleaved His-
Msl5 and cleaved His-tag separated from cleaved Msl5 (lane 5). 
 
Affinity purified Msl5 was injected onto the 8 mL MonoS 10/100 GL cation 
exchange column attached to the ÄKTA Purifier10 FPLC system (Fig. 2.2 A). In the 
chromatogram, only 3 colored lines are shown: red (260 nm wavelength), blue (280 nm), 
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and green (gradient of 100 mM to 1 M salt in the MES buffer). The 260 and 280 nm 
wavelengths are excellent in analytical biochemistry; amino acids tryptophan and 
tyrosine optimally absorb light at approximately 280 nm, while nucleic acids absorb best 
at 260 nm. Thus the ratio of 260:280 nm is widely used as a gauge for protein purity and 
nucleic acid contamination (Glasel, 1995). Approximate 260:280 ratios for various 
amounts of protein and nucleic acid are outlined in Table 2.16 below.  
Table 2.16. Ratios for wavelengths 260:280 (nm) of protein and RNA (Held 2001). 
Amount Protein (%) Amount Nucleic Acid (%) 260 nm : 280 nm 
100 0 0.60 
90 10 1.2 
70 30 1.6 
50 50 1.75 
0 100 1.95 
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A                                                
   
B   
                    
Figure 2.2. Cation exchange purification of Msl5. (A) Chromatogram of cation exchange 
(MonoS) purification using the ÄKTA Purifier10 for C. merolae Msl5. (B) SDS-PAGE 
analysis of elution fractions. Lanes 1 and 2 are the protein sample (2.5 ug) before and 
after buffer exchange, and are not represented in the chromatogram. Lane 3 is the flow-
through. Lanes 4-5 are the wash fractions. Lanes 6-7 are each elution fractions from the 
first elution peak (27.19 min). Lanes 8 and 9 are the elution fractions at 29.29 and 30.67 
min, respectively. MW refers to the protein marker. 
 
In the chromatogram are 3 major peaks; fractions from each of the peaks were 
analyzed by SDS-PAGE (Fig. 2.2 B). From the profile of each peak (height, width, and 
260:280), the middle peak looked to be the cleanest (Fig. 2.2 A). Indeed, from inspecting 
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the load (lanes 1-2), peak 1 (lane 3), peak 2 (lanes 6-7), and peak 3 (lanes 8-9), it’s clear 
that cation exchange was useful in removing contaminants (Fig. 2.2 B). Interestingly, 
several light bands slightly below the Msl5 band (around the 45 kDa marker) followed 
Msl5 throughout both affinity and cation exchange chromatography (lanes 6-7, Fig. 2.2 
B). This lead me to suspect that they are C-terminally truncated versions of Msl5 made 
during recombinant expression. Reasons for truncated products include cryptic initiation 
sites in frame with the coding region, premature stop codons, and limited proteolysis; of 
these, the latter two are most likely due to the role of the N-terminal His-tag in affinity 
purification (Kramer and Farabaugh, 2007; Jennings et al., 2016; Baggett et al., 2017). 
Even with a shortened tail, truncated Msl5 would have the His-tag and have a very 
similar amino acid constitution, resulting in it co-purifying with full-length protein 
(Jennings et al., 2016). There are genetic and biochemical ways to ensure only full-length 
protein is purified: silent mutations and a C-terminal tag. Silent mutations made to the 
gene would lower the frequency of premature termination and an additional tag (i.e. 
FLAG) on the C-terminal end of the protein would exclude C-terminal truncations 
(Jennings et al., 2016). 
In an effort to remove the truncated products (and other contaminants) from Msl5, 
size exclusion chromatography was used. According to chromatograms from Gel 
Filtration Standards (Bio-Rad) being run on the same system, the peak at 14.5 mL 
translates to 45 +/- 10 kDa (Fig. 2.3 A; La Verde et al., 2017). While the standards and 
work by La Verde suggested the Superdex200 column would not be suitable, I performed 
the purification due to the availability of size exclusion columns and because Msl5 had 
not yet been attempted on the system (2017). Upon analysis by SDS-PAGE, it’s not clear 
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that fractions from the SEC peak (lanes 3-6) are more pure than the load (Fig. 2.3 B). In 
subsequent biological replicates, CmMsl5 was purified by batch affinity chromatography 
followed by cation exchange chromatography. 
 
A            B 
 
 
Figure 2.3. Size exclusion purification of Msl5. (A) Chromatogram of Cm Msl5 after size 
exclusion (Superdex200) purification uing the ÄKTA Purifier10. Peaks are labeled 
according to the fractions analyzed. (B) SDS-PAGE analysis of peak fractions from the 
chromatogram in A. Lanes 1-4 in the gel refer to fractions C1-C4 in the chromatogram. 
 
2.6.2. Bioinformatics of Msl5 
As discussed in the introductory chapter, there is no Py-tract or poly-U region in 
C. merolae. While Mud2 presumably recognizes a sequence downstream of the BPS that 
is not enriched with uridine or cytosine, no other information is yet known. This suggests 
Msl5 and Mud2 are likely behaving similarly to budding yeast, where BBP (the yeast 
homolog) defines the BPS rather than a Py-tract-driven interaction (Berglund et al., 1997; 
Garrey et al., 2006). To address this question, I first wanted to see how similar the Msl5 
sequence was to its yeast and human counterparts (Selenko et al., 2003; Chang et al., 
2012; Jacewicz et al., 2015). 
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An initial BLAST (Basic Local Alignment Search Tool) search was not fruitful, 
as protein sequences nearest C. merolae were often other extremophiles such as 
Galdieria sulphuraria. As such, I performed a multiple sequence alignment against 
homologs to C. merolae Msl5 that included human (SF1) and budding yeast (BBP). The 
alignment was for the purpose of observing similarity and mapping predicted secondary 
structures (Fig. 2.4). I’ve included the solution structure of a domain of human SF1 (C. 
merolae Msl5 homolog) in complex with RNA, as well the crystal structure of human 
SF1-U2AF65 interacting domains (Fig. 2.5-2.7; Liu et al., 2001; Wang et al., 2013). The 
alignment was done using STRAP and CLUSTALW software (Fig. 2.4; Gille et al., 
2014). 
Msl5 is 36.6% similar to human and 25.2% identical (Fig. 2.4). Msl5 is 32.3% 
similar to yeast and 21.5% identical. Yeast and human are 45.7% similar and 36.9% 
identical. Thus Msl5 is more similar to human than yeast, but yeast and human proteins 
are the most similar based on sequence (Fig. 2.4). Protein structure prediction done using 
the Phyre2 (Protein Homolgy/AnalogY Recognition Engine) server revealed the highest 
confidence and coverage (100.0% confident, 43% Coverage) was the PDB entry 4WAL, 
which is the crystal structure of yeast BBP (Kelley et al., 2015; Jacewicz et al., 2015). 
Furthermore, the Phyre2 homology modeling of Msl5 with yeast BBP produced the same 
alignment as done with STRAP. Together these results give confidence in the secondary 
structure predictions and domain assignment for Msl5. To that end, using alignments and 
modeling, it appears that Msl5 is missing canonical sequences for the ULM, SPSP/PPxY, 
and zinc knuckle motifs (Fig. 2.4).  
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Figure 2.4 Alignment and predicted domain structures of the Msl5 against human (SF1) 
and yeast (BBP) homologs. Similarity was shown with “*” and identity with “!”. The 
UniProt identifiers for the sequences in (B) for Cm Msl5, Hs SF1, and Sc BBP are  
CMI29C, Q15637, and Q12186, respectively. 
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Budding yeast and some other invertebrates have two zinc knuckle motifs; human 
SF1 and vertebrate homologs have a single conserved zinc knuckle, while Msl5 has none 
(Berglund et al., 1997). The single zinc knuckle of SF1 is labeled “SF1 Zn/Zinc 
Knuckle,” while the second zinc motif of yeast BBP is labeled “Zinc Knuckle 2” (Fig. 
2.4). The conserved zinc knuckle is implicated in protein-protein interactions and 
possibly negatively regulates RNA binding activity of BBP/SF1, as a truncated variant 
that lacks the conserved zinc knuckle has an 8-fold improved affinity for RNA (Garrey et 
al., 2006). It is also possible that the conserved zinc knuckle is involved in the 
displacement of BBP/SF1 from the BPS when U2 base pairs with the BPS/3’ SS (Garrey 
et al., 2006; Wang et al., 2008; Chang et al., 2012). Interestingly, the additional non-
conserved knuckle in yeast is involved in RNA binding and removal of that motif results 
in a complete loss of RNA binding ability (Garrey et al., 2006). Furthermore, the 
presence of hydrophobic residues linking the two yeast zinc knuckles suggests an 
additional alpha helix is present in yeast BBP (Fig. 2.4; Garrey et al., 2006). Those 
elements are unique for a branchpoint bridging protein and may be related to the 
preference of yeast BBP for a BPS with an upstream stem loop (Berkowitz et al., 1995; 
Berglund et al., 1997; Garrey et al., 2006). No structures of Msl5 homologs currently 
exist for any domains other than the KH-QUA2 and ULM. 
The ULM (U2AF Ligand Motif) interacts with the reciprocal UHM (U2AF 
Homology Motif) of Mud2/U2AF65 (Fig. 2.5; Selenko et al., 2003; Chang et al., 2012). 
The ULM is characterized by several positively charged amino acid residues (usually Lys 
and Arg) followed by a tryptophan that is known to interact with non-canonical RRMs, 
such as the UHM of ScMud2/U2AF65 (Fig. 2.5; Kielkopf et al., 2001; Zhang et al., 
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2012; Wang et al., 2013). The UHM-interacting tryptophan is position 22 in human and 
35 in yeast (Fig. 2.4). Msl5 does not contain a single tryptophan residue, or a stretch of 
contiguous positively charged residues. This brings to question the legitimacy of an 
Msl5-Mud2 interaction in C. merolae, which is addressed later in this chapter. 
 
Figure 2.5. The crystal structure of the SF1-U2AF65 complex highlights the interaction 
between the ULM and UHM. This human model was adapted from Wang et al., 2013. 
 
Msl5 is also missing the canonical SPSP and PPxY motifs, which have been 
shown to interact with Prp40 and other U1 snRNP proteins (Fig. 2.5; Chang et al., 2012). 
These motifs are within a coiled-coil domain, and have been found to regulate the 
splicing of a subset of human pre-mRNA transcripts (Lipp et al., 2015). In addition, 
phosphorylation of the SPSP motif induces an “arginine claw” fold around the 
phosphorylated serines. This event changes the structure of the ULM and makes the 
coiled-coil interface more accessible to the UHM of ScMud2/U2AF65 (Manceau et al., 
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2006; Zhang et al., 2013). Phosphorylation of the SPSP also increases the specificity of 
SF1 for UHM targets, but decreases the affinity for RNA binding (Chatrikhi et al., 2016). 
Surprisingly, only the KH-QUA2 (hnRNP K Homology-Quaking 2 Homology) 
domain is conserved in Cm Msl5 (Fig. 2.6 A). The structure of the KH-QUA2 domain in 
complex with RNA has been solved with both solution NMR (Nuclear Magnetic 
Resonance) and X-ray crystallography (Fig. 2.6; Liu et al., 2001; Jacewicz et al., 2015). 
KH-QUA2 folds into the canonical #1-"1-"2-#2-#3-"3-"4 topology adopted by the 
STAR (Signal Transduction and Activation of RNA) family of proteins (Vernet and 
Artzt, 1997; Liu et al., 2001). For clarification, the KH domain itself refers to #1-"1-"2-
#2-#3-"3 and QUA2 makes up "4 (Fig. 2.4; Liu et al., 2001; Valverde et al., 2008). A 
hydrophobic groove brings the N- and C-terminal regions of the KH-QUA2 domain 
together, which interact with the 3’ and 5’ ends of the BPS, respectively (Fig. 2.6 B; Liu 
et al., 2001). The conserved QUA2 motif, the GPRG loop, and a loop within the KH 
domain all interact to create the hydrophobic cleft rich in arginine and serine that binds 
the single-stranded negatively charged RNA (Fig. 2.6 B; Liu et al., 2001). Binding 
experiments with various truncations have shown that this domain is necessary and 
sufficient for binding RNA for SF1 (Berglund et al., 1998a; Liu et al., 2001). 
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A 
                          
B 
                                
Figure 2.6. Predicted structure and domains of Msl5. (A) Ribbon representation of the 
SF1 KH-QUA2 domain in complex with 11 nucleotides of the human BPS. (B) Surface 
representation of the hydrophobic cleft that interacts with the BPS. The GPRG (GxxG) 
loop and KH domain (variable loop) are highlighted. These human models were adapted 
from Liu et al., 2001. 
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2.6.3. Functional Interactions of Msl5 with the Branchpoint Sequence 
The human BPS is quite degenerate; accordingly, SF1 is able to recognize 
YXCURAY, where Y is a pyrimidine, R is a purine and X is any nucleotide (Keller and 
Noon, 1984; Green, 1986). Yeast BBP binds the highly conserved UACUAAC sequence, 
which human SF1 prefers as well (Moore et al., 1993; Berglund et al., 1997). The BPS in 
C. merolae is xACUAAC and is conserved across all 27 introns of the Cm intronome 
(Matsuzaki et al., 2004; Stark et al., 2015). To test whether or not Msl5 had similar 
affinity for the BPS than its yeast and human homologs (Table 2.17), I performed a series 
of RNA binding experiments and employed both fluorescence polarization and 
electrophoretic mobility shift assays (EMSAs). 
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Table 2.17. Binding affinities of Msl5 homologs for the  
branchpoint sequence of pre-mRNA. 
Protein RNA target KD (nM) Method Literature 
SF1 22nt rp51A pre-RNA 30000 EMSA Berglund et al., 
1997 
BBP 22nt rp51A pre-RNA 500 EMSA Berglund et al., 
1997 
SF1 34nt AdML pre-
mRNA 
6000 EMSA Berglund et al., 
1998b 
U2AF65 34nt AdML pre-
mRNA 
1000 EMSA Berglund et al., 
1998b 
SF1 + U2AF65 34nt AdML pre-
mRNA 
300 EMSA Berglund et al., 
1998b 
SF1 24nt rp51A pre-RNA 
(upstream SL) 
340 EMSA Garrey et al., 
2006 
SF1 22nt rp51A pre-RNA 310 EMSA Garrey et al., 
2006 
BBP 22nt rp51A pre-RNA 25 EMSA Garrey et al., 
2006 
BBP 24nt rp51A pre-RNA 
(upstream SL) 
4 EMSA Garrey et al., 
2006 
U2AF65 57nt B3P3 pre-mRNA 
(Mullen et al., 1991) 
509 ± 4 ITC Chatrikhi et al., 
2016 
SF1 
(phosphorylated) 
57nt B3P3 pre-mRNA 78 ± 9 ITC Chatrikhi et al., 
2016 
SF1 57nt B3P3 pre-mRNA  40 ± 1 ITC Chatrikhi et al., 
2016 
SF1 + U2AF65 57nt B3P3 pre-mRNA 2 ± 1 ITC Chatrikhi et al., 
2016 
 
I used fluorescence polarization as a binding assay to test the specificity of Msl5 
for BPS RNA. RNA oligonucleotides ro64, ro66, and ro52 corresponded to the Cm BPS 
(3'-fluorescein), 3’ U4 snRNA (5’-fluorescein), and U4 5’ stem loop (5’-fluorescein). 
Using the mfold server, secondary structures were predicted for each of the RNA 
oligonucleotides used in FP and EMSA (Zuker and Jacobson, 1998; Waugh et al., 2002; 
Zuker, 2003). Of the 4 RNA sequences, only ro52 (the U4 5’ Stem Loop) generated a 
secondary structure (Fig. 2.7). 
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Figure 2.7. Simulated RNA folding of the U4 5’ Stem Loop (nucleotides 22-50), 
corresponding to ro52 used in various binding experiments. ro52 is the C. merolae U4. 
The remaining RNA oligonucleotides did produce reasonable structures and are mostly 
single-stranded. The predicted secondary structure was generated with the mfold server, 
and had a predicted free energy of Delta G = -10.10 (initially -9.60) kcal/mol. 
 
Fluorescein was chosen as a fluorphore because it has strong excitation and 
emission peaks, and because it can handle several exposures with minimal photo 
bleaching (Jöback et al., 1995). The saturation curve below shows the interaction 
between the C. merolae branchpoint bridging protein Msl5 against ro64, ro66, or ro52 
(Fig. 2.8). Notably, the solid black line (ro64, Cm BPS, ssRNA) is very steep and quickly 
becomes a plateau, while spaced (ro66, U6 3’ end, ssRNA) and dotted (ro52, U4 5’ Stem 
Loop, dsRNA) never plateau (Fig. 2.8). The “plateau” on a curve indicates the labeled 
ligand population has become fully bound. 
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Figure 2.8. Saturation curve from fluorescence polarization measurements of Msl5 
titrated against three RNA targets (15 nM). Each curve represents the binding of CmMsl5 
to the Cm BPS (ro64, solid), U4 3’ end (ro66, slashed), and U4 5’ stem loop RNA (ro52, 
dotted). Curve fitting for all 3 data sets was done using Equation 2. 
 
The data were fitted to the Hill Equation to quantify cooperativity and binding 
affinity (section 2.2.3), both with the Hill Coefficient floating (Equation 2) and fixed to 1 
(Equation 3). While minimizing constraints is often the best way to analyze an 
interaction, I wanted to see how the model behaved if the Hill Coefficient was set to 1. 
The Hill Coefficient describes the cooperativity of an interaction; a value of 1 indicates 1 
molecule of the ligand is interacting with one other molecule. Given that the interaction 
between homologs of Msl5 and the BPS have been characterized and shown to be 1:1, I 
expected Msl5 to behave similarly (Liu et al., 2001; Garrey et al., 2006; Chatrikhi et al., 
2016). As such, there should be little difference in binding affinity between a variable 
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and fixed coefficient if Msl5 truly interacts with the BPS RNA in a non-cooperative (1:1) 
manner. Indeed, the KD of Msl5 for the BPS RNA (ro64) was 44 ± 4 nM when the Hill 
Coefficient was fixed to 1, and was 42 ± 2 nM when the Hill Coefficient was allowed to 
float (Table 2.18). Each data point on the curve represents the average from 12 replicates, 
and the error bars were generated from the standard deviations of those replicates (Fig. 
2.8). From these binding experiments, Msl5 has very similar affinity for the conserved 
Cm BPS relative to published work with its homologs (Tables 2.17 and 2.18). The 
affinity of Msl5 against 3’ end of U4 (ro66) was 10 X worse (400-500 nM), the error and 
cooperativity were very high, further indicative of a nonspecific interaction (Table 2.18). 
Table 2.18. Binding affinities of Msl5 for RNA oligonucleotides measured by FP. 
RNA target KD (nM) Hill Coefficient R2 (goodness of fit) Fit to 
Equation 
ro64 (Cm BPS) 42 ± 2 1.3 ± 0.07 0.99878 2 
ro64 (Cm BPS) 44 ± 4 1 0.99716 3 
ro66 (ssRNA) 440 ± 3000 27 ± 500 0.61990 2 
ro66 (ssRNA) 490 ± 120 1 0.98849 3 
ro52 (dsRNA) 3400 ± 1000 0.7 ± 0.05 0.99841 2 
ro52 (dsRNA) 1400 ± 180 1 0.99498 3 
 
I next wanted to test how well Msl5 binds a Cm pre-mRNA transcript, and how 
well it discriminates against a mutated BPS. To that end I used the electrophoretic 
mobility shift assay (EMSA) and titrated increasing concentrations of Msl5 against 25 
nM RNA. In order to ensure the technique was analogous to FP, ro64 and ro62 were 5’ 
end-labeled with [32P] (Fig. 2.9). A single gel shift of each was performed as a proof of 
principle for comparing Msl5 binding via FP and EMSA (Fig. 2.9). Msl5 begins to 
noticeably shift the  [32P]-labeled ro64 at 50 nM, although not quite by 50% as seen in FP 
(Fig. 2.9 A). Surprisingly, even at 5000 nM Msl5 does not shift ro62 (Fig. 2.9 B). These 
results highlight the specificity Msl5 has for the BPS. 
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 B 
             
 
 
Figure 2.9. EMSA measurements of Msl5 binding Cm BPS. (A) Msl5 titrated against the 
Cm BPS (ro64). (B) Msl5 titrated against the 3’ end of U6 snRNA (ro62). Both RNA 
probes were  [32P]-labeled and 25 nM (24000-28000 cpm) was mixed in each reaction. 
 
 
The bands were quantified as intensities, which were converted into percentage of 
RNA free and bound. Percentages of RNA bound were plotted against [Msl5] (nM) and 
fitted against the Hill Equation to generate saturation curves and binding affinities (Fig. 
2.10; Table 2.19). 
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Figure 2.10. Saturation curve from EMSA binding assay of Msl5 titrated against two 
RNA targets (25 nM). Each curve represents the binding of CmMsl5 to the Cm BPS 
(ro64, solid), U6 3’ end (ro62, slashed). Curve fitting for both data sets was done using 
Equation 2. 
 
 
Table 2.19. Binding affinities of Msl5 for RNA oligonucleotides measured by EMSA. 
RNA target KD (nM) Hill Coefficient R2 (goodness of fit) Fit to 
Equation 
ro64 (Cm BPS) 64 ± 4 1.4 ± 0.15 0.99792 2 
ro64 (Cm BPS) 66 ± 8 1 0.99494 3 
ro62 (ssRNA) > 5000 n/a n/a 2 
ro62 (ssRNA) > 5000 n/a n/a 3 
 
The RNA oligonucleotide ro64 was used in both FP and EMSA binding 
experiments to confirm that the results obtained from either experiment was similar. 
Msl5 bound ro64 with similar affinity using either FP or EMSA, and these values (KD of 
40-70 nM) were in-line with published work (Tables 2.16-2.19). Gel shift assays were 
next performed using 3 different variants of nascent 072C Cm RNA: wild type (WT) pre-
mRNA, mutant (MUT) pre-mRNA, and mRNA (Fig. 2.11-2.13; section 2.3.1). The 
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purpose of the experiment was to determine if Msl5 was able to discriminate against 
mutant pre-mRNA or mRNA transcripts. Given that C. merolae seems to lack many of 
the splicing factors necessary for improved fidelity, it would be advantageous for Msl5 to 
avoid binding anything in the nucleus that is not a normal pre-mRNA (Stark et al., 2015).  
The pre-mRNA transcripts included the full intron and 40 nucleotides upstream and 50 
downstream of each flanking exon. The mRNA transcript had a contiguous stretch of 
exonic sequence (section 2.3.1). The secondary structures of each of these RNA were 
predicted with the mfold server and associated software, as previously described (Zuker 
and Jacobson, 1998; Waugh et al., 2002; Zuker, 2003). The 5’ splice site (5’ SS), 3’ 
splice site (3’ SS) and BPS are highlighted in the pre-mRNA structures of wild type 
(WT) and mutant (MUT) transcripts (Fig. 2.11-2.12). A black dot marks the branchpoint 
adenosine (A95) for the WT structure (Fig. 2.11) as well as the A95G mutation in the 
mutant transcript (Fig. 2.12). The exon-exon junction of the spicing event is marked for 
the mRNA transcript (Fig. 2.13). I wanted to visualize the most energetically favourable 
secondary structures for each transcript to check if the 5’ SS and BPS mutations 
dramatically altered the structure of the pre-mRNA. If the structures were similar, and the 
BPS was single stranded/accessible for both WT and MUT, I could be reasonably sure 
that the mutations would only affect the Msl5-BPS interaction through an altered BPS. 
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Figure 2.11. Simulated RNA folding and predicted secondary structure of WT pre-
mRNA. The predicted secondary structure of C. merolae 072C WT pre-mRNA was 
generated with the mfold server. Predicted free energy: Delta G = -115 kJ/mol (initially -
157 kJ/mol). 
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Figure 2.12. Simulated RNA folding and predicted secondary structure of mutant pre-
mRNA. The predicted secondary structure of C. merolae 072C mutant pre-mRNA was 
generated with the mfold server. Predicted free energy: Delta G = -127 kJ/mol (initially -
144 kJ/mol). 
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Figure 2.13. Simulated RNA folding and predicted secondary structure of WT mRNA. 
The predicted secondary structure of C. merolae 072C WT mRNA was generated with 
the mfold server. The predicted secondary structure was generated with the mfold server. 
Predicted free energy: Delta G = -57 kJ/mol (initially -64 kJ/mol). 
 
While these models may be wildly inaccurate, they illustrate the effect of 
sequence on RNA structure. The 5’ SS and BPS were mutated in the MUT pre-mRNA, 
and could easily cause structural changes that make the protein more difficult to 
recognize for splicing factors beyond the original sequence mutation. The lowest energy 
models for WT and MUT 072C transcripts seemed reasonably similar, and both had 
single stranded BPSs (Fig. 2.11-2.12). When splicing is complete and the mRNA product 
is released by the spliceosome, the transcript would have a very different structure 
compared to when it contained an intron, as was seen by the lowest energy model (Fig. 
2.13; Warf and Berglund, 2010). Binding of Msl5 to pre-mRNA (WT and mutant), as 
well as mRNA was measured through EMSA in triplicate. RNA generated from IVT and 
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run on a native acrylamide gel often generates multiple bands due to the adoption of 
different secondary structure (Derrick and Horowitz, 1993). Three distinct bands are seen 
in the first lane of the WT pre-mRNA EMSA, and the top two have likely adopted 
different secondary structures while the third is degraded RNA, evidenced by band shifts 
(Fig. 2.14). The first noticeable shift occurs by 100 nM Msl5 (lane 8), and further shifts 
occur at each subsequent step (lanes 9-12), leaving a question of whether the multiple 
shifts were the result of different RNA conformations or cooperative binding. The answer 
was revealed when the data was analyzed and later fit to the Hill Equation. Gel shifts of 
the mutant transcript and mRNA appeared to be progressively worse (Fig. 2.15-2.16). 
 
               
Figure 2.14. EMSA measurement of Msl5 binding the WT 072C pre-mRNA transcript. 
C. merolae WT pre-mRNA was made from IVT then [32P]-labeled. 25 nM (24000-28000 
cpm) of RNA was present in each reaction. 
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Figure 2.15. EMSA measurements of Msl5 binding the mutant 072C pre-mRNA 
transcript. C. merolae mutant pre-mRNA was made from IVT then [32P]-labeled. 25 nM 
(24000-28000 cpm) of RNA was present in each reaction. 
 
 
            
Figure 2.16. EMSA measurements of Msl5 binding the 072C mRNA transcript. The C. 
merolae mRNA was made from IVT then [32P]-labeled. 25 nM (24000-28000 cpm) of 
RNA was present in each reaction. 
 
Each of these gels, and their replicates, were transformed into respective fractions 
of bound RNA and plotted against Msl5 concentration (Fig. 2.17). As the RNAs were all 
relatively large and presented the KH-QUA2 domain the opportunity for a non-canonical 
(i.e. cooperative) interaction, the Hill Coefficients resulting from these EMSAs were of 
great interest. 
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Figure 2.17. Saturation curves of CmMsl5 against various 072C RNA transcripts: WT 
pre-mRNA (black); mutant pre-mRNA (grey); mRNA (dotted grey). Each point 
represents the average of 3 or more intensities from replicate EMSAs. Curve fitting for 
all 3 data sets was done using Equation 2. 
 
 
The curves were fitted to the Hill Equation to generate binding affinities and 
respective Hill Coefficients. From this curve fit, the Msl5-072C pre-mRNA interaction 
had a Hill Coefficient of 0.8 ± 0.12 (R2 = 0.99559), which suggested that there was no 
cooperativity at play (Table 2.20). Strikingly, the binding affinity of Msl5 for the 175 nt 
full-length intron (IVT 072C WT pre-mRNA) was identical to that of the 11 nt BPS oligo 
(ro64). The tight binding of Msl5 to both short and long BPS-containing RNA suggests 
that there were no additional contacts made between Msl5 and the full-length pre-mRNA 
that either promoted or inhibited the interaction.  
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Table 2.20. Binding affinities of Msl5 for various Cm 072C Nascent transcripts. 
RNA target KD (nM) Hill Coefficient R2 (goodness of fit) Fit to 
Equation 
WT pre-mRNA 46 ± 9 0.8 ± 0.15 0.99559 2 
WT pre-mRNA 43 ± 8 1 0.99390 3 
MUT pre-mRNA 8100 ± 4700 0.3 ± 0.13 0.97474 2 
MUT pre-mRNA 210 ± 92 1 0.96764 3 
mRNA 1300 ± 670 1.7 ± 1.23 0.92841 2 
mRNA 2100 ± 1600 1 0.92154 3 
 
 
2.6.4. Structural Measurements of Msl5 with CD Spectroscopy 
Circular dichroism (CD) was measured to assess the secondary structure content 
of Msl5 free and bound to BPS RNA (Fig. 2.18). CD spectra data points were taken for: 
buffer + RNA (ro64); buffer + protein; buffer + protein + RNA. The buffer + RNA 
(ro64) data was subtracted from the data from buffer + Msl5 + RNA (ro64) in order to 
exclude the CD effect of RNA. Using the software and reference database from the 
K2D3 server, the alpha helical and beta sheet content was determined (Louis-Jeune et al., 
2012). CD was also employed to determine the thermal stability of Msl5 (Fig. 2.19). 
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Figure 2.18. CD spectra of Msl5 and the Cm consensus BPS. Overlay of circular 
dichroism spectra of Msl5 (dotted) and Msl5 bound to BPS RNA oligo in a 1:3 molar 
ratio (line). All spectra data was generated from 8 accumulations using a Jasco J-815; 
samples were scanned in 15mM NaH2PO4 pH 7.5, 40mM NaF buffer. The background 
reference (buffer + ro64 RNA) was subtracted from the buffer + protein +RNA prior to 
graphing and secondary structure estimation. 
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Figure 2.19. Thermal stability analysis of Msl5. Data was generated using the Peltier 
temperature controller attached to the Jasco J-815. The C. merolae Msl5 sample was 
scanned in 15mM NaH2PO4 pH 7.5, 40mM NaF buffer. 
 
Wave-scans performed on both free and ro64-bound Msl5 were done in duplicate, 
from 260 nm to 189 nm (Fig. 2.18). The 189 nm cut-off was due to high-tension (HT) 
reaching 600V at 190 nm. Thermal stability was similarly measured in duplicate but was 
regrettably not measured for an Msl5-RNA complex (Fig. 2.19). The wave-scan spectra 
for free versus bound Msl5 appeared to be different, with free Msl5 having smaller 
minima and maxima (Fig. 2.18). When the data was extracted and uploaded onto the 
K2D3 server, secondary structure predictions were very similar to each other (Table 
2.21). The measured secondary structure content disagrees with the prediction done using 
the PSIPRED server for "-helix and #-strand content, but not intrinsically disordered 
regions (Jones, 1999; Buchan et al., 2013). The thermal transition of Msl5 was 
determined to be 56.5 ± 1°C, which was very close to the 55°C Tm reported for yeast 
BBP and the limit for survivability of C. merolae (Matsuzaki et al., 2004; Garrey et al., 
2006). 
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Table 2.21. Secondary structure of Msl5 by Circular Dichroism and predictive software. 
Species "-helix (%) #-strand (%) Intrinsically 
Disordered (%) 
Method 
Msl5 (Free) 77.62 ± 5 1.80 ± 2 20 CD Spec 
Msl5 (ro64-bound) 77.64 ± 5 1.76 ± 2 20 CD Spec 
Msl5 (Free) 35 5 19 PSIPRED 
 
2.6.5. Recombinant Expression and Purification of Msl5/Mud2 Dimer 
Co-expressed His-CmMud2 and Msl5 was purified by incubation with Ni-NTA 
resin, washed, and then eluted by centrifugation. The expression and elution fractions 
were subsequently analyzed on a 10% polyacrylamide SDS-PAGE at 22 mA for 50 min 
(Fig. 2.20). The His-Mud2 and Msl5 constructs are 145.25 kDa and 36.23 kDa; His-
Mud2 migrated slightly below the 200 kDa marker while untagged Msl5 was thought to 
be a band near 45 kDa. Further analysis was needed to confirm the presence of Msl5. 
Several contaminant bands were visible near the 66 kDa, 31 kDa, and 21 kDa markers. 
 
                       
Figure 2.20. Co-expression and Ni-NTA batch purification of His-Mud2 and Msl5 
analyzed on a 12% SDS-PAGE. Elut 1 and 2 refer to the first and second fractions 
collected, while 3 and 4 correspond to fractions 14 and 15. 
 
Unlike Msl5 alone, the Mud2/Msl5 dimer is a large (180 kDa) complex that 
seemed an excellent candidate for size exclusion purification over the Superdex200 
10/300 GL column (GE). Both La Verde (2017) and the chromatogram of the Gel 
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Filtration Standards suggested that 180 kDa proteins are separated from 150 kDa proteins 
without peak overlap/contamination (La Verde, 2017). Thus this step should have 
improved purity and removed free Mud2 and Msl5 proteins. Affinity-purified sample was 
injected 1 mL at a time and ran through the Superdex200/ÄKTA Purifier10 system (Fig. 
2.21 A). The first peak was suspected to be within the void volume of the column: 
fractions that contain aggregates of misfolded or degraded protein products (Fig. 2.21 A; 
Carpenter et al. 2010). From SDS-PAGE analysis, only Peak 2 was kept in each run 
because it was the only peak that contained bands near the 200 kDa and 45 kDa markers 
(Fig. 2.21 A, B). SDS-PAGE was perhaps the best available technique because band 
intensities could be equated with stoichiometry, which was expected to be 1:1 (Berglund 
et al. 1998b; Selenko et al., 2003). Band quantification showed that the bands near 200 
and 45 kDa from the elution (lanes 7-10) had a 1:2 stoichiometry (Fig. 2.21). The 
stoichiometry of the proteins suggested there’s a population of free Mud2 as well as 
dimer. It would be unlikely that E. coli would synthesize equal amounts of the proteins; 
having an affinity tag on Msl5 and doing two separate affinity purifications would have 
limited the amount of non-dimerized protein (Gräslund et al., 2008).  
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Figure 2.21. Size exclusion chromatography purification of the Mud2/Msl5 heterodimer. 
Red is 260nm and blue is 280 nm. A) Representative chromatogram of the size exclusion 
purification and B) corresponding SDS-PAGE analysis of the fractions. Peaks 1-5 are 
labeled on the gel and the chromatogram, corresponding to the various elution fractions 
of the size exclusion chromatogram. Peaks 6 and 7 were not shown on the chromatogram 
and corresponded to later (smaller) fractions. Mud2 and Msl5 were recombinant C. 
merolae proteins. 
 
While the presence of His-Mud2 was evidenced by the band slightly below 200 
kDa in the lysate of induced cells and subsequent purifications, I wanted to verify the 
presence of Msl5. The band near 45 kDa was suspected to be Msl5 because His-Msl5 
migrated similarly (Fig. 2.1), but DnaJ is a 41 kDa E. coli chaperone known to co-purify 
during immobilized metal affinity chromatography (Gräslund et al., 2008). With a 
polyclonal rat "-Msl5 (gift of Dr. Robert Burke’s lab, UVIC) and monoclonal goat " rat 
HRP IgG (Santa Cruz Biotechnology sc-2065), I performed a Western Blot to verify that 
Msl5 was present in the His-Mud2 pull-down. Previously purified Msl5 (lane 1) was 
compared with the Mud2 pull-down (lane 3), revealing that the brightest bands of each 
sample appear near the 37 kDa marker (Fig. 2.22). This confirmed that Msl5 is present in 
the elution and bound to Mud2. When comparing lanes 1 and 3, it appeared that Msl5 
from the dimer ran slightly higher (Fig. 2.22). Given that both samples were untagged 
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and very similar in size, three factors likely contributed to this: i) the pure Msl5 sample 
was older and may have been exposed to proteases; ii) the gel ran on a slant; iii) different 
quantities were loaded, obscuring the analysis.  
                                        
Figure 2.22. Western Blot of His-CmMsl5 and His-CmMud2 affinity pull-downs. The 
primary antibody was polyclonal rat " CmMsl5 and the secondary was goat " rat. 
 
With reasonable evidence that there was a population of Mud2 and Msl5 
heterodimer, the concentration needed to be determined. Assays that measure total 
protein, such as spectrophotometry (260/280 nm wavelengths or the Bicinchoninic acid 
assay), were not appropriate since there were 2 different proteins. Standardization was 
done through SDS-PAGE by titrating known amounts of previously purified Msl5 
against 2 uL of the purified dimer (Fig. 2.23). Band quantification revealed that Msl5 of 
the dimer, and Mud2 by association, was approximately 2000 uM (Fig. 2.23). 
Interestingly, the stoichiometry of the Mud2:Msl5 was 1:1.3 (lane 10, Fig. 2.23). 
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Figure 2.23. The standardization of CmMud2/Msl5 by comparison against known 
amounts of CmMsl5. Quantification of band intensities showed that the concentration is 
approximately 2000 nM (or 2.5 pmol per uL). 
 
2.6.6. Fluorescence Polarization and Bioinformatics of Msl5/Mud2 Dimer 
The ideal assay to measure the effect of CmMud2 on the Msl5-BPS interaction is 
the gel shift. EMSA allows for the use of large RNA sequences, whereas FP is limited to 
RNA of approximately 40 nucleotides in size due to tumbling and polarization of the 
fluorphore (Prystay et al., 2001). The Cm Mud2/Msl5 heterodimer was titrated against 
the 11-nucleotide long BPS (ro64) in FP due the lack of available IVT RNA and a series 
of troubleshooting problems that occurred during that time. Given those constraints, this 
experiment intended to address the question of whether Mud2 affects the RNA binding 
ability of Msl5. The anisotropy values were transformed and plotted against dimer 
concentration to generate saturation curves (Fig. 2.24). During curve fitting, The Hill 
Coefficient was set to 1 (A), 2 (B), 3 (C) and variable/float (D). Unlike the Msl5-BPS 
interaction, forcing the Hill Coefficient to 1 severely distorted the shape of the curve 
(Fig. 2.8 and 2.24 A). Indeed, from comparison of the various Hill Coefficients and 
corresponding R2 values, it’s clear the value is 2-3 (Table 2.22). This indicates the 
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interaction between Mud2, Msl5, and the RNA is cooperative and similar to the 
cooperative interaction in yeast and humans (Berglund et al., 1998b; Zhang et al., 2012). 
Unfortunately the amount and concentration of Mud2-Msl5 dimer after purification was 
only sufficient for a single triplicate experiment to a maximum of 250 nM (Fig. 2.24). 
For that reason, this experiment provided an insight into cooperativity of the Mud2-Msl5-
RNA interaction, but not binding affinity (Table 2.22). 
  
 
Figure 2.24. Fluorescence polarization of the CmMud2/Msl5 heterodimer titrated against 
the Cm BPS RNA. The saturation curves represent the binding of CmMsl5 to the Cm 
BPS (solid black) and U4 3’ end (dotted). (A-C) Curve was fitted with the Hill 
Coefficient set from 1-3, respectively, using Equation 3. (D) Curve was fitted with the 
Hill Coefficient floated using Equation 2. 
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Table 2.22. Dissociation constants and Hill Coefficients for FP binding  
assays of the Msl5/Mud2 dimer against the Cm BPS. 
RNA 
Target 
Apparent KD (nM) Hill 
Coefficient 
R2 (goodness of fit) Fit to 
Equation 
ro64 1X1013 ± 3X10-10 1 0.92532 3 
ro66 3X1015 ± 2X1013 1 0.45138 3 
ro64 180 ± 90 2 0.95218 3 
ro66 1900 ± 1000 2 0.60416 3 
ro64 132 ± 35 3 0.95240 3 
ro66 850 ± 1000 3 0.68398 3 
ro64 147 ± 122 2.5 ± 2.5 0.95312 2 
ro66 315 ± 1X105 16 ± 170 0.77679 2 
 
While the Cm Mud2-Msl5-RNA interaction has been shown to be likely 
cooperative, many interesting questions are not directly addressed with a binding assay 
using 11 nucleotides of the BPS. These questions include how Mud2 affects binding of 
Msl5 to a full-length intron, or what sequence Mud2 recognizes. This experiment wasn’t 
expected to have allowed for a Mud2-RNA interaction, because the short RNA would 
likely be sequestered in a groove of Msl5 and not extend enough to contact Mud2 (Liu et 
al., 2001; Zhang et al., 2012; Jacewitz et al., 2015). Furthermore, footprinting studies of 
SF1/BBP and U2AF65/Mud2 proteins have shown that SF1/BBP protects the 7 
nucleotides of the BPS and two nucleotides on each end (11 total), while U2AF65/Mud2 
begins contact with the Py-tract 3 nucleotides downstream of the BPS (Berglund et al. 
1998a). RNA oligonucleotide ro64 represents the 11 nucleotides of the BPS, providing 
no ligand for Mud2. Since the KH-QUA2 domain and BPS affinity of Msl5 seem highly 
conserved, it seems unlikely Mud2 would contact the 11 nucleotide-protected region of 
the BPS (Berglund et al., 1997). Structurally, the U2AF65-SF1 human interaction 
involves rearrangements of both proteins (Zhang et al., 2012). While the concentration 
was quite small in this experiment, the binding affinity appears to be 5-fold lower, from 
about 40 nM to 180 nM (Tables 2.17 and 2.21). Perhaps the Mud2-Msl5 interaction in 
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Cm modifies the topology of the KH-QUA2 domain and thus the affinity of Msl5 for the 
BPS. This alteration would be unlikely and unique for Msl5 and Mud2, but they are quite 
divergent from yeast and human homologs. Despite sequence differences, branchpoint 
selection is likely driven by Msl5 and stabilized by Mud2, as occurs in yeast. 
In order to get some insight into CmMud2 besides the binding experiment, I 
performed a series of BLAST searches and multiple sequence alignments. CmMud2 is 
1316 amino acids in size, while human and yeast homologs are 475 and 527 respectively. 
Amazingly, no BLAST searches (of varying constraints) produced a single result that 
aligned to the first 800 residues. Searches that include only the first half of the protein 
will not produce a single result other than itself. Interestingly, both human 
ScMud2U2AF65 and U2AF35 homologs are identified in the BLAST search, but occur 
in overlapping regions (resides 1200-1316). Multiple sequence alignments with human 
and budding yeast (S. cerevisiae) homologs revealed one particular region to be 
conserved: RRM3, or the U2AF Homology Motif (Fig. 2.25). The UHM interacts with 
the ULM of SF1/BBP (Fig. 2.5; Henscheid et al., 2008; Wang et al., 2013). 
ScMud2/U2AF65 have been shown to contain 3 RRMs, of which RRM1 and 2 are 
implicated in binding the Py-tract/Poly-U region, while RRM3/UHM is involved in 
binding SF1/BBP (Selenko et al., 2003; Zhang et al., 2012).  
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Figure 2.25. Alignment and predicted secondary structure of the U2 Homology Motif 
(UHM) of Mud2 against human (SF1) and yeast (BBP) homologs. Similarity was shown 
with “*” and identity with “!”. The UniProt Identifiers for C. merolae Mud2, U2AF65, 
and ScMud2 were CMS438C, P26368, and P36084 respectively. 
 
The UHM of Mud2 is 45.5% similar and 26.7% identical to human, and 31.7% 
similar and 20.2% identical to yeast (Fig. 2.25). Human and yeast are 40.6% similar and 
25.7% identical. Interestingly, the UHMs of Msl5 and U2AF65 are the most similar 
based on sequence. Furthermore, each of the RNP motifs (RNP2 and RNP1) agrees with 
the consensus sequences (Fig. 2.25; Wang et al., 2013). This alignment, together with the 
results showing both Msl5 and Mud2 were able to co-purify, make a strong argument for 
an Msl5-Mud2 interaction in C. merolae. 
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Chapter 3 
Functional and Structural Characterization of Snu13 
This chapter follows the structural and functional investigation into Snu13, a 
double-stranded RNA binding protein associated with the assembly of the U4/U6 di-
snRNP. The structure of the protein was determined by X-ray crystallography; to verify 
the structure was that of a functional Snu13, fluorescence polarization was used to 
measure the binding affinity of the protein to its target, the U4 5’ stem loop. 
3.1. Methods - Expression and Purification of C. merolae Snu13 Protein 
3.1.1. Recombinant Expression of Snu13 from Rosetta pLysS (DE3) Cells 
Dr. Andrew M. MacMillan from the University of Alberta generously provided 
the plasmid vector pMCSG7, which features an N-terminal 6xHis-tag and a T7 promoter. 
Dr. Martha Stark cloned Snu13 from the C. merolae genome into the pQLinkH vector 
(Addgene plasmid 13667) using primers 1 and 2 (see sections 2.1 and 4.4). The gene was 
then cloned into pMCSG7 from pQLinkH using primers 3 and 4 (Table 3.1). 
Table 3.1. Primers used to clone Snu13 from the Cm genome into pMCSG7. 
Primer Plasmid Sequence 
1 (fwd) pQLinkH ATG CTT GGA TCC ATG GAA CCT TTG AGC TCC AC 
2 (rev) pQLinkH GGT ACG CTC TCG GAT CGG CCT GAT TCG GCG 
3 (fwd) pMCSG7 TAC TTC CAA TCC AAT GCA GAA CCT TTG AGC TCC 
ACT GAA GCG 
4 (rev) pMCSG7 TTA TCC ACT TCC AAT G TTA TCA GAG CAG AAG CTG 
TTC GAT CTT TGT TCG 
 
103ng of pMCSG7-Snu13 was transformed into 50 uL of Rosetta pLysS (DE3) 
competent cells by means of heat shock. 100 uL of LB was added and the mixture was 
plated on LB agar supplemented with ampicillin and chloramphenicol, each at a 1:1000 
dilution. The plate was incubated at 37°C for 18 hours. 2 colonies were selected to 
inoculate 90mL of LB/AMP/Chlor broth. The broth was incubated in a shaker set at 250 
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RPM at 37 °C for 18 hours. 10 mL of the broth was added to 1 L LB/AMP/Chlor broth 
for induction. The cells were induced at an OD600 of 0.65 with 0.1 mM IPTG. Induction 
was carried out for 3.5 hours before centrifugation for 12 min at 3500 RPM and re-
suspension in 10 mL Snu13 Wash Buffer (Table 3.2). The ~10 mL cell suspension was 
centrifuged for 15 min at 3200 RPM, before the supernatant was discarded and the cell 
pellet was flash-frozen in liquid nitrogen before storage at -80°C.  
Table 3.2. Complete list of the buffers used in the purification of Snu13. 
Buffer Components 
Snu13 Wash Buffer 20 mM HEPES-Na-OH pH 7.5, 300 mM NaCl, 30mM 
Imidazole 
Benzonase Buffer 50mM Tris-HCl pH8, 1.5mM MgCl2, 50mM NaCl 
Benzonase Removal Buffer 20mM HEPES-NaOH pH 7.5, 5mM #-mercaptoethanol, 
500mM NaCl 
Snu13 Elution Buffer 20mM HEPES-Na-OH pH 7.5, 300mM NaCl, 275mM 
Imidazole 
Snu13 Storage Buffer 20mM HEPES-Na-OH pH 7.5, 85mM NaCl, #-
mercaptoethanol 
 
3.1.2. Lysate Preparation and Affinity Chromatography  
In order to purify Snu13 from bacterial lysate, batch binding affinity 
chromatography was performed. Each pellet of Snu13-induced Rosetta cells was treated 
with Protease Inhibitor Cocktail Tablets (Sigma-Aldrich), EDTA-Free, then re-suspended 
with 11 mL Snu13 Wash Buffer. After re-suspension, the sample was sonicated 13X 
using 10 second bursts and 1 minute rests. Streptomycin sulfate was added as a nucleic 
acid precipitant and the lysate was cleared via centrifugation at 25000 XG for 12 min. 
The supernatant was collected and mixed with equilibrated nickel resin (Ni-NTA Resin) 
in a 50 mL conical tube. The tube was rotated end- over-end for one hour at 4°C. The 
resin was pelleted by centrifuging the tube for 2 min at 700 Xg and 4°C. Resin was 
washed twice with 10mL Snu13 Wash Buffer, and again centrifuged for 2 min at 700 g 
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and 4°C. After the second wash was aspirated off, the resin was treated with the 
RNA/DNA endonuclease Benzonase (Sigma-Aldrich) to remove all nucleic acid that co-
purified with the RNA-binding protein. 35 units of Benzonase in 1mL Benzonase Buffer 
were added to the resin, followed by agitation every 5 minutes for 1 hour (Table 3.2). 
Benzonase was cleared from the Snu13-bound resin by washing twice with 10mL of 
Benzonase Removal Buffer (Table 3.2). One additional wash was done using 10mL of 
Snu13 Wash Buffer. 1mL elution fractions were collected using Snu13 Elution Buffer 
(Table 3.2). Based on OD260/260 values and protein concentration (via NanoDrop 
Spectrophotometer), only the first 10 elution fractions were kept. 
3.1.3. His-Tag Cleavage And Removal  
1mg of TEV protease (Addgene pRK792) was mixed with the pooled eluate (100 
mg). The protein/TEV mixture was dialyzed for 18 hours in Snu13 Storage Buffer (Table 
3.2). Following cleavage/dialysis, the sample was mixed with the Ni-NTA resin, rotated 
end-over-end for an hour, and centrifuged for 2 min at 700 g. The flow through (cleaved 
protein) was collected for downstream purification/testing. 
3.1.4. Size Exclusion Chromatography Purification 
Snu13 was further purified via size exclusion chromatography (SEC) using a 
Superdex200 10/300 GL column in-line with the ÄKTA Purifier 10 system (GE 
Healthcare Life Sciences). For optimal resolution on this column, 5 mg of protein was 
loaded per run. From the chromatogram, the 260 nm and 280 nm peaks were used to 
determine where the protein eluted. After running post-SEC samples on a 12% SDS-
PAGE gel ((25 mA, 60 min) and taking OD260/280 readings, SEC elution fractions were 
pooled and concentrated to 10mg/mL using Millipore Amicon® Ultra 10K 15 mL 
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Centrifugal Filters. The protein was used for crystal trials, fluorescence polarization, and 
small angle X-ray scattering.  
3.2. Methods - Fluorescence Polarization of Purified Snu13  
3.2.1. Set-up of the Fluorescence Polarization Binding Assay 
Various concentrations of Snu13 and RNA oligonucleotide together and the 
corresponding anisotropy signal was measured. The two probes used are detailed in 
Table 3.3. RNA oligonucleotides ro52 and ro26 correspond to the Cm U4 5’ stem loop 
(SL) and the Sc U6 stem loop, both of which were ordered from Integrated DNA 
Technologies as 5’-fluorescein-labeled probes (Table 3.3).  
Table 3.3. Fluorescein-labeled RNA oligonucleotide probes used in FP Binding Assays. 
Identity Sequence 
ro52: Cm U4 5’ SL (6-FAM)5'-UUGCCCAGAUGAGGUUCUCCGAUGGGUAA3’ 
ro26: Sc U6 SL 5'-UUCCCCUGCAUAAGGAU-(6-FAM)-3’ 
 
Reactions were set-up for Fluorescence Polarization (FP) binding assays as per 
Table 3.4 in 90 uL. Reactions were mixed in 1.5 mL Eppendorf microtubes and then 
transferred to Nunc Thermo Scientific black 384-well Microplates. The FP Reaction 
Buffer 2 was 25 mM HEPES-NaOH pH 7.5, 85 mM NaCl, and 5 mM #-
mercaptoethanol. Anisotropy was measured using a BioTek© Synergy 2 Multi-Mode 
reader. Concentration of RNA probe was 5 nM for the measurement of binding affinity 
(KD) and ranged from 0 to 12000 nM for the measurement of active protein fraction. 
Table 3.4. FP reagents used for the binding experiments of Msl5 with BP RNA probe. 
FP Reaction Reagents Volume Final Concentration 
Snu13 40 uL 0 to 100000 nM 
FP Reaction Buffer 2 45 uL 1 X 
Fluorescein-labelled probe 
(ro52, ro26) 
5 uL 0 to 12000 nM 
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3.2.2. Analysis of FP data 
Fluorescence polarization measurements (parallel and perpendicular) were 
converted into anisotropy values with Gen5 Data Analysis Software (Biotek Instruments) 
and subsequently into percent of RNA probe bound by protein. RNA % bound values 
were plotted with their respective protein concentration using Kaleidagraph Software 
against a Hill Equation (see below) to determine binding affinity (KD). As described in 
section 2.2.3, Equation 1 was used to convert anisotropy to percent of RNA probe bound, 
Equation 2 was used as the Hill Equation for a floating Coefficient, and Equation 3 was 
used as the Hill Equation for a fixed Coefficient.  
3.3. Methods - Bioinformatics and Structural Modeling 
 
3.3.1. Multiple sequence alignment and modeling 
 
Protein sequences were identified from NCBI BLAST searches, taken from the 
UniProt database, and aligned with STRAP software (Gille et al., 2014). Secondary 
structure predictions for Snu13 and its homolog were done using the PredictProtein 
server (Yachdav et al., 2014). The PDB files for S. cerevisiae Snu13p and H. sapiens 
15.5K were taken from the RCSB Protein Data Bank (Table 3.5). 
Table 3.5 UniProt and RCSB Accession numbers for Snu13 homologs. 
Organism UniProt Accession Number RCSB PDB File 
C. merolae CMP335C  
G. sulphuraria M2XBTS  
H. sapiens P55769 2JNB, 3SIU, 2OZB 
S. cerevisiae P39990 2ALE 
  
3.4. Methods - X-ray Crystallography of Snu13 
 
3.4.1. Hanging-drop/vapor diffusion crystallography of purified Snu13  
 
Purified protein was concentrated to 10mg/mL in Snu13 Storage Buffer and sent 
1 mL to Dr. Andrew M. MacMillan’s lab (Table 3.2). Several crystal trial attempts were 
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made in-house using Crystal Screens 1 and 2 from Hampton Research, but were 
unsuccessful. Dr. Erin L. Garside (then a PhD student of the MacMillan Lab) 
successfully crystallized Snu13. The drop/reservoir buffer used was 31% PEG 3350 with 
100 mM sodium acetate pH 4.4. The drops were 2 uL in volume; 1uL protein to 1uL well 
solution. To each well, 500 uL of reservoir buffer was added. Vaseline was used as a 
sealant. Crystallography was done at room temperature (approx. 20°C) in the dark. Drops 
were analyzed via light microscopy daily. 
3.4.2. X-Ray diffraction of Snu13 crystals and data analysis 
 
The crystals were collected with loops, coated in cryo-protectant (20% v/v 
glycerol), and flash-frozen in liquid nitrogen. The samples were mailed-in to the Stanford 
Synchrotron Radiation Light Source and diffraction data was collected remotely. Dr. 
Garside initially used the HKL 2000 and CCP4 software suites for auto-indexing, 
integration, scaling, and merging (Otwinowski and Minor, 1997; Potterton et al., 2003). 
PHENIX was used for structure refinement (Adams et al., 2010). With Dr. Garside’s 
assistance, the entire process was replicated. The crystallographic phase problem was 
solved by molecular replacement using yeast Snu13p (PDB ID 2ALE) as the search 
model. Structural alignment and visualization were done with PyMOL for Mac. 
3.5 Results and Discussion 
 
3.5.1. Recombinant Expression and Purification of Snu13 
 
His-Snu13 was affinity purified by incubation with Ni-NTA resin, washed, and 
then eluted by centrifugation. The expression and elution fractions were subsequently 
analyzed on a 12% polyacrylamide SDS-PAGE (Fig 3.1 A, B). The His-Snu13 construct 
was 21.3 kDa; on 12% polyacrylamide SDS-PAGE, it migrated slightly below the 21.5 
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kDa band of the Broad Range Molecular Weight Marker (Fig. 3.1). After batch 
purification, 15 mL of purified Snu13 was dialyzed with TEV protease and ran over Ni-
NTA resin to separate the cleaved His tag from Snu13. Cleaved Snu13 was 15.9 kDa and 
ran in-between the 21.5 and 14.4 kDa markers. The protein was then concentrated to 5 
mg/mL and analyzed by SDS-PAGE (Fig. 3.1 C). 
       A                      B                          C 
                     
Figure 3.1. The expression and affinity purification of Snu13. (A) Expression of C. 
merolae His-Snu13 in Rosetta pLysS. (B) Ni-NTA batch purification of His-Snu13. (C) 
Analysis of Snu13 after His-tag removal and concentration. SDS-PAGE of 12% 
polyacrylamide was used for analysis. 
 
3.5.2. X-ray Crystallography of Snu13 
 
X-ray crystallography demands high sample purity, often upwards of 97% 
(Vidovic et al., 2000). To remove contaminants present after affinity purification, size 
exclusion chromatography was performed (Fig. 3.2 A). After the sample was 
concentrated to 10 mg/mL, 30 ug was run on a 12% polyacrylamide gel to reveal 99% 
purity (Fig. 3.2 B). Hanging-drop vapor diffusion using purified Snu13 performed by Dr. 
Garside yielded beautiful looking rod-shaped crystals (Fig. 3.2 C). 
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A                                                      B 
          
                   C  
                     
Figure 3.2. Purification and Crystallography of Snu13. (A) Chromatogram of C. merolae 
Snu13 after size exclusion (Superdex200 10/300 GL) purification using the AKTA 
Purifier 10. Red and blue lines relate to 260 nm and 280 nm wavelengths, respectively. 
(B) SDS-PAGE analysis of the purified and concentrated sample. (C) Rod-shaped Snu13 
crystals generated and photographed by Dr. Erin L. Garside at the MacMillan Lab 
(University of Alberta). 
 
Due to the small size of the crystals, Dr. MacMillan recommended that Dr. 
Garside collect diffraction data from the Stanford Synchrotron Radiation Light Source. 
The protein crystals were mounted on a small loop, coated with 20% glycerol, frozen in 
liquid nitrogen, and mounted onto the beamline (Fig. 3.3 A). Exposure to photons from 
the beamline generated a diffraction pattern that was later used to construct an electron 
density map (Fig. 3.3 B). 
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       A                           B 
               
Figure 3.3. X-ray diffraction of Snu13 crystals at the Stanford Synchrotron Light Source. 
(A) Picture of a C. merolae Snu13 Crystal mounted on a loop in-line with the beamline. 
(B) Raw image of a diffraction pattern created by exposing the crystal to photons. Dr. 
Erin L. Garside provided both images. 
 
 
3.5.3. Data Analysis and Crystal Structure of Snu13 
 
A phase is the position of a point in time along a wave. The phases of the photons 
that encountered the crystal relate to the position of the electrons in the crystal. The phase 
problem of X-ray crystallography describes the loss of phase that occurs when the 
intensity of a reflection is measured. All of the dots on the diffraction image are 
reflections (Fig. 3.3 B). Molecular replacement was the best option for solving the 
crystallographic phase problem of Snu13 because the resolution range of the data set was 
43.21-2.35 Å (Angstroms), multiple isomorphous replacement was not performed, and a 
good search model was available. If the resolution of the dataset was high enough (1.5 Å 
is the rule of thumb), and the molecule was small enough, statistics could have been used 
to predict the phase for all of the reflections of the dataset. Multiple isomorphous 
replacement would have allowed for the phase to be measured from the effect of the 
heavy atoms. Molecular replacement only required that a nearly identical structure be 
oriented correctly into the unknown unit cell of Snu13. Advances in computation have 
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made the model orientation trivial, but the importance of the search model remains 
paramount (Evans and McCoy, 2008). 
To determine the best search model for molecular replacement, a multiple 
sequence alignment was performed using STRAP and PredictProtein software programs 
(Gille et al., 2014; Yachdav et al., 2014). High sequence similarity is a good indicator of 
low rms deviation (root-mean-square deviation) between two models, which means the 
structures are highly similar (Evans and McCoy, 2008). A multiple sequence alignment 
of Snu13 against homologs of human, budding yeast, and the red alga Galdieria 
sulphuraria revealed high sequence conservation among all of the sequences (Fig. 3.4). 
This suggested that the structure of Snu13 was highly conserved and likely important to 
the Cm splicing pathway. Snu13 shared the highest similarity with yeast Snu13p at 57%, 
which made it one of the most-conserved proteins among the entire Cm splicing suite 
(Stark et al., 2015). Thus the model for yeast Snu13p (PDB ID 2ALE) was selected as 
the search model for molecular replacement (Black et al., 2016).  
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Figure 3.4. Sequence alignment with sequences from G. sulphuraria (Snu13g), (Snu13g), 
Homo sapiens (15.5K), and S. cerevisiae (Snu13p). Sequence identity is indicated by: 
sequence identity (*), conservation (:) and partial conservation (.). The predicted 
secondary structures of "-helices and #-strands overlay the alignment. 
 
The X-ray crystal structure of Snu13 was solved to 2.35 Å with a completeness of 
99.39% (Table 3.6; Black et al., 2016). The model was refined until the working R-factor 
was 0.1662 and RFREE was 0.2200 (Table 3.6). If a perfect search model were used, the 
R-factor would have been 0; if a completely random model were used, it would be about 
0.63 (Kleywegt and Jones, 1997). The closer the RFREE value is to the R-factor, the 
better the result of modeling. The X-ray structure of Snu13 was considered more than 
acceptable and has lower R-values than some structures of human and yeast homologs 
(Vidovic et al., 2000; Dobbyn et al., 2007). The space group of the crystal was P212121 
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which describes an otherhombic lattice and rectangular prism as the unit cell (Heller, 
1952). There are currently 12 submissions in the RCSB PDB (Research Collaboratory for 
Structural Bioinformatics Protein Data Base) for Cyanidioschyzon merolae proteins and 
10 of those are unique. The crystal structure of Snu13 is currently the only splicing 
protein from C. merolae in the PDB, under the ID of 5EWR (Black et al., 2016). It also 
worth noting that Snu13/5EWR is the first crystal structure of a protein to be published 
from a lab at the University of Northern British Columbia. 
Table 3.6. Data collection, phasing, and refinement statistics.  
Adapted from Black et al. 2016. 
Data Collection CM-Snu131 
Space group P212121 
Cell dimensions    
    a, b, c (Å) 30.33, 57.58, 65.38 
    a, b, g  (°) 90, 90, 90 
Wavelength (Å) 1.1271 
Resolution (Å) 2.35 
I / sI 21.36 (11.85) 
Completeness (%) 99.77 (99.39) 
Redundancy 7.7 (7.6) 
Refinement  
Resolution (Å) 43.21-2.35 
No. reflections 158498 
Rwork / Rfree 0.1662/0.2200 
No. atoms  
    Protein 933 
    Water 42 
B-factors (Å2)  
    Protein 49.5 
    Water 40.0 
R.m.s deviations  
    Bond lengths (Å) 0.016 
    Bond angles (°) 1.52 
[1] Statistics for highest resolution shell (2.434-2.35 Å) are shown in parenthesis. 
 
The structure of Snu13 was highly conserved when compared to human 15.5K 
and yeast Snu13p (Fig. 3.5 A). It maintained the "-#-" sandwich of the L7 family of 
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proteins (Fig. 3.5 A). Several ribbon structures were overlaid: Snu13 (green); yeast 
Snu13p (cyan); human 15.5K (yellow); human 15.5K bound to U4atac RNA and Prp31 
(purple); human 15.5K bound to U4 snRNA and Prp31 (pink). The rms deviation was 
very low (0.014 Å) for all of the alpha carbons of the overlaid structures, evidence of 
their similarity (Fig. 3.5 A; Black et al., 2016). The structural comparisons also provide 
links to the various binding functions of Snu13 in C. merolae. Overlay of the Snu13 with 
yeast revealed 5 residues hypothesized to interact with either Prp3 or Prp4 during U4/U6 
di-snRNP assembly (Fig. 3.5 B; Dobbyn et al., 2007). The U4/U6 di-snRNP comprises 
Snu13, Prp3, Prp4, Prp31, the Lsm and Sm complexes, as well as U4 and U6 snRNAs 
(Nottrott et al., 2002; Will and Lührmann, 2011). When Snu13 was superimposed onto 
the human homolog (15.5K) bound to the U4atac kink-turn, the RNA-binding residues 
were determined (wireframe, Fig. 3.5 C).  
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Figure 3.5. Structural comparison of C. merolae Snu13 with orthologs. Images were 
adapted from Black et al. and arranged using PyMOL (2016). (A) Structural overlay of 
ribbon diagrams of Snu13 (C. merolae; PDB: 5EWR; green), Snu13p (S. cerevisiae; 
PDB: 2ALE; cyan), 15.5K (human; PDB: 2JNB; yellow), 15.5K (human bound to U4atac 
RNA and prp31; PDB: 3SIU; magenta), 15.5K (human bound to prp31 and U4 snRNA; 
PDB: 2OZB; light pink) (B) Conservation of the hydrophobic pocket proposed to interact 
with Prp3.  Shown are ribbon digrams of CmSnu13 (green; PDB: 5EWR) overlaid on 
Snu13p (S. cerevisiae; PDB: 2ALE) highlighting the residues lining the hydrophonic 
pocket: F9 (Y28), P68 (P87), L69 (L88), Y78 (Y97), F80 (F99). Yeast identification 
followed by algal in parentheses. (C) Detail of overlay of CmSnu13 (C. merolae; PDB: 
5EWR; ribbons, green) with 15.5K bound to U4atac RNA (human; PDB: 3SIU; ribbons, 
magenta; RNA in stick representation). 
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Pull-downs, mutational studies, binding assays, and structural studies have 
revealed Snu13 interacts with the U4 5’ stem, Prp31, and the Prp3/Prp4 heterodimer (Fig. 
3.6; Nottrott et al., 1999; Vidovic et al., 2000; Nottrott et al., 2002; Hamma et al., 2004; 
Dobbyn et al., 2007; Liu et al., 2011; Liu et al., 2015; Hardin et al., 2015; Nguyen et al., 
2015). An overlay of Snu13 with human 15.5K suggested Snu13 would be capable of the 
same interactions (Fig. 3.5). This also demonstrated how minimal (if any) conformational 
changes are required of the globular Snu13 to accommodate multiple protein and RNA 
interactions (Fig. 3.6). 
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Figure 3.6. Close-up of the RNA binding domain of human 15.5K (light blue) associated 
with the kink-turn of human U4 snRNA (pink) and Prp31 (human 61K, green). RNA 
binding residues are shown in red wireframe. The PDB file 3SIU (human 
15.5K/U4/Prp31) was used as the model and was visualized using PyMOL. 
 
A hydrophobic pocket of Snu13p is theorized to interact with Prp3 (human 90K) 
or Prp4 (human 60K) during U4/U6 assembly (Dobbyn et al., 2007). Cryogenic electron 
microscopy structures of the tri-snRNP particle in yeast and humans suggest that Prp4 is 
the most likely candidate (Nguyen et al., 2015; Agafonov et al., 2016). Cm residues Y28, 
P87, L88, Y97, and F99 form this putative protein-binding pocket and were based on an 
alignment with yeast Snu13p (Fig. 3.7; Dobbyn et al., 2007).  
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Figure 3.7. Hydrophobic pocket of Snu13 is clearly seen from the molecular surface, 
while the rest of the protein is shown in ribbon. The pocket comprises residues Y28, P87, 
L88, Y97, and F99. This region is hypothesized to interact with U4 protein Prp3 (90K) or 
Prp4 (60K) during di-snRNP assembly. Snu13 from C. merolae was used for the 
modeling, which was done with PyMOL [PDB ID 5EWR]. 
 
Alignment of Snu13 with human 15.5K in complex with U4 snRNA reveals 
binding likely occurs between #-strands 1-2 and 3-4 (Fig. 3.5 C and 3.6; Vidovic et al., 
2000). Furthermore, modeling of Snu13 with all human and yeast structures (free or 
bound to proteins/RNA) suggests all of the interactions require minimal changes (Fig. 
3.5-3.7). Solution and crystal structures of human 15.5K in complex with Prp31 suggest 
"-helices 2 and 3 would interact with Prp31 (Fig. 3.6; Liu et al., 2011; Liu et al., 2015). 
3.5.4. Fluorescence Polarization of Snu13 and the U4 5’ Stem Loop 
 
In order to demonstrate that Snu13 was a conserved protein, it was critical to 
prove that the same construct used to generate a crystal was also functional. Fluorescence 
polarization was used to measure the RNA binding ability of Snu13 against an RNA 
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oligonucleotide of the Cm U4 5’ stem loop (Fig. 3.8 A, B middle structure). Several 
experiments were performed in triplicate and two of those included the same sample that 
crystallized. The average from 12 replicates of Snu13 against U4 5’ SL and 6 replicates 
against the control (Sc U6 SL) was used to generate a saturation curve (Fig. 3.8 A, B left 
structure). The standard deviation of each data set was used for error. 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
 
 
 
 
 
 
 
 
 
 
 
!! 92 
     A 
         
     B  
          
Figure 3.8. Saturation curve of Snu13 against the U4 5’ SL. Adapted from Black et al. 
(2016). (A) Fluorescence polarization was measured for C. merolae Snu13 titrated 
against 5'-fluorescein-labeled RNAs of U4 (C. merolae U4 5' stem loop) and U6 (S. 
cerevisiae U6 RNA stem loop). Dissociation constants (KD) were determined by fitting 
this data to the Hill equation. (B) Secondary structures of the two RNA oligos used in the 
binding experiment (Cm U4 and Sc U6) as well as Hs U4 5’ SL for comparison. The 
human structure is adapted from Vidovic et al. (2000). 
 
The binding affinity of Snu13 was 160 ± 10 nM for the Cm U4 5’ SL and 
approximately 16 uM for the control oligo (Table 3.7). The measured KD was similar to 
values reported in literature, demonstrating that Snu13 is structurally and functionally 
conserved (Table 3.7). The U4 5’ stem loop has been defined as having a purine-rich 
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asymmetrical loop with 5 nucleotides on one side, and 2 on the other (5 + 2). An 
extensive bioinformatics search done of U4 snRNAs by Nottrott et al. revealed that the 
U4 5’ stem loop is highly conserved (1999).  The canonical U4 5’ SL has human-
equivalent positions of U31, G32, A33, G43, and A44 that are identically conserved, 
while positions A29 and A30 are purines (Fig. 3.8 B; Stevens and Abelson, 1999). Cm 5’ 
SL is identical to human except for G29, which is a purine and still fit the canonical 
model (Fig. 3.8 B). X-ray crystallography and FRET experiments of human 15.5K bound 
to the U4 5’ SL revealed that the flanking stems of the bound asymmetrical loop bend to 
65° to each other and U31 is sequestered between #-strands 1-2 and 3-4 (Fig. 3.5 C and 
3.6; Vidovic et al., 2000). The folded conformation of the stem loop is described as a 
“kink-turn” and U4 has been shown to adopt the kink-turn in presence of metal ions 
alone (Goody et al., 2004). Accordingly, Snu13 belongs to a novel class of kink-turn 
binding proteins (Nottrott et al., 1999; Kühn et al., 2002; Marmier-Gourier et al., 2003; 
Soss and Flynn, 2007). Given that the Snu13-RNA interaction was within the range of 
literature values (8 – 150 nM), it was not surprising the U4 5’ SL was also similar (Table 
3.7). 
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Table 3.7. Comparison of Protein-RNA Affinities. Adapted from Black et al. (2016). 
Protein RNA target Method Apparent KD (nM) Literature 
15.5K U3 snoRNA EMSA 30 Watkins et al., 2000 
15.5K U8 snoRNA EMSA 40 Watkins et al., 2000 
15.5K U14 snoRNA EMSA 8 Watkins et al., 2000 
15.5K U4 snRNA EMSA 20 Watkins et al., 2000 
15.5K U3 snoRNA EMSA 130 ± 13 Szewczak et al., 2002 
L7Ae Kt-7 23S RNA FRET 0.9 ± 0.2 Turner et al., 2005 
Snu13p U3 snoRNA EMSA 75 Dobbyn et al., 2007 
Snu13p U4 snRNA EMSA 150 Dobbyn et al., 2007 
15.5K U4 5' stem loop SPR 27 Soss and Flynn, 2007 
CmSnu13 U4 5' stem loop FP 160 ± 10 Black et al., 2016 
EMSA: electrophoretic mobility shift assay; SPR: surface plasmon resonance; FP: 
fluorescence  polarization 
 
Recombinant proteins do not have native conditions during their expression and 
may not have the appropriate chaperones or chemical modifications necessary to create 
an identical version (Weinstein et al., 2002; Gräslund et al., 2008). Furthermore, in vitro 
studies are never able to reproduce the environment in which an interaction occurs. The 
functionally active population of a recombinantly expressed and purified protein is 
therefore likely below 100%. A thorough review article on the interpretation of binding 
data provided a mathematical model that predicted the amount of complex formed if the 
KD and amounts of ligand and receptor were known and the receptor (protein) population 
was assumed to be 100% (Hulme and Trevethick, 2010).  
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 Using Equation 8, the expected fraction of Snu13 bound by U4 at a 1:1 molar 
ratio would be expected to be 38% given the KD of 150 nM and concentration of 150 nM 
(Hulme and Trevethick, 2010). In an effort to quantify the fraction of recombinant Snu13 
that was functionally active, the U4 5’ SL (ro52) was titrated against a fixed 
concentration of Snu13 (150 nM). The fraction of protein bound was plotted against the 
ratio of RNA to protein (Fig. 3.9). The measured fraction of Snu13 bound by U4 was 
approximately 0.325 or 32.5% (Fig. 3.9). Based on this model, the active fraction of 
Snu13 is about 85% and the adjusted KD of Snu13 for the U5 SL would be approximately 
135 nM. 
 
             Equation 5 !!!!
             Equation 6 !!!
             Equation 7 !!!
             Equation 8 
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Figure 3.9. Functionally active fraction of Snu13 determined by RNA titration. Cm U4 5’ 
SL (ro52) was titrated against 150 nM Cm Snu13. The resulting anisotropy 
measurements were converted into fraction of protein bound (%) and plotted against the 
molar ratio of probe to protein (grey line). The theoretical values assume the active 
fraction was 100% and were based on Equation 8 (black line). 
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Chapter 4 
 
Assembly of the Cm U4/U6 di-snRNP 
 
This chapter covers all of the experiments done to assemble the Cm U4/U6 di-
snRNP in a step-wise fashion. The majority of the Cm spliceosome has not been studied, 
and it is very interesting to parse-out which mechanisms are conserved and which are 
novel. The U4/U6 di-snRNP assembly pathway has been studied in humans and yeast, 
and based on the C. merolae di-snRNP genes present, the assembly is theoretically 
similar. Gel shift assays were performed to biochemically probe di-snRNP assembly 
using in vitro-transcribed U4 and U6 snRNA and recombinant proteins. Of the 5 Cm 
U4/U6-associated proteins discovered (Snu13, LSms, Sms, Prp3, and Prp4), Snu13, 
LSm, and Sm proteins were used in the assay. Expression and purification conditions of 
Prp3, Prp4, and Prp31 require further optimization. 
4.1 Methods – Preparation of Proteins Used in U4/U6 di-snRNP Assembly 
 
4.1.1. Expression and Purification of Cm Snu13 and LSm/Sm Complexes 
 
Cm Snu13 was expressed and purified as described in Chapter 3. Rader lab 
members Kirsten Reimer and Fatimat Shidi prepared the LSm and Sm complexes 
respectively. The LSm and Sm proteins were expressed in Rosetta pLysS (DE3) cells 
then purified with both affinity (1 mL HisTrap) and size exclusion (Superdex200 10/300 
GL) column chromatographic techniques (ÄKTA Purifier 10, GE Healthcare Life 
Sciences). 
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4.2 Methods – In vitro Transcription of Cm U4 and U6 snRNA 
 
4.2.1 Preparation of U4 And U6 DNA Templates For In vitro Transcription 
 
In order to generate DNA templates for the U4 and U6 snRNAs, the polymerase 
chain reaction (PCR) was performed using Taq Polymerase (New England Biolabs). 
Primers for the U4 and U6 DNA templates were designed and ordered from Integrated 
DNA Technologies. PCR reactions and primer sequences are outlined below (Table 4.1). 
Components of Reaction                                                     Thermocycler Program 
 
Cm Genomic DNA (262 ng/uL)            1 uL 
Taq Polymerase (5000 units/mL)        0.4 uL                          95°C    2 minutes 
Taq Reaction Buffer (10x)                   5 uL                             95°C    20 seconds 
Forward primer (10 uM)                       2.5 uL                         56°C    20 seconds     35 cycles 
Reverse primer (10 uM)                      2.5 uL                         68°C    45 seconds 
dNTPs (10 mM)                                     1 uL                               68°C    5 minutes 
Water                                                    up to 50 uL 
 
 
Table 4.1. PCR primers used to generate Cm U4 and U6 DNA templates for in vitro 
transcription and their respective annealing temperatures. 
Identity Sequence 
U4 RNA (fwd) AAATTAATACGACTCACTATAGGGATACTTGCGCAGTGTCG
GTTG 
U4 RNA (rev) CTTTCCAAAAATTTCCACCAAGCGC 
U6 RNA (fwd) AAATTAATACGACTCACTATAGGGTGCGCCTTTATCGGC 
U6 RNA (rev) AAAAAGGTATACCTCGAGACGATTGTCC 
 
 
4.2.2. In vitro Transcription of Cm U4 and U6 RNA Transcripts 
 
In vitro transcription (IVT) of Cm U4 and U6 snRNA was done cold as per the 
HiScribe T7 High Yield RNA Synthesis kit (New England Biolabs). Each IVT reaction 
was set-up according to Table 4.2 in 0.2mL clear PCR tubes (Corning) and was left for 
12 hours at 37°C. 
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Table 4.2. Composition of the IVT reactions that generated Cm U4 and U6 RNA 
transcripts. The reactions were carried out in 20 uL for 12 hours at 37°C. 
IVT Reaction 
Reagents 
Cm U4 snRNA 
Reaction 
Cm U6 snRNA 
Reaction 
Template DNA 4 uL PCR Product 
(Cm U4 DNA, 250 
ng) 
4.4 uL PCR Product 
(Cm U6 DNA, 250 
ng) 
T7 RNA 
Polymerase Mix 
1.5 uL 1.5 uL 
T7 Reaction Buffer 
(10x) 
1.5 uL 1.5 uL 
ATP (100 mM) 1.5 uL 1.5 uL 
UTP (100 mM) 1.5 uL 1.5 uL 
GTP (100 mM) 1.5 uL 1.5 uL 
CTP (100 mM) 1.5 uL 1.5 uL 
Water 7 uL 6.6 uL 
 
Each IVT product was mixed with equal volume formamide, heated at 65°C for 3 
min then purified on a 6% polyacrylamide (19:1) 7M urea gel which ran in 1 x TBE at 
400 V for 60 min. RNA gel bands were visualized by UV shadowing, excised into a 1.5 
mL Eppendorf tube and crushed with a micro pestle (DWK Life Sciences). The crushed 
gel was mixed with 400 uL water and heated for 10 min at 70°C. The gel slurry was 
subsequently loaded onto a Performa Spin Column (Edge Bio) and spun for 3 min at 850 
xg. RNA precipitation was done by adding 1.5 uL glycogen (20 mg/mL), 1/10 volume 
3M sodium acetate, and 1 mL cold ethanol (100%) and subsequently being stored for 18 
hours at -20°C. The precipitated RNA was pelleted by centrifugation at 17000 xg for 30 
min at 4°C. Each RNA pellet was washed twice with 70% cold ethanol before being 
resuspended in 50 uL water and stored at -20°C. The full-length sequences of the 
products are presented in Table 4.3. For reference purposes, the Accession Number and 
Chromosomal locations for U4 and U6 are #AP006487 Chromosome 5/222390- 222566, 
and #APOO6501 Chromosome 19/483497- 483364, respectively. 
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Table 4.3. Sequences of the full-length U4 and U6 snRNA generated from IVT. 
snRNA Sequence 
U4 AUACUUGCGCAGUGUCGGUUGUUGCCCAGAUGAGGUUCUCCGAUG
GGUAACGGUAUGCU GAACACAAACAAUUUACCACAGUGGACUUU 
UUAACCGGUCCGUCUGUGACGGGCAUGCC 
UCAAGCCCAGCCACGUGCGAAGAACACGUG 
UUCUGCGCUUGGUGGAAAUUUUUGGAAAG 
U6 GGUGCGCCUUUAUCGGCGAUUUGCCCGAAUCGUCGGUAGGGGUAC
GCGCCGUCCAUUCCAUGGAUAACAAACUGAGAUGAUCAGCUUCCG
CACUGCGCAAGUAUGCGGACAAUCGUCU CGAGGUAUACCUUUUU 
 
4.3 Methods – Assembly of the U4/U6 di-snRNP 
 
4.3.1. U4 and U6 Annealing Assays 
 
A 9% acrylamide/TBE gel (native) was made and cooled to 4°C. Every reaction 
was then set-up in a 1.5 mL microtube (Eppendorf) and included Buffer D, 5X Splicing 
Mix, and one or both RNA (Table 4.4). Dye was added immediately prior to injection 
into the polyacrylamide gel. For heated reactions, the mixture was heated at 65°C for 3 
min (VWR Standard Heatblock) before the block was removed from the apparatus and 
placed on the bench for 1 hour to gently cool. After 30 min of cooling, the non-heated 
reactions were set-up and incubated at room temperature (on bench) for 30 min. For 
samples with one RNA, there was no incubation. 
Table 4.4. Buffer components used in U4 and U6 snRNA annealing reactions. 
Buffer Components 
5X Splicing Mix 300 mM KPO4, 12.5 mM MgCl2, 15% PEG 8000 
Buffer D 20 mM HEPES-NaOH pH 7.9, 50 mM KCl, 0.2 mM EDTA,  
20% Glycerol 
 
The Annealing Reaction I is as follows: 
 
5X Splicing Mix                                     2 uL 
Buffer D                                                        4 uL 
U4 RNA (8 pmol per reaction)                 2 uL  
U6 RNA (11 pmol per reaction)                     2 uL 
Water                                                                 to 10 uL 
6X Native Dye                                        2 uL 
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Once the reactions were complete, native dye was added and the samples were 
injected into the pre-chilled 9% native polyacrylamide gel. The gel was then ran at 300V 
for 1 hour at 4°C. Once ran, the gel was placed in 100 mL of 0.5 ug/mL ethidium 
bromide and stained for 30 min before it was rinsed with water and exposed with the 
Fluor Chem Q imager (Protein Simple). 
4.3.2. U4/U6 di-snRNP Assembly 
 
With the annealing reaction successful, the next steps were optimization and the 
addition of U4/U6 di-snRNP associated proteins (Cm Snu13, LSm, Sm). The di-snRNP 
Assembly Reaction I was set-up as follows: 
Di-snRNP: 
5X Splicing Mix                                     2 uL 
Buffer D                                                        4 uL 
U4 RNA (2 pmol per reaction)                 1 uL  
U6 RNA (2.5 pmol per reaction)                   2 uL 
Water                                                                 to 9 uL 
12 uM Protein (Snu13, LSm or Sm)        1 uL 
 
Reactions were set-up similar as previously described (section 4.3.1). A 9% 
acrylamide/TBE gel was poured and cooled to 4°C. Heated reactions were mixed, heated 
to 65°C, and cooled for 1 hour prior to mixing unheated reactions. Once the reactions 
were ready, protein was added (when applicable) and incubated at room temperature (on 
bench) for 30 min. Samples with only one RNA (and no protein) were not incubated. 
Once the reactions were complete each sample was injected into a pre-chilled 9% native 
polyacrylamide gel. The gel was then ran at 300V for 1.5 hour at 4°C. When finished the 
gel was put into 100 mL of 0.5 ug/mL ethidium bromide and stained for 30 min before 
exposure with with the Fluor Chem Q imager (Protein Simple). 
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4.4. Methods – Recombinant Expression of Cm Proteins Prp3, Prp4, and Prp31 
 
 4.4.1. Cloning of Cm Prp3, Prp4, and Prp31 
 
The pQLink H and N plasmid vectors (H denotes N-terminal His-tag, N is 
untagged) were purchased from Addgene (plasmids 13670 and 13667) and modified by 
Rader lab member Fatimat Shidi to allow for ligase-independent cloning (LIC), 
previously discussed in section 2.1.1. LIC using these plasmids and the SwaI and PacI 
restriction enzymes has been described in detail (Scheich et al., 2007). The figure below 
illustrates the use of LIC to construct a plasmid containing both Cm Prp3 and Prp4 (Fig. 
4.1).  
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Figure 4.1. Overview of ligase-independent cloning to produce a single plasmid  
with two genes. 
 
Having expressed and purified several proteins, it became apparent that an 
expression vector was needed that contained a C-terminal affinity tag. Thus the pQLinkC 
plasmid was constructed by modifying the pQLinkN (untagged) plasmid vector. A 
cleavable C-terminal 6x His tag downstream of the LIC sites SwaI and PacI was added 
by including the TEV protease recognition site upstream of the 6x His sequence. The 
forward and reverse primers are listed below, with the gene-specific region in capitals 
and the TEV recognition site in bold (Table 4.5). 
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Table 4.5. Primers used to modify pQLinkN into pQLinkC, as well as to subclone  
Cm Prp4 and Prp31 into pQLinkH and C plasmid vectors. 
Gene Target Plasmid Sequence 
Top strand pQLinkN 
(becomes C) 
AGCTTAGAGAACCTGTACTTCCAATCCGGTAC
CCACCATCACCATCATCATTAGGC 
Bottom strand pQLinkN 
(becomes C) 
TCAGCCTAATGATGATGGTGATGGTGGGTACC
GGATTGGAAGTACAGGTTCTCTA 
Cm Prp4 fwd pQLinkH TAC TTC CAA TCC CAC CGA AGT CAC GAA 
TTT CGA GCA GAG 
Cm Prp4 rev pQLinkH TTA TCC ACT TCC CAC G CTA TGC GTA TAA 
CCT GTG GAC 
Cm Prp31 fwd pQLinkH TAC TTC CAA TCC CAC GCA AGC ACT GGC 
GTT TCT GC 
Cm Prp31 rev pQLinkH TTA TCC ACT TCC CAC G TTA TGC TTC ATC 
CTC ATC TAC ACC 
Cm Prp31 fwd pQLinkC TAC TTC CAA TCC CAC G AGG AGA AAT TAA 
CT ATG AGC ACT GGC GTT TCT G 
Cm Prp31 rev pQLinkC TTA TCC ACT TCC CAC G TGC TTC ATC CTC 
ATC TAC ACC 
 
Three plasmid constructs were made for the remaining 3 proteins of the di-
snRNP: N- and C-terminally labeled Prp31 variants, as well as a construct with both 
tagged Prp4 and untagged Prp3. The rationale was that co-expression of a predicted 
heterodimer should produce the most stable product. The Cm genes for Prp4 and Prp31 
were cloned from genomic DNA into pQLinkH and pQLinkC plasmids using the primers 
listed in Table 3.3. Once Cm Prp4 was cloned into pQLinkH, Prp3 was then also 
subcloned from a pQLinkN plasmid using LIC. Prp3 was subcloned into the pQLinkN 
plasmid by Dr. Martha Stark. The Prp4 and Prp31 genes were amplified from genomic 
DNA using Q5 High Fidelity (HF) DNA Polymerase (New England Biolabs). Based on 
the predicted annealing temperatures of primers for Prp4 and Prp31 (66°C and 65°C 
respectively), 66°C was used as the annealing temperature and both PCR reactions were 
executed simultaneously.  
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The following plan includes the details of the PCR reaction: 
Q5 HF Polymerase (2000 units/mL)   0.5 uL 
Q5 Reaction Buffer (5x)                        10 uL                               98°C    30 seconds 
Genomic DNA                                      250 ng                       98°C    15 seconds 
Forward primer (10 uM)                       2.5 uL                         66°C    30 seconds     35 cycles 
Reverse primer (10 uM)                      2.5 uL                         72°C    15 seconds 
dNTPs (10 mM)                                     1 uL                               72°C    5 minutes 
Water                                                    to 50 uL 
 
All 3 genes were ready for entry into their respective vectors (Cm Prp4 and Prp31 
were PCR-amplified and Cm Prp3 was in pQLinkN). LIC requires T4 DNA Polymerase, 
a 5’-3’ polymerase with 3’-5’ exonuclease activity. The target pQLink plasmids (H and 
C) were linearized with pmlI (NEB) then treated with T4 polymerase and one 
deoxyribose nucleoside triphosphate (dNTP) species. T4 chews backward until it reaches 
the same dNTP that was added, where it stops due to constant removal and addition. The 
insert is treated similarly, with a dNTP added that’s complementary to the one used for 
the plasmid. So long as the “chewed-back” regions have been designed complementarily, 
ligation will occur without an enzyme. A flowchart was included to outline the details of 
LIC (Fig. 4.2). 
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Figure 4.2. Overview of the reactions and incubations used in LIC to build the various 
Cm Prp3/4- and Prp31-containing constructs. 
 
4.4.2. Glycerol Stocks of DH5! Transformed with Prp3+Prp4 and Prp31 
 
5 uL of each LIC reaction was mixed (pQLinkH-Prp3+Prp4; pQLinkH-Prp31; 
pQLinkC-Prp31) with 50 uL thawed DH5" cells in 1.5 mL microtubes (Eppendorf) on 
ice for 25 min. The cells were heat-shocked at 42°C for 45 seconds followed by ice for 5 
min. 300 uL L.B. was added to each tube and the cells recovered for 20 min in a shaker 
(New Brunswick Scientific, model Innova 40) set at 37°C and 300 RPM. The cells were 
then centrifuged for 10 seconds, resuspended in 100 uL fresh L.B. and plated on L.B. 
agar supplemented with 20 ug/mL ampicillin (IBI Scientific) followed by an 18 hour 
incubation at 37°C. 
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Several colonies from each plate (DH5" with either Prp3 and Prp4, or Prp31) 
were selected to inoculate 2 mL L.B. broth aliquots (20 ug/mL ampicillin) that were 
placed in a shaker at 37°C and 300 RPM for 16 hours. Their plasmids were purified using 
the EZNA Mini Kit (Omega) and restriction enzyme digests (EcoNI and SapI, NEB) 
were performed on the plasmids for 1 hour at 37°C. Each sample was injected into a lane 
of a 1% agarose gel and ran at 120 V for 105 min. All 3 constructs were successfully 
created and their corresponding DH5" transformants were stored as glycerol stocks. 1 
mL of each overnight broth was mixed with 80 uL DMSO (Sigma Aldrich) into 2 mL 
microtubes (Corning) and stored at -80°C. 
4.4.3. Transformation of Rosetta pLysS Cells with Prp3, Prp4, And Prp31 
 
3x 50 uL of Rosetta pLysS (DE3) cells were thawed on ice in 1.5 mL Eppendorf 
tubes (Fisher Scientific) for 15 min before adding 150 ng of either pQLinkH-Ppr3/4, 
pQLinkH-Prp31, or pQLinkC-Prp31. The tubes sat on ice for 30 min before being heat-
shocked for 45 seconds at 42°C and returned them to ice for another 5 min. 250 uL of 
L.B. broth (Fischer Scientific) was added and the cells were placed in a shaker at 37°C 
and 300 RPM for 30 min. The cells were the centrifuged (Eppendorf, model Centrifuge 
5417 C) for 10 seconds then resuspended in 100 uL fresh L.B. broth and plated on L.B. 
agar supplemented with 20 ug/mL ampicillin (IBI Scientific) and chloramphenicol 
(Sigma-Aldrich) antibiotics. The plates were incubated at 37°C for 18 hours and each 
produced between 30 and 100 transformants. 
4.4.4. IPTG-Induction of Prp3, Prp4, And Prp31 with Rosetta pLysS Cells 
 
One transformant colony from each plate (Rosetta pLysS cells transformed with 
pQLinkH-Ppr3/4, pQLinkH-Prp31, or pQLinkC-Prp31) was used to inoculate 10 mL 
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L.B. broths supplemented with 20 ug/mL each of ampicillin and chorlamphenicol. Each 
culture was put in a shaker for 18 hours at 37°C and 300 RPM. 2mL of each overnight 
broth was added to to 3x 20 mL L.B. broths (20 ug/mL ampicillin and chloramphenicol) 
for small scale expression (9 cultures in total). All of the cultures were placed in a shaker 
for about 3.7 hours at 300 RPM and 37°C until they reached an OD600 of approximately 
0.5 (Beckman Coulter, model DU 800). All of the cultures were induced with 1 mM 
Isopropyl-#-D-1-thiogalactopyranoside (IPTG, VWR) before being split-up for induction 
under 3 different temperatures: 16°C, 25°C, and 37°C (for 18 hours, 12 hours, and 4 
hours respectively). After induction under each condition was complete, 15 mL of each 
culture was centrifuged for 30 min at 3200 RPM and 4°C (Beckman Coulter, model 
Avanti HP-20 XPI) and the supernatant discarded. All cell pellets were flash-frozen in 
liquid nitrogen then stored at -80°C. Both before and after induction, 1 mL of each 
culture was taken and resuspended in SDS loading buffer to a final concentration of 1 
OD unit per 100 uL (A600) before being storage at -20°C. Expression was checked via 
12% polyacrylamide (37.5:1 acrylamide/Bis, Bio-Rad) gel via sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). Each sample at was heated at 95°C for 
5 minutes then centrifuged at 20000 Xg for 3 minutes. 10 uL of each sample was injected 
into the gel ran at 22 mA for 50-60 minutes. 
4.4.5. Auto- Induction of Prp3, Prp4, And Prp31 with Rosetta pLysS Cells 
 
Auto-induction requires two types of media: a non-inducing media for growth and 
short-term storage, as well as an inducing media for expression (Studier, 2005). MDG 
and ZYM-5052 are the non-inducing and auto-inducing media, respectively. For 
convenience, 3 stocks were made ahead of time: 50x M, 50x 5052, and 1000x Trace 
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Metals. The final concentrations used in the growth and expression of transformed 
Rosetta cells are shown below (Table 4.6). 
Table 4.6. Components of the MDG and ZYM-5052 media used in Auto-Induction. 
MDG (non-inducing) components ZYM-5052 (auto-inducing) components 
2 mM MgSO4 2 mM MgSO4 
0.5% w/v Glucose (Sigma Aldrich) 10 mg/mL Tryptone (Fischer Scientific) 
0.25% w/v L-Aspartate  
(Sigma Aldrich) 
5 mg/mL Yeast Extract (Fischer Scientific) 
  
1x M 1x M 
25 mM Na2HPO4 25 mM Na2HPO4 
25 mM KH2PO4 25 mM KH2PO4 
50 mM NH4Cl 50 mM NH4Cl 
5 mM Na2SO4 5 mM Na2SO4 
  
1x Trace Metals 1x 5052 
10 uM FeCl3 0.5% v/v Glycerol 
4 uM CaCl2 0.05% w/v Glucose 
2 uM MnCl2 0.2% w/v Lactose 
2 uM ZnSO4  
0.4 uM CoCl2  
0.4 uM CuCl2  
0.4 uM NiCl2  
0.4 uM Na2MoO4  
0.4 uM Na2SeO3  
0.4 uM H3BO3  
 
Prior to auto-induction of Cm Prp3 and Prp4, Rosetta pLysS (DE3) cells were 
transformed with pQLinkH-Prp3/4 as described above but plated on MDG agar 
supplemented with 20 ug/mL carbenicillin (IBI Scientific) and chloramphenicol. The 
plates were incubated at 37°C for 24 hours, as transformants were slower to grow. One 
transformant colony was selected from each plate to inoculate 2 mL MDG broth 
supplemented with 20 ug/mL each of carbenicillin and chorlamphenicol. The cultures 
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were placed in a shaker for 18 hours at 37°C and 300 RPM. Both the MDG plate and 
culture are able to be stored at 4°C for several weeks (Studier 2005). The overnight MDG 
culture was used to inoculate 2x 25 mL cultures to a starting OD600 of 0.01 (in 250 mL 
Erlenmeyer flasks for aeration). One culture was placed at 16°C for 48 hours and the 
other at 37°C for 24 hours, both in shakers at 300 RPM. Samples were taken before and 
after induction and analyzed via SDS-PAGE. 
4.5 Methods – Protein Disorder Predictions 
 
 4.5.1 In silico Modeling of Intrinsic Disorder 
 
Amino acid sequences for Snu13, Prp3, Prp4, and Prp31 were taken from NCBI 
and UniProt databases (Table 4.7). Each protein sequence was uploaded to the server 
DisEMBL Intrinsic Protein Disorder Prediction 1.5 (Linding et al., 2003; Iakoucheva and 
Dunker, 2003). 
Table 4.7. NCBI and UniProt accession numbers of U4/U6 di-snRNP proteins. 
Protein NCBI Accession Number UniProt Identifier 
Snu13  CMP335C 
Prp3  CMT170C 
Prp4 XP_005538590.1  
Prp31 XP_005539062.1  
 
4.6 Results and Discussion 
 
 4.6.1. Preparation of di-snRNP Components 
 
In the human and yeast models of the spliceosome, the U4 and U6 small nuclear 
RNA (snRNA) base-pair to form the U4/U6 di-snRNA (Bringmann et al., 1984; 
Hashimoto and Steitz, 1984). The association of related proteins to the RNA create the 
U4/U6 di-small nuclear ribonucleoprotein complex (di-snRNP). The predicted secondary 
structure of the Cyanidioschyzon merolae U4/U6 di-snRNA revealed 3 regions of base 
pairing, denoted by Stems I-III (Fig.  4.3; Stark et al., 2015). Importantly, the canonical 
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binding regions of the U4/U6 associated proteins are conserved which suggests a similar 
model for di-snRNP assembly as compared to human and yeast (Nottrott et al., 2002; 
Hardin et al., 2015). The predicted secondary structure of the yeast U4/U6 di-snRNP is 
based on known interactions between U4/U6 associated proteins and RNA (Fig. 4.3; 
Hardin et al., 2015). There are Cm homologs present for every U4/U6-related protein; 
conservation would suggest this complex is important for splicing (Fig. 4.3). 
 
               
 
Figure 4.3. The Cyanidioschyzon merolae U4/U6 di-snRNP, based on human and yeast 
modeling. Placement of the proteins was guided by a cryo-EM yeast structure (Nguyen et 
al., 2015) and the RNA secondary structure was adapted from Stark et al., 2015. 
 
The assembly pathway of the U4/U6 di-snRNP was previously determined 
through a series of gel shifts (Nottrott et al., 2002; Hardin et al., 2015; Liu et al., 2015; 
Theuser et al., 2016). The Sm and LSm proteins bind the 3’ ends of U4 and U6, 
respectively, which likely occurs before RNA base pairing (Karaduman et al., 2006). 
Snu13 binds the U4 5’ stem loop and acts as a nucleating factor for the assembly of 
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remaining proteins Prp3, Prp4, and Prp31 (Nottrott et al., 2002). The Prp3/4 dimer and 
Prp31 both make contact with Snu13, the U4 5’ stem loop, and Stem II (Nguyen et al., 
2015; Agafonov et al., 2016). In yeast and likely humans, Prp3/4 and Prp31 bind 
independently of each other (Hardin et al., 2015). Here, assembly of the Cm U4/U6 di-
snRNP was similarly demonstrated by EMSAs (electrophoretic mobility shift assays). 
Base-paired U4/U6 snRNAs would migrate slower than either of the two alone. Bound 
proteins would cause the RNA to migrate slower still. Of the U4/U6 associated proteins, 
only Snu13 and the two heteroheptameric rings (LSm and Sm) were available due to 
complications with expression and purification. The available proteins were checked on a 
polyacrylamide gel prior to use in gel shift assays (Fig. 4.4). Snu13 and the two 
heteroheptameric rings (LSm and Sm) were about 90%, 60%, and 80% pure respectively 
(Fig. 4.4). 
                              
Figure 4.4. SDS-PAGE analysis of purified Cm Snu13, LSm, and Sm proteins for use in 
the assembly assays. The black bars show the expected sizes of Snu13 (left) and the LSm 
proteins (right), while the grey bars show the expected sizes of the Sm proteins (right). 
All proteins are recombinantly expressed and purified C. merolae proteins. 
 
4.6.2. U4 and U6 snRNA Base-Pairing Assay 
 
In vitro transcribed Cm U4 and U6 snRNAs were mixed together at two different 
temperatures to determine base-pairing efficiency (Fig. 4.5 A). Base pairing between U4 
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and U6 was confirmed by the presence of bands that ran slower (lanes 3-4) than those of 
either snRNA alone (lanes 1-2, Fig. 4.5 A). Heating to 65°C and allowing a 1 hour cool-
down yielded 71% of base-paired U4 as compared to only 17% if the snRNAs were left 
on ice for the hour (Fig. 4.5 B). 
 
A                                                       
                                          
B 
                                      
Figure 4.5. U4 and U6 RNA annealing assay. (A) Electrophoretic mobility shift assay of 
C. merolae U4 and U6 snRNA. (B) Bar graph representing the amount of U4 base-paired 
to U6, expressed as percentage. 
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4.6.3. U4/U6 di-snRNP Assembly Assay 
The first U4/U6 di-snRNP assembly assay was done using U4, U6, and Snu13. 
Snu13 was selected because EMSAs and single molecule FRET (fluorescence resonance 
energy transfer) previously showed that Snu13 was required to interact with U4/U6 
before either Prp3/4 or Prp31 were able to bind (Nottrott et al., 2002; Karaduman et al., 
2006; Hardin et al., 2015). All combinations of RNA and protein were mixed with and 
without pre-heating of RNA. The first 6 lanes re-confirmed previous findings that heat 
improved base-pairing efficiency (Fig. 4.6). Base-paired U4/U6 produced several bands, 
the highest of which was slightly above the band corresponding to Snu13 and either U4 
or U6 (lanes 3, 6, 7-8, 10-11, Fig. 4.6). The highest band present was produced when 
Snu13 was mixed with base-paired U4/U6 (lanes 9, 12, Fig. 4.6). This assay showed that 
Snu13 was able to interact with 3 different RNA species: U4, U6, and U4/U6. Given that 
the U4 5’ stem loop would be accessible regardless of whether or not U4 is base-paired to 
U6, the affinity of Snu13 should be very similar for both U4 and U4/U6 (Fig. 4.3). Snu13 
was in 10-fold excess to U4 and U6 snRNAs because the intention of this assay was to 
show U4, U6, and Snu13 were able to assemble into a single complex. While Snu13 
shifted both U4 and U4/U6 (lanes 7, 9, 10, 12), Snu13 also shifted U6 alone (lanes 8 and 
11, Fig. 4.6). The Snu13-U6 interaction is likely non-specific and a result of the molar 
excess of protein to RNA. Optimization of this experiment would include stoichiometric 
ratios of protein to RNA, which should eliminate non-specific interactions such as 
Snu13-U6. 
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Figure 4.6. U4 and U6 Cm di-snRNP assembly assay with Snu13 done by 
electromagnetic mobility shift with 9% polyacrylamide gels.  
 
Next, assembly of Snu13, Sms, and LSms onto the U4/U6 di-snRNA was 
observed (Fig. 4.7).  This experiment was successfully repeated twice (5 attempts were 
made) and unfortunately the RNA bands without protein were difficult to distinguish 
from those with protein. The first 3 lanes show snRNA alone and base-paired (lanes 1-3, 
Fig. 4.7). Snu13 and the Sm proteins both produced gel shifts that confirmed those 
proteins were able to bind the di-snRNA (lanes 4 and 6, Fig. 4.7). Unfortunately, the 
LSm proteins did not seem to interact with U4/U6 (lane 5, Fig. 4.7). It was later 
discovered that the pI of the LSms was very high, and it is possible that the basic protein 
complex migrated upward. If the positively charged LSms had interacted with the RNA 
and migrated upward, there should not be bands visible. In comparing lanes 3 and 5, the 
RNA bands appear to be similar (Fig. 4.7). This suggests that the LSms did not interact 
with the RNA. Overall, native gel electrophoresis has shown that: i) U4 and U6 are able 
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to base-pair; ii) in excess, Snu13 is able to interact with either snRNA alone; iii) Snu13 
and the Sm proteins are each able to assemble onto the U4/U6 di-snRNA. 
 
                     
Figure 4.7. U4 and U6 di-snRNP assembly assay with Snu13, LSm, and Sm proteins. 
Electromagnetic mobility shift assay for assembly of the C. merolae di-snRNP was done 
with a 9% polyacrylamide gel. 
 
As mentioned above, availability of di-snRNP proteins was limited to Snu13, 
Sms, and LSms because Prp3, Prp4, and Prp31 could not be expressed and purified. In 
fact, during the U4/U6 EMSA experiments, only Prp3 was known to exist. Expression 
and purification attempts of Prp3 yielded small quantities of protein (data not shown). 
Prp3 was expressed as a fusion protein with Maltose Binding Protein (MBP), a well-
studied protein useful for both affinity purification as well as improving solubility of its 
fusion partner (Sachdev and Chirgwin, 2000). After purification over both nickel- and 
maltose-bound resin, cleavage of the MBP tag revealed Prp3 was not very soluble: over 
half of the protein was lost as a precipitant (data not shown). Several months later, Dr. 
Martha Stark discovered Prp4 and Prp31 when she performed additional pull-down 
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assays and mass spectrometry analyses (XP_005538590.1 and XP_005539062.1, 
respectively). Prp31 was subcloned into two separate constructs: pQLinkH and pQLinkC, 
featuring N- and C-terminal TEV-cleavable 6x His-tags. Prp4 was subcloned into 
pQLinkH, and Prp3 was later added to the same plasmid for co-expression of tagged 
Prp4 and untagged Prp3. While sub-cloning of Prp31 was straightforward, ligase-
independent cloning (LIC) was employed for Prp3 and Prp4 (Fig. 4.1 and 4.2). Agarose 
gel electrophoresis revealed successful amplification of the Prp4 gene from the Cm 
genome (Fig. 4.8 A). Using LIC, which utilizes long complementary overhangs to 
replace the need for ligase, Prp4 was cloned into pQLinkH and verified by EcoNI and 
NcoI restriction enzyme (RE) digests (Fig. 4.8 B). Lanes 2-3 and 5-6 showed the 
supercoiled and NcoI-linearized plasmid (Fig 4.8 B). If Prp4 was successfully inserted 
into the plasmid, dual RE digest would have produced two double-stranded (base-paired, 
bp) fragments of 4865 and 1426 bp in size. RE digest and DNA sequencing confirmed 
that the gene was properly inserted (lanes 4 and 7, Fig 4.8 B). As explained in detail 
(section 4.4.1), LIC allows for unrestricted addition of genes into a single plasmid using 
the SwaI and PacI restriction enzymes (Scheich et al., 2007). Untagged Prp3 was excised 
from pQLinkN with PacI and added to SwaI-linearized pQLinkH-Prp4. Since the large 
plasmid contained multiple cut sites for each RE, EcoNI and SapI RE digests were 
individually performed to verify both genes in pQLinkH (Fig. 4.8 C). Both digests 
produced 2 dsDNA fragments as expected, with some uncut plasmid left in the SapI-
digested lane (lanes 3-4, Fig. 4.8 C). 
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    A                                                               B 
       
                                        
                                       C 
                                        
 
Figure 4.8. Cloning of Prp4 and Prp3 into pQLinkH. (A) Amplification of Cm Prp4 gene 
by PCR. (B) Restriction digest check of Cm Prp4 insertion into pQLinkH. (C) Restriction 
digest check of Cm Prp3 insertion into pQLinkH-Prp4. 
 
 
N-terminally His-tagged Prp4 was available both on its own and in the same 
plasmid as Prp3. This was important for a control to ensure both proteins could be 
visualized by SDS-PAGE (Fig 4.9). Prp4 was clearly expressed when Prp4- and 
Prp3/Prp4-tranformed E. coli cells were induced with IPTG at 37°C (lanes 3 and 5, Fig. 
4.9). While both proteins are similar in size, there was no difference between lanes 3 and 
5, suggesting that Prp3 was either not expressed or expressed poorly (Fig. 4.9).  
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Figure 4.9. SDS-PAGE analysis of Cm Prp3 and Prp4 co-expression through IPTG 
induction at 37°C. 
 
Using both IPTG as well as auto-induction (sections 4.4.4 and 4.4.5), several co-
expression trials were done at 16°C, 25°C, and 37°C (Fig. 4.10). A single band above the 
45 kDa marker appeared after co-expression for all 3 temperatures, but whether or not it 
contained both Prp3 and Prp4 was unknown (lanes 3-4, 6, 8, Fig. 4.10). Auto-induction 
worked at 16°C but remained ambiguous for 37°C (lanes 4, 9, Fig. 4.10). Co-expression 
attempts of Prp3/4 thus far have only confirmed expression of Prp4. Restriction enzyme 
digest and DNA sequencing confirmed that both genes were present and properly 
oriented (Fig. 4.8 C). Both genes contained a T7 promoter sequence, but transcription 
efficiency is nonetheless lower for downstream genes (Kim et al., 2004). 
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Figure 4.10. SDS-PAGE analysis of Cm Prp3 and Prp4 co-expression through IPTG and 
auto-induction at various temperatures. 
 
N- and C-terminal 6x His-tag versions of Prp31 were cloned. Both constructs 
were transformed into E. coli and induced with IPTG at 37°C (Fig. 4.11). N-terminally 
tagged Prp31 appeared to weakly express at 37°C (lanes 2-3), but no convincing bands 
appeared for the C-terminal tagged version (lanes 4-5, Fig. 4.11).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11. SDS-PAGE analysis of Cm Prp31 expression through IPTG induction at 
37°C. 
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Further attempts were made to check the expression of Prp31 at 16°C, 25°C, and 
37°C (Fig. 4.11). Unfortunately there was no evidence by SDS-PAGE that Prp31 was 
successfully induced at any temperature using IPTG (Fig. 4.12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.12. SDS-PAGE analysis of Cm Prp31 expression through IPTG induction  
at various temperatures. 
 
4.6.4. Prediction of Intrinsically Disordered Regions 
X-ray crystal structures exist for the complete sequences of Snu13 (PDB ID 
5EWR), LSm (4M77), and Sm (3CW1) proteins. X-ray crystallography demands that the 
protein be highly structured so that the electron density is high enough for mapping 
(Dunker et al., 2001). Indeed, a protein that is highly dynamic or flexible would be 
difficult to even crystallize, as crystallization occurs when a homologous sample creates 
a uniform lattice. Crystal structures of Prp3, Prp4, and Prp31 are all incomplete; the only 
full-length structures of these proteins have been obtained through cryogenic electron 
microscopy (Nguyen et al., 2015; Agafonov et al., 2016). The inability of these proteins 
to readily crystallize suggests there are flexible regions that allow for flip-flopping in 
solution. A region that is flexible is often defined as being intrinsically disordered 
(Iakoucheva and Dunker, 2003). Intrinsically disordered proteins (IDPs) are regularly 
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difficult to recombinantly express and purify (Dunker et al., 2001). In an effort to 
determine why Prp3, Prp4, and Prp31 were difficult to work with, in silico mapping of 
intrinsic disorder was performed. Using the DisEMBL Intrinsic Protein Disorder 
Prediction 1.5 server, intrinsically disordered regions were first predicted for Snu13 (Fig. 
4.13).  
           
Figure 4.13. Output for Predicted Intrinsic Disorder of the DisEMBL Intrinsic Protein 
Disorder Prediction 1.5 server. Example output for Cm Snu13. Loops/Coils are blue, Hot-
Loops are red, and Remark-465 is green. Loops/Coils is defined by the “Dictionary of 
Secondary Structure of Proteins” and each residue is assigned a secondary structure value 
(alpha helix, 3-10, beta strand, or none). Hot-Loops are a subset of Loops/Coils, whereby 
mobility is predicted based upon C-alpha temperature B-factors. Remark-465 searches 
for missing coordinates in submitted X-Ray structures submitted in the RCSB PDB. 
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Snu13 was used as a control to adjust the parameters of the algorithm, as its 
crystal structure was previously characterized (Fig. 4.14 A; Black et al., 2016). By 
altering parameters for predictions according to Loops/Coils, Hot-Loops, and Remark-
465, Loops/Coils produced the most reliable prediction when compared to the crystal 
structure of Snu13 (Fig. 4.14 A). Loops/Coils is defined by the “Dictionary of Secondary 
Structure of Proteins” and each residue is assigned a secondary structure value: alpha 
helix, 3-10, beta strand, or none (Dunker et al., 2001; Iakoucheva and Dunker, 2003). 
Hot-Loops are a subset of Loops/Coils, whereby mobility is predicted based upon C-
alpha temperature B-factors. Remark-465 searches for missing coordinates in submitted 
X-Ray structures submitted in the RCSB PDB. 
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Figure 4.14. Map of predicted intrinsically disordered regions within the U4/U6 di-
snRNP proteins. (A) Crystal structure of C. merolae Snu13 with the first 33 amino acids 
highlighted to show the lack of electron density (PDB ID 5EWR). (B) Bar graph of 
predicted disorder (left) and recombinant protein expression (right) for C. merolae 
proteins Snu13, Prp3, Prp4, and Prp31. The left vertical axis describes the predicted 
intrinsic disorder, denoted by black bars. The right vertical axis describes the protein 
expression relative to Snu13 in E. coli. Analysis was done using the DisEMBL Intrinsic 
Protein Disorder Prediction 1.5 server. 
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Intrinsic disorder was then predicted for Prp3, Prp4, and Prp31 (Fig. 4.14 B). 
Total predicted intrinsic disorder was plotted against expression of the same protein (Fig. 
4.14 B). Predicted disorder and protein expression were not good indicators for each 
other, as Snu13 and Prp4 were 22% and 30% disordered; yet both resulted in protein 
expression (Fig. 4.14 B). Prp3 and Prp31, similar to Snu13 in total predicted disorder, 
could not be expressed (Fig. 4.14 B). It might also be that the location of intrinsic 
disorder affected expression success, but Prp3 and Prp4 both have flexible regions on the 
N- and C-terminals, yet Prp3 was not visibly expressed (Fig. 4.14 A). Failure to express 
Prp3 and Prp31 could still be explained by loss of transcriptional efficiency and location 
of disordered regions (Dunker et al., 2001; Kim et al., 2004). 
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Chapter 5 
General Discussion and Conclusion 
5.1. Improving the yield of the Msl5/Mud2 dimer 
The expression and purification of Msl5/Mud2 dimer was inefficient. 2 L of 
transformed Rosetta pLysS cells were induced with 1 mM IPTG for 14 hours at 28°C. 
The lysate was affinity purified via batch binding followed by size exclusion 
chromatography. This method produced 70 uL of CmMud2/Msl5 dimer at a 
concentration of 2000 nM. There are several steps that could be optimized. Overnight 
expression conditions should involve a lower temperature (i.e. 18°C), and auto-induction 
should also be attempted. The volume of culture should be increased and the affinity 
purification should be done using the FPLC system. Using an FPLC system for the 
immobilized metal ion affinity chromatography (IMAC) has advantages for purifying a 
protein complex, namely that it is more controlled, less disruptive, and allows for an 
elution gradient accompanied with UV sensors. 
5.2. Role of the branchpoint bridging protein Msl5 
Full length Msl5 binds the Cm BPS/pre-mRNA with similar affinity to reported 
values for homologous interactions (Tables 2.17, 2.18, and 2.20). Alignment of the 
protein sequence against human and yeast revealed that the only conserved domain 
present in C. merolae is KH-QUA2, which is necessary and sufficient for RNA binding 
activity in humans (Fig. 2.4 and 2.6; Berglund et al. 1998a; Liu et al. 2001). While RNA 
binding is localized to KH-QUA2, human SF1 requires U2AF65 (Mud2) for optimal 
binding and target specificity (Berglund et al. 1998b). KH-QUA2 comprises the #1-"1-
"2-#2-#3-"3-"4 topology adopted by the STAR family of proteins (Vernet and Artzt, 
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1997; Liu et al. 2001). The domain folds into a hydrophobic groove that binds the single-
stranded BPS (Fig. 2.6 B; Liu et al., 2001). Yeast BBP diverges from SF1 and other 
homologs as it requires the N-terminal Zinc knuckle for RNA binding activity, but not 
Mud2 (Garrey et al. ,2006). The additional Zinc knuckle may explain why BBP prefers a 
BPS with an upstream stem loop (Fig. 2.4; Berkowitz et al., 1995). Since Msl5 lacks a 
Zinc knuckle motif, KH-QUA2 is expected to be necessary and sufficient for BPS 
binding activity in C. merolae. Overall, Msl5 is expected to be similar to human SF1 in 
that KH-QUA2 is necessary and sufficient for BPS selection, The RNA binding domain 
is located in the middle of Msl5 and is the only region of Msl5 predicted to have 
secondary structure (Fig. 2.4). It would be interesting to probe the function of the 
flanking regions by incorporating truncations or mutations. Perhaps the unstructured 
sequences interact with Mud2 and bypass the need for a canonical ULM (Fig. 2.5). 
5.3. Bridge between Msl5 and the 5’ splice site   
The yeast two-hybrid assay revealed that yeast BBP contacts Mud2 and Prp40, 
while Prp40 contacts U1, BBP and Prp8 (Abovich and Rosbash, 1997). In this way, 
Prp40 links the 3’ and 5’ splice sites by interacting with BBP and U1 (Fig. 1.3). Prp40 is 
missing in C. merolae, along with all other U1 associated proteins (Stark et al. 2015). 
One possibility is that Mud2 replaces the role of Prp40. While there is no sequence 
similarity between the proteins, much of the Mud2 sequence is novel and likely 
disordered. Intrinsically disordered proteins are evolutionarily advantageous as they can 
accommodate several different protein interactions (Dunker et al., 2001). Rsp31 or 
SRSF2 could also fill the role of Prp40, or interact with Mud2 to bridge the BPS and 5’ 
splice site. Rsp31 and SRSF2 are serine-arginine (SR) rich splicing factors; SR proteins 
!! 128 
are postulated to facilitate the 5’ SS-BPS bridge (Krainer et al., 1990; Kohtz et al., 1994; 
Li and Manley, 2005). The SR proteins do not and would not require secondary 
structures similar to that of Prp40. Prp40 is characterized as having a WW domain: 40 
amino acids containing several proline repeats and two tryptophan residues 20 residues 
apart (Bork and Sudol, 1994). The resulting fold produces a curved, triple-stranded 
antiparallel #-sheet (Macias et al., 1996). Several motifs have been recognized as ligands 
for WW domains, including: PPxY, LPxY, phosphoserine, and phosphothreonine 
(Aragón et al., 2012; Bruce et al. 2008; Lu et al., 1999). Cm Msl5 lacks the PPxY/LPxY 
motif, suggesting a novel protein-protein interaction is responsible in bridging the BPS 
and 5’ SS (Fig. 2.4 and 2.5). To verify a novel functional interaction of Msl5 or Mud2 
against Rsp31 and SRSF2, several in vitro (gel shift, fluorescence polarization) or in vivo 
(yeast two hybrid, fluorescence microscopy) methods are available. 
5.4. Role of the U2 Auxiliary Factor Mud2 in C. merolae 
The interaction between Msl5 and the BPS in Cm was confirmed by both 
fluorescence polarization and EMSAs, but several questions are left unanswered (Fig. 
2.8-2.9, 2.14-2.17). Do Mud2 and Msl5 recognize the BPS as a dimer, or does one of the 
proteins bind RNA first? What is the sequence recognized by Mud2, and is there still a 
preference for uridine despite the lack of a Py-tract or poly-U region? The 145 kDa Mud2 
is also much larger than the 54 kDa human or 60 kDa yeast homologs, and rigorous 
BLAST searches failed to generate a single search result for the first 800 amino acids 
(Stark et al. 2015). It would be very interesting to study the function of the N-terminal 
half of Mud2, as it may have evolved to replace an otherwise essential protein that is 
missing in C. merolae. Structural studies of a complex of Msl5, Mud2, and pre-mRNA 
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using cryo-EM or X-ray crystallography would provide insight into the mechanism of 
BPS recognition. Cryo-EM is able to capture different conformational states of the likely 
dynamic and intrinsically disordered Mud2, where as cross-linking and/or truncations 
would likely be required for X-ray crystallographic studies. 
5.5. Displacement of Msl5/Mud2 from the pre-mRNA 
Once the BPS/3’ SS has been recognized by Msl5/Mud2, the proteins must be 
displaced in order for U2 snRNA to base-pair with the BPS/3’ SS region and drive the 
Commitment Complex into the Pre-Spliceosome of the splicing reaction. Two DExD/H 
box proteins, Sub2 and Prp5, have been implicated in the displacement of Msl5/Mud2.  
Genetic experiments in yeast have shown that the function of Sub2 is not needed if the 
Mud2 gene is deleted (Kistler and Guthrie, 2001). Prp5 drives the Commitment Complex 
(Complex E, Fig. 1.1; Fig. 1.2) to the Pre-Spliceosome stage (Complex A, Fig. 1.1; Fig. 
1.4) in an ATP-dependent manner (Perriman and Ares, 2000). Perhaps Sub2 displaces 
Mud2 in C. merolae as well, although the mechanism for Msl5 displacement remains 
unknown. With so many related diseases and a spliceosome that offers complexity, pre-
mRNA splicing is a competitive field of study. Elucidating the mechanism of Msl5 
displacement is arguably the most urgent step forward from this research. Once 
understood, it would unlock new information applicable to all eukaryotes and possibly 
offer a pharmaceutical target for a splicing-related disease. 
5.6. Prp4 connects Snu13 and the 5’ Stem Loop with Stem II 
Binding assays and X-ray crystallography have revealed conservation of the 
function and structure of Snu13. The crystal structure of Snu13 (5EWR) is the first 
reported structure of a Cyanidioschyzon merolae splicing protein (Fig. 3.5). The next step 
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of this project would be to confirm the Snu13-Prp4 interaction in vitro. It has long been 
known that the Snu13-Prp3/Prp4 interaction connected the U4 5’ Stem Loop with Stem II 
of the di-snRNP (Nottrott et al., 2002). The interaction between Snu13 and Prp4 
specifically was suggested when high-resolution cryo-EM structures showed that they 
were more proximal to each other than Snu13 and Prp3 (Nguyen et al., 2015; Agafonov 
et al., 2016). A biochemical assay has yet to support the protein-protein interaction and 
offers an opportunity to validate the canonical di-snRNP architecture using C. merolae. 
5.7. Assembly of the U4/U6 di-snRNP 
Snu13 and Sm proteins were both able to assemble onto base-paired U4/U6 di-
snRNA (Fig. 4.5 and 4.6). Thus far, U4/U6 di-snRNP assembly in C. merolae is similar 
to human and yeast models, in that Snu13 and Sm proteins require only U4 or base-
paired U4/U6 (Nottrott et al., 2002; Hardin et al., 2015). The LSm complex did not 
appear to interact with the U4/U6 di-snRNA, as the lane with U4/U6 appeared to be the 
same as U4/U6 mixed with the LSms (Fig. 4.6 B). It is possible that the recombinant 
LSm complex was denatured or misfolded. Furthermore, the pI of the LSm complex 
(>10) gave it a global positive charge; perhaps the pI affected how the sample migrated. 
To address the possibility of a denatured/misfolded complex, freshly purified 
recombinant LSms should be centrifuged prior to use in the EMSA. To address the 
possibility that the positively charged LSms ran upward, EMSAs should be performed 
with the electrodes reversed. 
5.8. Chaperones and solubility factors of thermophilic organisms 
Prp3 and Prp31 were not successfully expressed. In an effort to determine the 
cause of poor expression, an in silico analysis of intrinsically disordered regions was 
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done. There was no obvious link between predicted disorder and expression (Fig. 4.13). 
Perhaps the failed expression was not due to intrinsic disorder or transcriptional 
inefficiency; the problem could be the thermophilic nature of Cyanidioschyzon merolae 
(Sterner and Liebl, 2001). Thermophilic organisms have adapted to survive harsh 
conditions. Protein synthesis is a costly event and the thermophile would have likely 
evolved a strategy to maintain protein levels as efficiently as possible at high 
temperatures. Translation and degradation is one way to regulate protein turnover. A less 
energetically costly method would be to have reduced synthesis coupled with repair 
pathways and solutes that help to keep proteins stable. It may also be that some genes 
from a thermophile such as C. merolae require chaperones (bacterial chaperones GroEL 
and GroES may help) or specific ions present during protein synthesis (Sterner and Liebl, 
2001). The Rosetta pLysS E. coli strain was used throughout this thesis because it 
featured an additional plasmid with tRNA rare to E. coli, an eloquent reference to the 
Rosetta Stone and the ability to recognize more codons. Having rare codon tRNA should 
improve success with recombinant expression of eukaryotic proteins. These tRNA genes 
have been optimized for human expression, however, and may not be optimal for Cm 
proteins. One final thought that may be useful for future expression work is optimizing 
promoter strength and plasmid copy number for each specific protein/complex. Many of 
these Cm splicing factors are RNA binding proteins, which may well wreak havoc in a 
bacterial cell, resulting in toxicity and poor expression. 
5.9. Intrinsically disordered regions and splicing proteins 
BLAST searches and multiple sequence alignments suggested there were regions 
of Msl5 and Mud2 that lacked secondary structure or “order” (Fig. 2.4 and 2.19). CD 
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Spectroscopy of Msl5 revealed 20% of the protein was intrinsically disordered (Table 
2.20). The crystal structure of Snu13 lacked electron density for the first 33 residues, 
indicative of a random coil (Fig. 3.4, 3.5, 4.13). Predictions of intrinsic disorder within 
di-snRNP proteins Snu13, Prp3, Prp4, and Prp31 ranged from 20-30% (Fig. 4.13). All of 
these results paint a picture that intrinsically disordered regions may be important for the 
function of C. merolae splicing proteins. Pre-mRNA splicing is an incredibly dynamic 
process where splicing factors are constantly rearranged or undergoing conformational 
changes. It would be evolutionarily advantageous for an organism with a reduced 
spliceosome to have intrinsically disordered proteins, as they are able to interact with 
multiple protein targets (Dunker et al., 2001; Iakoucheva and Dunker, 2003). 
5.10. Conclusion 
Msl5 interacts with the BPS with an affinity of about 50 nM, which is similar to 
literature values for yeast BBP and human SF1/U2AF65. During the recognition of an 
intron-containing pre-mRNA, branchpoint sequence selection in C. merolae is likely 
driven by Msl5 and stabilized by Mud2. The large and unique Mud2 protein may have a 
novel role in C. merolae beyond facilitating BPS recognition. Structural and functional 
studies of Snu13 and Msl5 have revealed that some Cm splicing factors are highly 
conserved. Snu13 represents the first crystal structure of a C. merolae splicing protein to 
be reported (PDB ID 5EWR). While Snu13 is highly similar to human and yeast, so too 
is the U4 5’ stem loop with the exception of a single nucleotide (G29A), which remains a 
purine. These results highlight the conservation and importance of the Snu13-U4 
interaction during di-snRNP assembly. Several components of the U4/U6 di-snRNP, 
including U4, U6, Snu13, and the Sm proteins were able to assemble in a stepwise 
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manner. Di-snRNP proteins Prp3, Prp4, and Prp31 were not successfully expressed and 
purified, leading to an investigation of novel or unstructured regions of the protein. It was 
found that several di-snRNP proteins in C. merolae were extended or intrinsically 
disordered, suggesting that some splicing factors may be performing multiple roles. This 
work has demonstrated that C. merolae is an interesting organism in which to study pre-
mRNA splicing. Conservation of a Cm structure or function underscores critically 
important aspects of splicing, while novelty reveals adaptations unique to the 
thermophilic red alga. 
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